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1. Introduction 
With the completion of the “Human Genome Project” in 2004, the post-sequencing 
era began, and scientists now were presented with the challenge to unravel every 
gene’s function (Wiemann et al., 2004).  Since experimental approaches in humans 
are limited due to technical and ethical reasons, animal models became important 
elements of biomedical research (Bockamp et al., 2002, Macchiarini et al., 2005). By 
using forward and reverse genetic approaches, various diverse murine models for 
experimental research purposes were already generated. Nevertheless, there is still 
a huge ‘phenotype gap’, that is the void between the available mouse mutant re-
source and the entire range of possible phenotypes. Closing this gap is necessary to 
fully elucidate genotype-phenotype correlations that hopefully lead to the discovery of 
novel strategies in prevention, diagnosis and therapy of human disease (Brown and 
Peters, 1996). Especially in the field of kidney diseases experimental animal models 
are urgently required. The incidences and prevalences of chronic progressive kidney 
diseases (CKD), especially occurring in the course of metabolic disorders, e.g., dia-
betic nephropathy (DN), are steadily rising and already represent a major health 
problem worldwide (Ritz, 2006, Jha et al., 2013). To this day, the complex pathoge-
netic processes of CKDs are not entirely understood. In particular, the relevant risk 
factors and conditions, that promote their development, have only in part been identi-
fied yet. In the past years, however, several different studies provided evidence for 
an existing causative link between a low nephron endowment, that is the number of 
nephrons per kidney after the completion of nephrogenesis, and the occurrence of 
hypertension and chronic kidney diseases later in life (Bertram et al., 2011). 
Pou3f3L423P mutant mice, recently derived from the phenotype-driven Munich ethyl-
nitrosourea (ENU) Mouse Mutagenesis Project harbor a recessive mutation in the 
transcription factor Pou3f3-gene. Initial phenotypic analysis revealed that adult ho-
mozygous Pou3f3L423P mutants of both sexes display increased plasma urea levels 
and smaller kidney weights as compared to heterozygous Pou3f3L423P mutants and 
non-mutant controls, possibly indicating renal dysfunction (Kumar et al., 2016). 
The present study used functional, as well as qualitative and quantitative morpholog-
ical analyses to characterize the renal phenotype of Pou3f3L423P mutant mice in order 
to gain further insight into the role of the transcription factor Pou3f3 in kidney devel-
opment and function, and to examine the suitability of Pou3f3L423P mutant mice as 
model organisms for nephrological research. 
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2. Scientific Background 
2.1. Genetic modification in the mouse 
The main challenge of the post sequencing era still remains in unraveling every 
gene’s function and the complex interactions of different genes in different tissues 
within the living organism (Wiemann et al., 2004). Among the many different animal 
models used for that purpose nowadays, the laboratory mouse regularly continues to 
be the model of choice (Rosenthal and Brown, 2007). Mice are easy to handle, main-
tain and transport, they reproduce quickly and their short lifespan makes it possible to 
study all stages of life within an adequate time frame. Furthermore, the availability of 
inbred strains facilitates the accuracy and reproducibility of experiments by reducing 
phenotypical variability owed to genetic differences (2001, Silver, 1995). This fact, in 
combination with the ability to modify the murine genome in a plethora of ways, 
makes mice the ideal candidates to mimic human disease states and study gene ac-
tions (Kile and Hilton, 2005, Acevedo-Arozena et al., 2008, Ericsson et al., 2013). 
Over the past years, many different methods of genetic modification have been es-
tablished. Basically, these methods can be classified in two categories. For one, 
there is a “gene driven” approach, where a selected candidate (endogenous or het-
erogenous) gene is overexpressed or otherwise modified, e.g., by use of homologous 
recombination in embryo-derived stem cells or gene-trap strategies, resulting in the 
production of a knock-out or knock-in organism (“reverse genetics”) (Thomas and 
Capecchi, 1987, Evans et al., 1997). Well established methods of genetic modifica-
tion in mice comprise pronuclear DNA microinjection, sperm-mediated as well as len-
tiviral gene transfer techniques, and somatic cell nuclear transfer (“cloning”) 
(Auerbach, 2004, Lavitrano et al., 2006, Pfeifer and Hofmann, 2009, Wilmut et al., 
2015). Furthermore, several novel genome engineering techniques emerged, that 
allow a broad range of alterations at specific DNA locations. Among these are chi-
meric nucleases, such as zinc-finger endonucleases (ZFN) and transcription activa-
tor-like effector nucleases (TALEN), consisting of a DNA-binding molecule, that is 
programmable and sequence-specific and linked to an unspecific DNA cleavage do-
main, as well as CRISPR (clustered regulatory interspaced short palindromic re-
peats)/CRISPR-associated (Cas) systems, which facilitate RNA-guided DNA modifi-
cation. In particular, the CRISPR-Cas technology presents an efficient and easily 
available tool for customized DNA alterations (Gaj et al., 2013). Altogether, the estab-
lished genetic engineering methods allow the in-detail assessment of hypotheses 
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regarding the function of specific genes, as well as the meticulous dissection of des-
ignated molecular pathways. However, presumptions about these gene functions and 
pathways need to be made in advance and the resulting phenotype is rarely predict-
able and therefore, does not always mirror the respective human disorder or condi-
tion (Russ et al., 2002). 
This issue is addressed by a completely different, complementary strategy, known as 
the “phenotype driven” approach. By using physical (ionizing radiation like gamma 
rays or X-rays) or chemical methods (e. g., procarbazine, N-ethyl-N-nitrosourea 
(ENU), chlorambucil), random mutations are generated. In the first instance the re-
sulting mutant offspring (i.e.,“founders”) are screened for interesting phenotypes 
(“forward genetics”). In subsequent analyses, the mutation causative for the observed 
phenotype is identified. That way yet unknown gene functions and pathways can be 
unraveled without previously needed knowledge about the genetic basis of distinct 
disease processes ( Russell et al., 1979, Rathkolb et al., 2000, Nguyen et al., 2011).  
Ionizing radiation and chlorambucil tend to cause large DNA deletions involving sev-
eral genes, making it difficult to identify the affected locus. Therefore, ENU with its 
preference to induce point mutations became the most favoured mutagen (Balling, 
2001). 
 
2.1.1. N-ethyl-N-nitrosourea (ENU) mutagenesis 
N-ethyl-N-nitrosourea (ENU) has long been known as the most potent germline mu-
tagen in mice (Russell et al., 1979, Weber et al., 2000). As a monofunctional alkylat-
ing agent, ENU has the property of transferring an ethyl group to reactive oxygen or 
nitrogen sites of the DNA. This leads to a DNA mismatch during replication 
(Noveroske et al., 2000), mainly inducing point mutations by single base-pair substi-
tutions (A-T to T-A transversions and A-T to G-C transitions). The predominant re-
sults are missense mutations (64%), however, nonsense mutations (10%) and splic-
ing errors (26%) can be found as well (Shibuya and Morimoto, 1993, Justice et al., 
1999). 
ENU is usually administered to adult male mice by a sequence of intraperitoneal in-
jections and mostly affects premeiotic spermatogonial stem cells. Hereby, the optimal 
dose and administration regime vary according to the strain of mouse being used 
(Weber et al., 2000).  Since the actions of ENU are dose-dependent, increased dos-
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es might cause higher mutation rates. However, the toxic and carcinogenic effects of 
ENU increase concomitantly, eventually leading to decreased viability and fertility. 
Treatment regimens with fractionated administration of a total ENU dosage of 250 – 
300 mg/kg were shown to yield better results regarding survival and fertility recovery 
rates than those with one single dose of 150 – 200 mg/kg (Cordes, 2005). These op-
timized treatment regimens can reach mutation rates of up to 1,5-6 x 10-³ per locus, 
that is one mutation every 1 to 2,5 Mb (Hitotsumachi et al., 1985, Aigner et al., 2008). 
Every gamete of an ENU-treated male harbours up to 1000 mutations, eventually 
giving rise to about 20 functional mutations (Hitotsumachi et al., 1985, Augustin et al., 
2005). Most of the time, these mutations lead to hypomorphic alleles (partial loss of 
function), they can, however, also result in nullimorphic alleles (complete loss of func-
tion), or even alleles with a gain of function (hyper-, neo-, antimorphic) (Noveroske et 
al., 2000). This is an additional advantage of ENU mutagenesis, as it bears the po-
tential of creating an allelic series that allows for investigation of a genes different 
activity levels and therefore mapping of functional domains (Barbaric and Dear, 
2007). Allelic series are usually established in region-specific screens, that focus on 
mutations in a particular chromosomal segment (Kile and Hilton, 2005). Genome-
wide screening strategies on the contrary aim for identifying candidate genes all over 
the genome, thus being very suitable for studying genetic diseases that involve dif-
ferent genetic and biochemical pathways (Kile and Hilton, 2005, Fox, 2007). In the 
last two decades, several large-scale ENU mouse mutagenesis projects have been 
established world-wide, allowing the systematic and efficient generation and estab-
lishment of numerous mutant mouse lines (Aigner et al., 2008, Nguyen et al., 2011). 
 
2.1.2. The Munich ENU mouse mutagenesis project 
As a part of the “German Human Genome Project”, the Munich ENU mouse muta-
genesis project is a large-scale, genome-wide, phenotype-driven approach to gener-
ate, detect and define new mutant mouse lines by ENU mutagenesis, which are rele-
vant for human inherited diseases (Hrabé de Angelis and Balling, 1998).  
Ten week old male mice on a C3HeB/FeJ (C3H) inbred genetic background are in-
jected intraperitoneally with ENU at a dose of 90 mg/kg three times in weekly inter-
vals (Hrabé de Angelis et al., 2000). After the treatment mice undergo an approxi-
mately 10 week long period of sterility, which is seen as indicator for a successful 
treatment (Russell et al., 1979). Subsequently the ENU-treated male mice are mated 
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to C3H wild-type females. The resulting first generation (G1) is screened for domi-
nant mutations, indicated by obviously aberrant phenotypes. Subsequently, miscella-
neous back- and side-crosses are carried out to define the mutations inheritance and 
to reveal recessive mutations in G3 animals (Hrabé de Angelis et al., 2000, Aigner et 
al., 2008). Moreover, non-causative mutations will be eliminated by approximately 
50% per generation, i.e., after 5 backcrosses, mouse mutants only possess one mu-
tation on the average (Aigner et al., 2008). Depending upon the presence of domi-
nant and recessive mutations, G1 and G3 animals undergo phenotyping, which in-
cludes, but is not limited to, clinical chemistry, behavior, dysmorphology, neurology, 
immunology, pathology and molecular expression profiling analyses (Hrabé de 
Angelis et al., 2000, Balling, 2001). Since ENU mutagenesis does not allow the use 
of molecular markers, identification of the mutated gene is done by linkage analysis 
using an outcross-backcross panel. Heterozygous mutants (C3H background) are 
mated to wild-type mice of another inbred strain such as BALB/c or C57Bl/6. From 
the resulting G1 offspring, male hybrids displaying the phenotype are then again 
mated to wild-type females of the second inbred strain. DNA analysis using a panel 
of genome-wide single-nucleotide polymorphisms (SNPs) or microsatellites, which 
are polymorphic for the two utilized inbred strains, is then carried out on samples 
from phenotypically mutant and phenotypically non-mutant G2 offspring (Lindblad-
Toh et al., 2000). 
Genotypic distinction yields determination of the chromosomal region in question, 
which is heterozygous in phenotypic G2 mutant mice and homozygous for the 
C57BL/6J genotype of the second inbred strain in phenotypic G2 non-mutant mice. 
For mapping of the causative mutation to a specific chromosomal region only 50 
phenotypic mutant G2 animals are needed. With the determination of the number of 
scored meioses and number of loci that exhibit combination of recombinant alleles, 
validation of the hypothesis regarding the linkage of two loci is realizable by chi-
squared (χ²) testing. Candidate gene selection and sequencing is therefore, based on 
linkage analysis in combination with the availability of the mouse genome sequence 
(Silver, 1995, Green, 1997, Balling, 2001). 
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2.1.3. Establishment of the mutant mouse line Pou3f3L423P 
The mouse line Pou3f3L423P was recently derived from the Munich ENU mutagenesis 
project within a special screen conducted to reveal kidney disease models. Hereby, 
elevated plasma urea levels (cut-off values: >70 mg/dl for males and >65 mg/dl for 
females) were used as a marker for impaired kidney function (Aigner et al., 2007). 
Initially, the line was referred to as HST011 (UREHR2), after identification of the 
causative mutation, the name was specified as Pou3f3L423P. 
Pou3f3L423P mutant mice harbor a recessive mutation in the transcription factor 
Pou3f3 gene, affecting the highly conserved homeodomain of the protein. Sequence 
analysis revealed a T→ C transition at nt 1268 (ENSMUST00000054883), leading to 
a missense mutation, namely an amino acid exchange from leucine to prolin at codon 
423. Homozygous mutant mice of both sexes are viable and fertile. In comparison to 
non-mutant littermates, they display a reduced body size and body weight, whereas 
other grossly evident phenotype alterations were not detectable (Kumar et al., 2016).  
Systemic phenotyping, following a standard protocol, which involves a wide array of 
parameters was performed in the German Mouse Clinic using homozygous 
Pou3f3L423P mutants and non-mutant controls of both sexes. Apart from increased 
plasma urea levels and reduced body and kidney weights, Pou3f3L423P mutants of 
both sexes display certain metabolic changes associated with renal dysfunction such 
as increased serum levels of creatinine, chloride and potassium, a slightly microcytic, 
erythropenic anemia, as well as decreased bone mineral density and content. Be-
sides, mutant mice display increased locomotor activity, but a decreased rearing ac-
tivity. This, however, is most likely due to deficits in balance, since the vestibular or-
gan of Pou3f3L423P mutants shows an abnormal diameter and curvature of the supe-
rior semi-circular canal. Regarding the inner ear, the hearing sensitivity of mutant an-
imals also seems impaired (Kumar et al., 2016). For a detailed analysis of the pheno-
type of Pou3f3L423P mutant mice, the interested reader is referred to the publication of 
Kumar et al. (2016).  
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2.2. Kidney structure and embryonic development 
2.2.1. Morphological and functional segmentation of the nephron 
The functional unit of the kidney is the nephron, which shows a characteristically 
segmented pattern. It consists of the renal corpuscle with the glomerular tuft and the 
Bowman’s capsule, where the blood is filtered into a tubular system, consisting of a 
proximal and distal part, linked by the loop of Henle with its thin descending (TDL) 
and thick ascending limb (TAL). In the tubular system, the filtrate is modified by reab-
sorption, secretion and concentration processes until it is finally delivered to the col-
lecting ducts for elimination (Kriz and Koepsell, 1974). The glomerular filtration barrier 
is composed of three layers, the fenestrated glomerular capillary endothelium, the 
glomerular basement membrane (GBM), and the podocyte slit diaphragm and pro-
vides substantial resistance to the hydrodynamic flow. When intact, the glomerular 
filter and its charge and size selectivity only allows particles smaller than approxi-
mately 69 kDa and preferably non- or positively charged molecules to pass. There-
fore, it prevents the loss of albumin with a molecular weight of around 63- 69 kDA. 
After filtration, the primary urine is isosmotic with the blood plasma. It continues to the 
proximal tubule, which is composed of a convoluted and straight part. The main func-
tion of this nephron segment consists of the reabsorption of filtered solutes. To en-
large the resorptive capacity, its lining cuboidal epithelial cells carry a luminal micro-
villi brush border and possess numerous mitochondria that provide energy for active 
transport systems (Taal et al., 2012). Of significance is the basolateral Na+/K+-
ATPase that facilitates the reabsorption of sodium. Water follows passively along the 
concentration gradient. Furthermore, the generated sodium gradient drives several 
co-transport channels for the reabsorption of glucose, amino acids and inorganic 
phosphate. Potassium and urea leave the lumen via simple diffusion and paracellular 
solvent drag. In addition, the proximal tubule is also important for the secretion of or-
ganic ions including ammonium and creatinine (Cunningham and Klein, 2013). The 
following intermediate tubule i.e. the thin descending limb of Henle’s loop (TDL) is 
defined by its passive permeability and spatial configuration in the renal medulla, 
which are both essential for water reabsorption. In mammals, there are short and 
long looped nephrons. The ones situated in the superficial or midcortical zones of the 
kidney generally possess short loops of Henle, whereas juxtamedullary nephrons 
hold long loops of Henle, which descend down into the inner medullary zone and play 
a major role for the urine concentration ability (Kriz and Koepsell, 1974). The de-
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scending thin limb has a low permeability for ions and urea, but is highly permeable 
for water. By presence of a high solute concentration in the surrounding renal medul-
la, this allows for osmosis and thus a substantial increase in urine concentration. The 
thin ascending limb, in contrast, is not permeable for water anymore but for ions, 
which as a consequence of the highly osmotic urine then follow along the concentra-
tion gradient from the tubular lumen into the medullary interstitium. This renders the 
interstitium near the papilla hyperosmotic and the passing urine hypoosmotic. The 
function of the ensuing straight part of the distal tubule, also known as thick ascend-
ing limb (TAL) of the loop of Henle is vital for creating and maintaining a hypertonic 
medullary interstitium, which provides the basis for the renal urine concentration 
mechanism via the countercurrent multiplier system. In the TAL, sodium, potassium 
and chloride ions are actively reabsorbed by the Na+-K+-2Cl- -cotransporter (NKCC2), 
which is exclusively expressed in this segment. At the same time the TAL is imper-
meable to water. Via K+-channels such as ROMK, potassium ions passively travel 
back into the tubular lumen, creating a positive electron potential. As a consequence, 
divalent cations such as Mg²+ and Ca2+ are absorbed via paracellular transport 
(Mount, 2014). Salt reabsorption is actively driven by the basolateral Na+/K+-ATPase, 
which transports Na+ into the interstitial fluid. Cl- ions follow along their chemical gra-
dient through CLC chloride channels. In the TAL at least two types of CL-
transporters, CLC-K1 and CLC-K2 are coexpressed. Moreover, the K+/Cl- cotrans-
porter (KCC4) allows for electroneutral K+- dependent passing of Cl- ions into the in-
terstitium (Mount, 2014). The TAL also plays an important role for acid-base balance 
by excreting ammonium and reabsorbing up to 15% of filtered bicarbonate. This is 
mainly facilitated by the Na+/H+-exchanger (NH3) (Mount, 2014). Furthermore the 
TAL together with the early convoluted part of the distal tubule are the origin of the 
abundant urinary glycoprotein (Uromodulin), also called Tamm-Horsfall protein 
(Pollak and Arbel, 1969, Pennica et al., 1987). The macula densa (MD), a cluster of 
specialized cells constituting the juxtaglomerular wall of the TAL at the point, where it 
meets the vascular pole of its parent glomerulus is critically involved in the regulation 
of the glomerular blood flow and thereby glomerular filtration rate (GFR). Depending 
on the intratubular sodium chloride concentration, the macula densa cells control the 
release of renin from juxtaglomerular cells and hereby regulate the tubular reabsorp-
tion of water and sodium via the renin-angiotensin-aldosterone-system (RAAS) (Burg, 
1982, Mount, 2014). 
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Figure 1) Selected transport pathways within the TAL 
Involved in transepithelial Na
+
Cl
- 
transport are e.g. NKCC2 (Na
+
-K
+
-2Cl
- 
cotransporter), K
+
-channels 
such as ROMK (renal outer medullary potassium channel), KCC4 (K
+
/Cl
- 
cotransporter) and CLC-K1/2 
(Cl
-
 channels).
 
The
 
NHE3 (Na
+
/H
+
-exchanger) is a key component of bicarbonate reabsorption (based 
on Mount, 2014). 
 
Following the loop of Henle, the distal convoluted tubule is the last segment of the 
tubular system before the filtrate reaches the collecting duct system and is excreted 
as urine. Just as its proximal counterpart, the distal convoluted tubule modifies uri-
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nary pH through the exchange of bicarbonate and protons. Upon that, it creates a 
Na+ concentration gradient via the basolaterally situated Na+-K+-ATPase. This caus-
es sodium to leave the lumen via simple diffusion or via a Na+/Cl- co transporter or a 
Na+/H+ antiporter, creating a negative electric potential all along the distal convoluted 
tubule. Consequently passive Na+ reabsorption is inhibited. Therefore the Na+-H+-
antiporter increases the secretion of H+ ions, creating an intracellular alkalosis and an 
accumulation of K+ ions in the tubular lumen. Contrary to the permanent electrolyte 
resorption in the proximal tubule, the distal tubule and the collecting duct respond to 
systemic signals, mainly hormones, such as aldosterone, angiotensin II, and antidiu-
retic hormone. This is urgently required to maintain homeostasis despite altered die-
tary intake or extra renal loss of salts and water (Reilly and Ellison, 2000, 
Cunningham and Klein, 2013). 
 
2.2.2. Embryonic and postnatal development of the murine kidney 
Mammalian nephrogenesis comprises the sequential formation of three pairs of kid-
neys, which arise from the intermediate mesoderm in cranio-caudal direction along 
the embryonic axis, recapitulating the phylogeny of the excretory system in the pro-
cess (Horster et al., 1999). In spatial and temporal sequence, the rudimental pro-
nephros evolves, followed by the temporarily functioning mesonephros and finally the 
permanent metanephros. Although there are significant differences in their complexi-
ty, they share the nephron as a basic structural unit (Desgrange and Cereghini, 
2015). In mice, pronephric development begins at embryonic day (E) 8 (McCrory, 
1972). Starting from the cranial part of the intermediate mesoderm, a subset of cells 
begins to aggregate and after undergoing mesenchymal-to-epithelial transition, an 
epithelial tube, the (pro)nephric duct begins to form. It keeps growing in caudal direc-
tion along the embryonic trunk until at E11 it reaches and fuses with the ventral por-
tion of the cloaca (Hoar, 1976). At its origin, a species-specific number of paired tu-
bules arise from the nephrogenic cord, one end opening into the coelom, the other 
into the nephric duct. As no further differentiation takes place, the development of the 
pronephros is aborted and also the cranial parts of the nephric duct undergo apopto-
sis (Davidson, 2008). The pronephros is mostly an atavistic structure, however, its 
evolutionary preservation is explained by the emergence of the (pro)nephric duct, 
whose caudal parts remain as the nephric (Wolffian) duct and eventually give rise to 
the permanent kidney (Moody, 2007). With the regression of the pronephric struc-
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tures at E9, the formation of up to 18 paired mesonephric tubules starts.  A clear dis-
tinction can be made between the cranial and the caudal sets, as only the first 4-6 
are connected to the nephric duct and fully developed. In spite of their simple design 
(no loop of Henle or juxtaglomerular apparatus are formed) these nephrons are able 
to produce scant amounts of urine. After all, the mesonephroi atrophy and degener-
ate from cranial to caudal at E14 (Vetter and Gibley, 1966, Sainio et al., 1997a). In 
males, some mesonephric tubules remain and form the vas deferens, epididymis and 
seminal vesicles. In females, they completely regress. Nevertheless the presence of 
the cranial parts of the nephric duct are required for the correct development of the 
Müllerian duct, which gives rise to the oviducts, uterine horns and parts of the vagina 
(Orvis and Behringer, 2007). The development of the enduring mammalian kidney 
begins with the formation of the metanephric mesenchyme from the posterior end of 
the intermediate mesoderm at around E10.5 (Dressler, 2006). For a short period of 
time, meso- and metanephros exist in parallel. 
 
Figure 2) Schematic overview of embryonal kidney development 
Mouse kidney development begins at about embryonic day (E) 8.5 with the formation of the (pro)nephric 
duct (ND) from the intermediate mesoderm (IM). Rostral parts undergo apoptosis while it elongates cau-
dally to reach the cloaca. In extending along the trunk the ND induces mesonephric tubule formation the 
adjacent IM. Around E10.5 the ureteric bud (UB) grows out of the ND into the metanephric mesenchyme 
(MM), a specialized population of IM cells. Reciprocal inductive interactions between the UB and the MM 
induce branching of the UB (adapted from Davidson et al., 2008, with permission). 
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The metanephric mesenchyme induces the outgrowth of the ureteric bud from the 
caudal end of the nephric duct. Subsequently the ureteric bud invades the metaneph-
ric mesenchyme at E11 and a series of reciprocal inductive interactions between 
these two primordial tissues triggers various morphogenetic differentiation events. 
Once the ureteric bud has entered the metanephric mesenchyme, it starts to grow 
and branch repeatedly in a dichotomous way, leading to the formation of the ureteric 
tree, which eventually becomes the urinary collecting duct system and the renal pel-
vis. The metanephric mesenchyme on the other hand develops into the nephrons, 
stroma, and most likely endothelia (Saxen and Sariola, 1987). Nephron formation 
begins with the epithelial cells at the ends of the ureteric bud prompting the surround-
ing mesenchyme cells to condensate, forming the induced mesenchyme or cap mes-
enchyme. The cap mesenchyme consists of several cell layers that are morphologi-
cally distinguishable from the more peripherally situated uninduced mesenchyme. 
Successively, a subset of cap mesenchyme 
cells that is located right underneath the terminal ureteric tree branches further cumu-
lates. The resulting pretubular aggregates rapidly proliferate to form a tightly adhering 
cluster of approximately 30 cells, which sequentially undergoes mesenchymal-to-
epithelial transition and forms a cyst-like structure, the renal vesicle at E 12.5 (Bard et 
al., 2001). Through a series of differentiating events, involving symmetry interruption 
and invagination, the renal vesicle firstly transforms into a comma-shaped body, fol-
lowed by an S-shaped body. The lower limb of the S-shaped body ultimately devel-
ops into the renal corpuscle, whereby the inner cell lining differentiates into the vis-
ceral epithelial cells (podocytes) and the outer cell lining into the parietal epithelial 
cells of the Bowman’s capsule. Angioblasts finally invade the lower cleft and contrib-
ute to the formation of the glomerular tuft (Eremina et al., 2003). As the central part of 
the S-shaped body proliferates, the emerging proximal and distal tubule differentiate 
and the middle part between them starts growing down into the medullary zone to 
shape/constitute the loop of Henle (Neiss, 1982). Finally the upper limb of the S-
shaped body turns into the distal convoluted tubule and fuses with the collecting duct 
(Saxén, 1987). 
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Figure 3) Schematic illustration of the morphological stages of metanephric development 
Signals from the ureteric bud (UB) induce the formation of the cap mesenchyme within the 
metanephric mesenchyme (MM). The subsequently developing pretubular aggregate undergoes 
mesenchymal-to-epithelial transition and forms the renal vesicle, which then differentiates into the 
comma- and the s-shaped body. The cleft of the S-shaped body is colonized by endothelial cell 
precursors that eventually help to form the renal corpuscle together with the distal limb of the of the s-
shaped body. The proximal limb fuses with the ureteric duct that eventually will form into the collecting 
ducts, and after a series of transformative events it differentiates into the nephrons tubule system. CD, 
collecting duct; DT, distal tubule; MM, metanephric mesenchyme; RV, renal vesicle; UB, ureteric bud; 
WD, Wolffian (nephric) duct (adapted from Bertram et al., 2016, with permission). 
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2.2.3. Molecular regulation of embryonic kidney development 
Embryonic kidney development is a very complex process that requires the expres-
sion of innumerable regulatory genes, which govern the precise temporarily and spa-
tially coordinated interaction of several networks of transcription and growth factors, 
their receptors and many other signaling molecules to warrant the physiological 
course of events in the developing kidney. 
2.2.3.1. Specification of the metanephric mesenchyme and formation of the 
nephric duct 
The first essential step in the course of kidney development consists of specification 
of the nephrogenic cord, i.e., the regions of intermediate mesoderm, the transient and 
permanent kidney structures originate from. Several genes that are involved in initial 
patterning processes in the course of pro- and mesonephric development also play 
important roles in the formation of the metanephric mesenchyme. Gene expression in 
kidney progenitor cells includes Odd-skipped related 1 (Odd1) (James et al., 2006), 
Eyes-absent 1 (Eya1) (Kalatzis et al., 1998), Hox11 paralogous members a,c and d 
(Wellik et al., 2002), paired-box transcription factor 2 (Pax2) (Dressler et al., 1990, 
Torres et al., 1995), Wilms tumor 1 (Wt1) (Kreidberg et al., 1993), Sine oculis family 
members (Six) 1, 2 and 4 (Xu et al., 2003), Spalt-Like Transcription Factor 1 (Sall1) 
(Nishinakamura et al., 2001) and Glial cell line-derived neurotrophic factor (Gdnf) 
(Moore et al., 1996, Pichel et al., 1996a, Pichel et al., 1996b, Sanchez et al., 1996). 
Metanephric mesoderm specification in particular is coordinated involving tripartite 
Eya-Hox-Pax and Eya-Six-Pax complexes. The coexpression of Eya1, Hox11 and 
Pax2 positively regulates Gdnf and Six2 expression (Brodbeck and Englert, 2004, 
Gong et al., 2007). Loss of function of any of the genes mentioned above results in 
incomplete formation of the intermediate mesoderm, whereby absence of the earliest 
markers Odd1 and Eya1 leads to complete renal agenesis (James et al., 2006, Xu et 
al., 1999). Renal agenesis also occurs if there is a loss of the LIM class homeodo-
main transcription factor LHX1 (aka LIM1), which is essential for the formation of the 
nephric duct (Tsang et al., 2000). Likewise, activated by Odd1 and Lhx1, the Pax2 
and Pax8 are critical for nephric lineage specification (Torres et al., 1995, Mansouri 
et al., 1998). The presumed redundancy of their function at the early stages of kidney 
development was endorsed in Pax2/8 double-mutant embryos, which show no signs 
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of nephric duct formation or expression of other nephric duct markers like Ret proto-
oncogene (c-Ret) at all (Bouchard et al., 2002).  
2.2.3.2. Outgrowth of the ureteric bud and branching morphogenesis 
The emergence of the ureteric bud and subsequent branching morphogenesis are 
regulated by many different stimulating and inhibiting signaling networks. Growth and 
branching of ureteric bud tips is promoted by factors released by metanephric mes-
enchyme cells. In contrast, cells alongside the ureteric bud stems (epithelial nephron 
progenitors and stromal cells) promote elongation, but oppress branching (Sweeney 
et al., 2008). These reciprocal interactions create a tight link between epithelial and 
mesenchymal compartments and guarantee for a balanced development of the ure-
teric tree. Hereby a signaling pathway of the transforming growth factor beta (TGF– ) 
superfamily, the glial cell line-derived neurotrophic factor (GDNF) pathway occupies a 
central role. Stimulated by growth factors, GDNF is secreted by the metanephric 
mesenchyme at E 10.5 (Gong et al., 2007, Reidy and Rosenblum, 2009). Its action is 
mediated through the c-RET receptor tyrosine kinase and the GPI-linked co-receptor 
GFRα1, both expressed by the nephric duct. GDNF triggers RET-positive cells from 
the nephric duct to grow outwards in the direction of the GDNF signal. Deficiency of 
either GDNF, c-RET or GFRα1 leads to a failure in ureteric bud formation (Pichel et 
al., 1996a, Moore et al., 1996, Sainio et al., 1997b, Davies and Fisher, 2002). 
GDNF/c-Ret signaling is modified by multiple factors. To prevent the formation of ec-
topic ureteric buds for example, it is important that the signal is localized to the region 
of anticipated ureteric bud outgrowth. By restricting Gdnf expression in the anterior 
parts of the nephrogenic cord, the forkhead transcription factor FOXC1 and the RO-
BO2/SLIT2 receptor ligand pair are able to prevent the formation of supernumerary 
ectopic ureteric buds (Kume et al., 2000, Grieshammer et al., 2004). Another known 
inhibitor of GDNF is the bone morphogenetic protein 4 (BMP4). It is secreted by 
stromal cells that surround the nephric duct and antagonize ureteric bud outgrowth, 
whereby its exact working mechanism remains elusive. BMP4 in turn can be inhibited 
by the gene product of Gremlin1 (Grem1), which is locally secreted around the 
emerging ureteric bud to maintain Gdnf expression (Michos et al., 2007). GDNF/c-
Ret as well as Bmp4/Gremlin signaling are not only essential for primary ureteric bud 
outgrowth but also for ureteric bud branching. In the course of branching morpho-
genesis the expression of c-Ret is restricted to the ureteric tree tips and that of Gdnf 
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to the surrounding mesenchyme, allowing branching only to occur at the end of the 
tips (Costantini and Shakya, 2006). Activation of Ret signals is mediated via several 
pathways including ERK MAP kinase, PLC  and PI3K (Fisher et al., 2001, Watanabe 
and Costantini, 2004, Ihermann-Hella et al., 2014). Moreover, several ureteric bud tip 
target genes are upregulated by GDNF/c-Ret signaling including Etv4, Etv5, Met, 
Mmp, Spry1 and Wnt11 (Pepicelli et al., 1997, Basson et al., 2005, Lu et al., 2009).  
Sprouty1 (Spr1) encodes for a cytoplasmic membrane-associated protein that be-
longs to a group of receptor tyrosine kinase signaling inhibitors. It is expressed in the 
ureteric bud and the metanephric mesenchyme and as part of a negative feedback 
loop prevents excessive GDNF/c-Ret signaling, which would result in formation of 
ectopic ureteric buds. Furthermore Spry1 helps to coordinate branching morphogen-
esis by regulating the synergistic interactions of GDNF/c-RET and the secreted gly-
coprotein WNT11 (Majumdar et al., 2003, Mason et al., 2006, Basson et al., 2006).  
Wilms’ tumor-1 (WT1), a zinc finger protein that can act as a transcription factor as 
well as a RNA binding protein, has manifold roles in nephrogenesis (Hohenstein and 
Hastie, 2006). It has also been proposed to regulate GDNF/c-Ret signaling, although 
the exact interactions yet remain unclear. It was suggested that it helps GDNF levels 
to exceed a critical threshold required for ureteric bud outgrowth. Also, it may regu-
late expression of Vascular Endothelial Growth Factor A (VEGF-A), which then stimu-
lates angioblasts to release a yet unknown signal that induces the expression of Gdnf 
and Pax2 (Donovan et al., 1999, Gao et al., 2005).  
Early metanephric development also relies on signaling via Fibroblast Growth Factor 
Receptors (FGFR) 1 and 2, which at around E 10.5 are expressed in the metanephric 
mesenchyme as well as the ureteric bud. In a conditional knockout mouse model it 
was shown that combined deficiency of Fgfr1/2 leads to renal agenesis. The ureteric 
bud initially forms, but subsequently fails to grow and branch. Concordantly, the met-
anephric mesenchyme is hypoproliferative with increased rates of apoptosis. In the 
metanephric mesenchyme expression of Eya1 and Six1 is still present, albeit it lacks 
expression of Pax2, Six2 and Sall1. Therefore it is indicated that FGF signaling lies 
downstream of Eya1 and Six1, and upstream of Pax2, Six2 and Spalt-Like Transcrip-
tion Factor 1 (Sall1) (Poladia et al., 2006b). This was endorsed by studies in Sall1-
mutants. Sall1 is one of four gene family members that encode for homologues of the 
Drosophila homeotic gene Spalt, a multi zinc finger transcription factor with activating 
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and repressing properties (Nishinakamura et al., 2001, Kanda et al., 2014). Renal 
defects in Sall1-mutants include failed outgrowth of the ureteric bud and increased 
apoptotic rates in the metanephric mesenchyme at E11.5 (Nishinakamura et al., 
2001). The absence of Sall 1 expression in both Six1 and Fgfr1/2 mutants indicates 
that the Eya1-Six1 complex and FGF signaling are necessary for Sall1 expression in 
the metanephric mesenchyme (Davies and Fisher, 2002, Poladia et al., 2006b).  
Besides, branching morphogenesis also requires several other molecules of the ex-
tracellular matrix (ECM) (Davies and Fisher, 2002). The basal lamina surrounding the 
ureteric bud is composed of collagen type IV, laminin and different proteoglycans 
(Saxen and Sariola, 1987, Ekblom et al., 1990). These proteoglycans, particularly 
heparan sulfate are able to bind growth factors such as FGFs with their glycosamino-
glycan side chains. Thereby they modulate their activity and for example are able to 
initiate branching (Coutts and Gallagher, 1995). Transmembrane proteins such as 
integrins α3 and α8 also have been shown to promote branching (Muller et al., 1997, 
Davies and Fisher, 2002). 
2.2.3.3. Survival and proliferation of the metanephric mesenchyme 
The default fate of the metanephric mesenchyme is apoptosis (Coles et al., 1993). To 
maintain cell survival, the ureteric bud secretes several soluble factors, inter alia TGF 
α, Epidermal Growth Factor (EGF), the metalloprotease inhibitor TIMP2 and several 
different BMPs (Coles et al., 1993, Di Marco et al., 1989, Lyons et al., 1995, 
Bernardini et al., 2001). During the course of kidney development the metanephric 
mesenchyme needs to grow continuously. This is partly facilitated by BMP4, which is 
secreted by the emerging tubules and stromal cells. Therefore the loss of mesen-
chymal cells to epithelial transition induces the remaining metanephric mesenchyme 
cells to multiply (Miyazaki et al., 2000). It was suggested that also BMP7 and FGF2 
synergistically prevent the mesenchyme from apoptosis (Dudley et al., 1999). In that, 
BMP7 is presumably more involved in promoting stromogenic than nephrogenic pro-
genitors (Dudley et al., 1995). FGF2 not only has anti-apoptotic properties itself, but 
also upregulates of Wt1 expression, which contributes to metanephric mesenchyme 
cell survival as well (Perantoni et al., 1995). 
While the nephron precursor cells in the cap mesenchyme are characterized by Six2 
expression, stromogenic progenitors surrounding the cap mesenchyme express the 
winged helix transcription factor Foxd1 (Hatini et al., 1996, Levinson et al., 2005, 
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Kobayashi et al., 2008). Stromal cells are essential for the epithelial development, not 
only by supporting the emerging nephrons in a mechanical way, but also as an im-
portant source of modulatory signals (Davies and Fisher, 2002). Apart from the above 
mentioned BMPs, there is evidence for the existence of stromal derived-factors that 
regulate the correct c-Ret expression upon ureteric bud branching morphogenesis in 
response to retinoic acid signaling (Batourina et al., 2001). In mice that are deficient 
of retinoic acid receptors (RAR) α and 2, in the embryonic kidney both expressed by 
stromal cells, ureteric bud branching is greatly impaired and expression of c-Ret is 
downregulated (Mendelsohn et al., 1999). 
2.2.3.4. Metanephric nephron formation 
In both meso- and metanephros the induction of nephron formation is facilitated by 
Wnt9b, coding for a member of the secreted Wnt signaling proteins (Carroll et al., 
2005). WNT9B is produced and released from the ureteric bud branches, and con-
sidered the primary paracrine signal for pre-tubular aggregate formation (Carroll et 
al., 2005). In concert with several other factors, including the FGF2, transforming 
growth factor (TGF 2) and the Leukemia inhibitory factor (LIF) WNT9B stimulates via 
the canonical -catenin signaling pathway the expression of several early nephron 
markers in the metanephric mesenchyme surrounding the ureteric bud (Perantoni et 
al., 1995, Barasch et al., 1999, Plisov et al., 2001). At the same time, WNT9B also 
promotes Six2 expression in the cap mesenchyme to maintain a self-renewing neph-
ron progenitor cell population (Karner et al., 2011). In the pretubular aggregates 
Wnt9b serves as initial activator, stimulating the expression of Pax8, Fgf8 and Wnt4 
(Grieshammer et al., 2005, Davidson, 2008). WNT4, acting in an autocrine fashion, 
then is required to maintain the expression levels and promote mesenchymal-to-
epithelial transition with subsequent formation of the renal vesicle (Stark et al., 1994, 
Kispert et al., 1998, El-Dahr et al., 2008).  
The following terminal differentiation process constitutes another critical step in 
nephrogenesis. It involves the downregulation of embryonic genes and the simulta-
neous acquisition or upregulation of distinct functional genes that characterize the 
final specialized cell type the epithelial progenitors eventually turn into (El-Dahr et al., 
2008). The exact interactions and mechanisms thereof still need to be fully elucidat-
ed. However, several of the involved transcription factors and signaling networks 
have been identified. Some of them, e.g. the p53 gene family, are involved in promot-
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ing the epithelial differentiation fate overall, while others govern the highly specific 
segmentation of the nephron (El-Dahr et al., 2008, Heliot et al., 2013). Once the renal 
vesicle has formed, the proximal domain, i.e. the part that is furthest from the ureteric 
bud, is characterized by high expression levels of Wt1 (Kreidberg et al., 1993). To 
allow glomerular podocyte development, Wt1 directly represses Pax2 activity (Ryan 
et al., 1995). Otherwise Pax2 and Pax8, acting downstream of Wnt4, induce the ex-
pression of Lhx1 (Narlis et al., 2007). Lhx1 a key regulator of the early stages of prox-
imal-distal nephron patterning (Kobayashi et al., 2005). Its expression is also ad-
vanced by WNT4 directly, probably in concert with FGF8 (Grieshammer et al., 2005). 
Lhx1 induces the expression of POU domain class 3 transcription factor 3 (Pou3f3, 
Brn1) and Notch ligand Dll1 (Nakai et al., 2003). While Lhx1 and Pou3f3 are required 
to specify the more distal segments of the nephron, including the loop of Henle and 
the distal convoluted tubule, Notch ligands Dll1 and Jag1 and the pathway modulator 
Lfng contribute to the development of the proximal tubule segments via Notch2 sig-
naling (Nakai et al., 2003, Cheng et al., 2007, Desgrange and Cereghini, 2015). By 
also controlling the mentioned Notch components as well as the Iroquois homeodo-
main transcription factor (Irx) family members 1 and 2, the Hepatocyte nuclear factor-
1  (HNF1B) governs intermedio-proximal nephron segment identity (Heliot et al., 
2013).  
 
 
 
Figure 4) Transcriptional networks in terminal nephron differentiation. 
CD, collecting duct; MET, mesenchymal-to-epithelial transition; UB, ureteric bud. See text for details (based 
on Horster et al., 1990, Davidson, 2008 and El-Dahr et al., 2008). 
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2.3. The importance of nephron endowment 
In the last decades, the number of nephrons in the kidney has emerged as an im-
portant parameter of renal structure and an important indicator of renal health (Moritz 
et al., 2008). Up to the present day, most textbooks state that a human kidney con-
tains approximately 1 million nephrons. This number does in fact come close to the 
average mean of the population, however, there appear to be tremendous inter-
individual differences. One of the most comprehensive studies, performed on autop-
sied kidneys from over 400 subjects of five racial groups, indeed yielded an overall 
12.8 fold variation. Nephron (glomerular) numbers of individual kidneys ranged from 
210,332 to 2,702,079 with an overall mean of 910,902 (Hoy et al., 2010a, Hoy et al., 
2010b). Several other studies go along with these findings by showing relatively simi-
lar mean values but large ranges of nephron numbers in kidneys of individuals with 
no signs of renal disease (Nyengaard and Bendtsen, 1992, Merlet-Benichou et al., 
1999). Several factors, including different methods applied for counting of nephrons 
(refer to section 2.5), might contribute to the high variability of nephron numbers in 
humans. Age-related decline in nephron numbers certainly plays a role, however, 
these wide variations have been shown to be already largely present at birth 
(Hinchliffe et al., 1992, Nyengaard and Bendtsen, 1992, Zhang et al., 2008). Hence, 
they are not only the result of a glomerular loss due to acute and chronic renal insults 
throughout life, but determined developmentally. The awareness of possible implica-
tions thereof was awakened in the late 1990s, when two hypotheses emerged. The 
Barker hypothesis, now known as the developmental origins of health and disease 
(DOHaD), represents the concept that many diseases with onset in adulthood have 
their origin during fetal development (Hales and Barker, 1992). In utero insults 
prompting the fetus to make adaptions that ensure short-term survival, may eventual-
ly increase the risk to develop particular diseases in the long-term, therefore factors 
altering developmental processes during gestation or shortly after birth can have life-
long consequences for the health of the individual. Concordantly in 1988, Brenner et 
al. proposed that a congenital low nephron number explains why a couple of patients 
are susceptible to hypertension and renal disease, whereas others under similar cir-
cumstances seem relatively insusceptible to the development of disease. It was pro-
posed that a nephron deficit and its concomitant reduction in surface filtration area 
lead to a compensatory glomerular hyperfiltration, which is associated with glomeru-
lar hypertension and hypertrophy. Initially these adaptive changes help to maintain 
20
 
 
 
an overall normal glomerular filtration rate (GFR). In the long run, however, they may 
result in secondary changes, e.g., glomerulosclerosis that can lead to further nephron 
loss, proteinuria and systemic hypertension (Brenner et al., 1988). Among the most 
appreciated concepts regarding the pathogenesis of progressive glomerulosclerotic 
lesions following an unspecified first insult are glomerular hyperfiltration (Brenner, 
1983), glomerular hypertrophy (Fogo and Ichikawa, 1989) and the impairment of the 
glomerular permselectivity with subsequent development of tubular and interstitial 
alterations (Remuzzi and Bertani, 1990). None of these concepts by itself, however, 
is able to explain the differences in development of CKDs in different animal models 
(Fogo et al., 1988, Yoshida et al., 1988). 
Low nephron endowment alone is unlikely to be the only factor initiating the devel-
opment of chronic kidney disease (CKD), but nowadays it is seen as a first hit, a risk 
factor that renders the kidney more susceptible for following secondary hits such as 
diabetes or obesity (Nenov et al., 2000). Irrelevant of the initial underlying cause, 
CKDs have the tendency to progress to end-stage renal disease (ESRD) with need 
for kidney replacement therapy i.e. dialysis or transplantation (Fogo, 2006). Conceiv-
ably, this progression is accelerated when the number of present and functioning 
nephrons in the kidney is already decreased at onset of disease. A plethora of factors 
has impact on metanephric development and thereby determination of nephron en-
dowment. Apart from genetic polymorphisms (regarding e.g. Pax2, Osr1, c-Ret), a 
large range of perturbances to the feto-maternal environment has been identified to 
alter nephron number (Moritz et al., 2008, Walker and Bertram, 2011). Among them 
are placental insufficiency and maternal glucocorticoid exposure as well as undernu-
trition (Moritz et al., 2008). Maternal undernutrition can either mean a deficit in total 
calorie intake or a deficit in distinct dietary components like protein (Hoppe et al., 
2007, Wlodek et al., 2007, Singh et al., 2007b, Langley-Evans et al., 1999, Moritz et 
al., 2009). However, maternal deficiencies in micronutrients like iron or vitamin A and 
D have also been shown to affect total nephron number in the offspring (Lelievre-
Pegorier et al., 1998, Maka et al., 2008). 
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 Figure 5) Causes and consequences of low nephron numbers.  
Apart from genetic polymorphisms, several other factors mainly relating to the intrauterine environment 
contribute to a congenitally low nephron endowment. Thereby, these so called “first hits” render the 
kidney more susceptible for disease development later in life in case a “second hit” follows. Once the 
vicious cycle of nephron loss and compensatory mechanisms is initated, progression towards renal 
failure is the consequence. CKD, chronic kidney disease; ESRD, end-stage renal disease; IUGR, in-
trauterine growth restriction; RAAS, Renin-Angiotensin-Aldosterone-System (based on data from Fogo 
and Ichikawa, 1989, and Luyckx et al., 2013). 
 
2.3.1. Interspecies differences in completion of nephron(no)genesis and neph-
ron numbers 
A lot of our knowledge about kidney development has been derived from studies in 
comparative animal models. Hence it is important to take species-specific differences 
into account, especially when putting results of experimental studies into a clinical 
context. One aspect of particular relevance is the completion of nephrogenesis (see 
Table 1). In humans, even though nephron maturation continues for a while after 
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birth, kidney development, i.e., nephronogenesis is basically completed at week 36 of 
gestation, whereas in rodents nephronogenesis lasts until at least 1 week postnatally 
(Zhong et al., 2012, Cullen-McEwen et al., 2016). Therefore, it is not only dependent 
upon in utero conditions, but also influenced by the postnatal environment. Under 
experimental conditions, most of these external factors can be controlled, however, 
another major aspect in which the human and the kidney of other mammalian spe-
cies differ, is the total number of nephrons formed. Due to long-term inbreeding the 
differences in nephron endowment seen between individual animals of the commonly 
used rodent strains are in general very small (Moritz et al., 2008). Therefore it stands 
in direct contrast to the human condition. 
 
  
Species Period of meta-
nephrogenesis 
Length of 
pregnancy 
Nephrons 
per kidney 
[x10³] 
References 
Human 5 – 36 weeks 40 weeks 210 – 2702  (Hoy et al., 2010a) 
Sheep 30 – 130 days 150 days 200 – 800 (Zohdi et al., 2007, Galinsky 
et al., 2011, Wintour et al., 
2003, Bains et al., 1996) 
Spiny 
Mouse 
19 – 37 days 40 days 7 (Dickinson et al., 2005) 
Mouse 11 dpc – pn 5-7 d 20 days 10 – 14 (Sims-Lucas et al., 2009, 
Cullen-McEwen et al., 2001, 
David et al., 2010, Walker et 
al., 2012) 
Rat 12 dpc – pn 8-10 d 22 days 25 – 35 (Cullen-McEwen et al., 
2011, Black et al., 2002, 
Zimanyi et al., 2002, 
Bertram et al., 1992) 
Pig 20 dpc – pn 21-25 d 112 days 812 – 2306 (Lodrup et al., 2008a, 
Lodrup et al., 2008b, van 
Vuuren et al., 2012) 
Table 1) Timing of metanephrogenesis and average number of nephrons formed in different mamma-
lian species. 
All cited studies used unbiased stereology for the determination of nephron numbers; dpc, days post concep-
tum; pn, post natum (modified from Moritz et al., 2008, and Cullen-McEwen et al., 2016). 
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2.3.2. Animal models of low nephron numbers 
As described in section 2.3., nephron endowment is determined by both, environ-
mental and genetic factors. Accordingly, a number of strategies to generate animal 
models with reduced nephron numbers exist. Probably the most straightforward ap-
proach is the performance of a surgical reduction in renal mass, e.g., an unilateral 
nephrectomy. Obviously, this yields a 50% reduction in nephrons, however, the ef-
fects on the cardiovascular system and the remaining kidney depend on the point of 
time the procedure is performed. Is the kidney removed right after birth, there is an 
association with the development of hypertension, whereas removal during adulthood 
yields no further negative effects (Woods, 1999, Woods et al., 2001, Ryba, 2011). 
This has been shown to be true also in a recently established ovine model for of low 
nephron endowment, in which an unilateral nephrectomy is performed in a sheep 
fetus around day 100 of gestation, i.e. before the end of metanephrogenesis (Moritz 
et al., 2005). 
Another strategy to create a priori low nephron numbers is to make use of known per-
turbations during pregnancy that result in a low birth weight or intrauterine growth 
restriction (IUGR), which has been shown to be associated with reduced nephron 
count (Luyckx and Brenner, 2005). Among these experimental manipulations are, 
e.g., maternal undernutrition, achieved by either a calorie restriction (global undernu-
trition) or a diet low in specific components such as protein, vitamin A or iron or by 
selectively depriving the fetus of nutrients by  creating a placental insufficiency by 
uterine vessel ligation (Moritz et al., 2008).  
Another experimental method that is not associated with reduced birth weights, but 
leads to offspring with hypertension and reduced nephron numbers is maternal glu-
cocorticoid administration during the critical early stages of renal development. In 
rats, dexamethasone exposure around day 14-15 of gestation, leads to significantly 
reduced, i.e., 30% lower nephron numbers after birth as well as an altered gene ex-
pression profile with reduced levels of GDNF, TGF-ß1 and BMP-4, indicating inter-
ference with nephron formation during branching morphogenesis (Singh et al., 
2007a, Singh et al., 2007b). Additionally, there are several models of genetically 
modified mice that exhibit reduced nephron counts. Apart from models for unilateral 
renal agenesis (Mesrobian, 1998, Wang et al., 2015), a few single gene deficiencies 
were found to be associated with alterations in nephron numbers. Benz et al. (2011) 
examined the kidneys of mice heterozygously deficient in the glial cell line-derived 
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neurotrophic growth factor (GDNF+/-). They examined 26 week-old animals of both 
sexes and compared them to sex- and age-matched wild-type controls. GDNF is a 
key molecule in signaling of branching morphogenesis of the ureteric bud. Therefore, 
GDNF deletion leads to reduced induction of branching and formation of nephrons 
(Costantini, 2010). Unbiased stereological investigations showed that GDNF+/- mice 
display a reduction in nephron number of approximately 30%, as compared to the 
wildtype animals (Benz et al., 2011). Furthermore, in these animals the mean glo-
merular volume was significantly higher. The glomerula of GDNF+/- animals also 
showed a proliferation of endothelial and mesangial cells, with a significant reduction 
in the podocyte density. Electron microscopically, a markedly thickened glomerular 
basement membrane was detectable. Blood pressure in GDNF+/- mice was not ele-
vated with a regular diet. However, being fed a high salt diet, GDNF+/- mice became 
hypertensive (Schlote et al., 2013). 
Mice with a homozygous Fgfr2 deficiency of the ureteric bud, represent another ge-
netically modified model of reduced nephron numbers (Poladia et al., 2006a). Com-
pared to control animals, these mice exhibited 24% lower nephron numbers, and 
morphological kidney alterations consistent with renal disease (thickening and hyper-
cellularity of the glomerular tuft, thickening of the capsule of Bowman, proteinaceous 
tubular casts), and increased serum levels of BUN. Additionally, the reduction in 
nephron numbers was associated with a significant increase of the systolic blood 
pressure by 20 mmHg and left-ventricular myocardial hypertrophy.  
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2.4. POU domain transcription factors 
Transcription factors are able to regulate gene expression in a time and cell type 
specific manner by either activating or inhibiting the transcription of one or more 
genes. They possess specific DNA binding sites, that allow them to interact se-
quence specific with the DNA (Latchman, 1997).  
Structural characteristic of all POU domain transcription factor family members is the 
eponymous POU domain. It was named after the first transcription factors in which it 
was identified: Pit-1, a pituitary-specific transcription factor, Oct-1/Oct-2, members of 
a transcription factor group, that bind to a specific ubiquitous octamer regulatory ele-
ment and Unc-86, a transcription factor that plays an essential role in the neurogene-
sis of the nematode Caenorhabditis elegans. Pit-1 as well as Oct-1 and Oct-2 are 
mammalian specific, however, regarding the POU domain there is sequence homol-
ogy to Unc-86 as well (Herr et al., 1988). Part of the POU domain consists of an evo-
lutionary highly conserved DNA-binding motif, the homeodomain (Sturm et al., 1988). 
It has been shown that members of the homeodomain protein superfamily are critical-
ly involved in the regulation of key processes in embryonic development (Gehring et 
al., 1994, Mitchell and Tjian, 1989). Besides the POU-type homeodomain (POUH) at 
the C terminus of the DNA binding motif, there is the POU specific domain (POUS) at 
the N terminus.  
 
 
 
Figure 6) Schematic illustration of the POU domain  
The POU-specific (POUS) and POU homeodomains (POUH) bind to opposite faces of the DNA and 
have a tail-to-tail orientation (adapted from Ryan and Rosenfeld, 1997, with permission). 
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Both sub-domains are connected by a variable linker region (Sturm and Herr, 1988). 
This bipartite arrangement allows taking on a variety of confirmations, thus facilitating 
the versatility in binding core DNA elements with different orientation and spacing. By 
using various coactivators, contingent upon binding to the DNA as a monomer or as 
a dimer, POU domain transcription factors can modulate the expression of distinct 
genes with spatio-temporal specificity. This also explains the fact that they often 
share crucial roles in the early stages of embryonic development, during lineage pro-
gression and when terminal cell differentiation takes place (Ryan and Rosenfeld, 
1997, Phillips and Luisi, 2000).  
2.4.1. Class III POU domain proteins 
According to the amino acid sequence of the POU domain, POU proteins have been 
classified into at least six different groups (Wegner et al., 1993). Four intronless 
mammalian class III POU genes have been established, which are predominantly 
expressed during development of the central nervous system: Brn-1, Brn-2, Brn-4 
and Tst-1/Oct-6/SCIP (He et al., 1989). All four of them are related with one another, 
as they show a high sequence homology (Hara et al., 1992).  
 
POU Transcription Factor (aliases) Tissue expression pattern 
 
Brn-1 (Otf-8, POU3F3) 
 
all levels of CNS in embryo and adult – more 
restricted expression in adult; intestine, kidney 
Brn-2 (Otf-7, N-Oct-3, POU3F2) all levels of CNS in embryo and adult – more 
restricted expression in adult 
Brn-4 (RHS2, N-Oct-4, POU3F4, Oft-9) all levels of CNS in embryo and adult, pancre-
as, Rathke’s pouch, whiskers, otic vesicle 
XLPOU 2 Spemann’s organizer (embryonal signaling 
center), mesoderm in gastrula, neuroectoderm, 
neural plate, notochord, brain 
Tst-1/Oct-6/SCIP (Oft-6, POU3F1) all levels of CNS, oligodendrocyte precursors, 
Schwann cells, testes, skin 
Table 2) Summary of expression patterns of mammalian Class 3 POU domain proteins.  
CNS, central nervous system (adapted from Ryan and Rosenfeld, 1997, with permission). 
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2.4.2. POU Domain Class 3 Transcription Factor 3 (POU3F3, BRN1) 
Pou3f3 is an intronless gene and abundant in guanine and cytosine throughout the 
entire coding region. The mammalian gene encodes characteristic alanine, glycine 
and proline repeats. They are well conserved between mice and humans regarding 
both position and number (Sumiyama et al., 1996). Pou3f3 and the closely related 
Pou3f2 (Brn2) are both expressed in the developing nervous system (He et al., 
1989). There they inhibit redundant functions in the production and radial migration of 
postmitotic upper-layer neurons (McEvilly et al., 2002, Sugitani et al., 2002). Defi-
ciency of both, Brn1 and Brn2 eventually results in laminar inversion of the neocortex. 
Only deletion of Brn2 yielded no detectable abnormalities in cortical development, 
while Brn1 knockouts showed a substantial derangement of cells in the cortical layers 
with a delayed radial migration of the layer III and IV neurons (McEvilly et al., 2002). 
While Brn2 expression is restricted to the brain, Brn1 is also expressed in the devel-
oping kidney (He et al., 1989). So far, two Pou3f3 knockout mouse lines have been 
established via homologous recombination. In both lines hemizygous knockouts did 
not exhibit any phenotypic alterations, whereas homozygous knockouts all died peri-
natally (McEvilly et al., 2002, Nakai et al., 2003). Apart from histological abnormali-
ties, i.e., the significant cellular disorganization in the hippocampal region and adja-
cent transitional cortical areas of the brain, one-day-old homozygous Pou3f3 knock-
out mice also exhibit abnormalities in the developing kidney, which were suspected to 
cause the perinatal deaths (McEvilly et al., 2002, Sugitani et al., 2002). To confirm 
this fact, Nakai et al. (2003) examined the kidneys of hemi- and homozygous Brn1 
knockouts. While hemizygous Brn1 knockout mice were virtually indistinguishable 
from their wildtype littermates, homozygous Brn1 knockout mice showed a striking 
reduction of 20% in kidney weight and elevated BUN (blood urea nitrogen) and po-
tassium levels in the serum. Further histological examination using H&E and PAS 
stained kidney sections yielded a reduction in the number of Henle’s loops with a 
concomitant prominence of interstitial cells, whereas collecting ducts and cortices 
with glomeruli appeared to have developed normally. 
To assess the expression of Brn1 during mouse kidney development an anti-BRN1 
antibody was used. Immunoreactivity was first detected within the renal vesicle, and 
subsequently in particular in regions of the S-shaped body, that were supposed to 
develop into the Henle loop, the Macula densa and the distal convoluted tubule. Dur-
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ing the following developmental stages, immunoreactivity within these areas contin-
ued to be positive, however, in the mature loop of Henle it was restricted to the thick 
ascending limb (TAL) (Nakai et al., 2003). BrdU labeling and TUNEL assay suggest-
ed, that the obvious reduction in Henle loops in newborn Brn1 deficient mice was due 
to a reduced cell proliferation and a premature induction of the caspase cascade, 
leading to an early onset of apoptosis during the primitive loop stage of Henle loop 
development (Nakai et al., 2003). Although hemizygous Brn1 knockout mice showed 
no histologically or clinically detectable abnormalities in kidney development and 
function, the expression levels of several TAL-related genes, including Umod, Ptger3, 
Nkcc2, Kcnj1 and Bsnd were significantly reduced (Nakai et al., 2003). 
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2.5. Quantitative morphological phenotyping of genetically modified animal 
models 
Since changes in function generally correlate with changes in morphology, histologi-
cal examination is an essential part in phenotyping of genetically manipulated organ-
isms. For studying effects of genetic manipulations, it is particularly critical to recog-
nize not only qualitative morphological alterations, such as inflammatory or degenera-
tive changes, but also differences regarding the basic constitution of the studied 
structure and its components. Evaluated parameters hereby might be volume, sur-
face area, length or number of structures in a given reference space, such as a cell 
or tissue (Weibel, 1979c, Howard and Reed, 2004, Lucocq, 2007, West, 2012). Being 
highly adapt to pattern recognition, the human visual system apparently lacks the 
ability to recognize small changes regarding spatial characteristics like sizes or nu-
merical densities of structures (Wanke, 2002, Boyce et al., 2010, Wanke, 2017). In 
fact, changes in the numerical densities of, e.g., cell section profiles in a respective 
reference compartment such as a tissue section can only be perceived, once the dif-
ference between the compared probes reaches approximately 25-40% (de Groot et 
al., 2005, Haschek et al., 2013). This yields the danger of missing subtle, yet poten-
tially pivotal morphological changes that might indicate early pathological changes. 
Therefore, researchers urgently rely on different methods that allow the precise and 
objective quantification of structures in all sorts of reference spaces like organs, tis-
sues, cells or even cellular subcompartments. To perform a direct measurement, 
however, it is necessary to view the structure of interest as a whole and together with 
its entire reference compartment. In general this is not possible due to the non-
transparency, size or three-dimensional complexity of the desired structure. Three-
dimensional imaging can be achieved by tissue clearing techniques, such as the so-
called CLARITY method (Azaripour et al., 2016) which uses different chemicals to 
replace tissue lipids by acrylamide-based hydrogels, resulting in an almost complete 
translucency of the tissue (Chung et al., 2013). However, most studies rely on the 
use of classical tissue slices. A consequence thereof is a loss of dimensionality that 
inevitably leads to a loss of spatial information - objects turn into section profiles, are-
as into lines, and lines into points. Furthermore, it is absolutely essential to keep in 
mind that the actual number of particles in a reference space cannot be obtained 
from the number of sectioned particle profiles, since there is an unpredictable varia-
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tion depending upon the size and shape as well as the spatial orientation of the re-
spective particles (Howard and Reed, 2004, Boyce et al., 2010, West, 2012). 
Artifacts related to tissue processing like shrinkage due to embedding, or unprecise 
information about the section thickness (Matenaers et al., 2018), together with the 
use of inappropriate sampling techniques further complicate it to obtain unbiased in-
formation from histological tissue sections and make a lot of scientists shy away from 
the implementation of quantitative morphological methods in their repertoire (Weibel 
et al., 1966). This is very unfortunate, since the application of stereological methods 
enables the generation of a large amount of significant data with a high degree of 
objectivity. The possibility to assess tissue quantitatively, ultimately broadens the tra-
ditional descriptive use of microscopy. According to Weibel, stereology comprises “a 
body of mathematical methods relating three-dimensional parameters defining the 
structure to two-dimensional measurements obtainable on sections of the structure“ 
(Weibel, 1979c). In other words, by applying principles of stochastic geometry and 
statistics, stereology enables researchers to obtain information about three-
dimensional structures from two-dimensional sections (Nyengaard, 1999, Madsen, 
1999). Hereby, the nature of the obtained information can either be qualitative or 
quantitative, but it is always three-dimensional. The term “morphometry” in contrast, 
refers to all methods used to measure morphological structures. Hence morphomet-
rical analyses are always quantitative, but don’t have to be three-dimensional (Weibel 
et al., 1967). Quantitative stereological analyses can be divided into model-based 
and design-based methods. Model-based stereology uses geometric properties of 
the studied objects and mathematical approximations based on assumptions like 
spatial homogeneity. This is often appropriate in material or geological sciences. In 
life sciences, however, they are generally biased, as the investigated objects, in this 
case biological structures, do not entirely comply with the geometrical model. There-
fore, even though they allow obtaining data quickly and uncomplicatedly, they mostly 
need to be largely viewed as outdated (Baddeley and Jensen, 2005, West, 2012). 
The new gold standard is set by design-based methods like the “disector”, a re-
nowned principle to estimate number and size of even arbitrarily shaped particles 
(Sterio, 1984). No prior knowledge about these particles is necessary, no presump-
tions need to be made here, precision and unbiasedness only rely on choosing an 
adequate sampling strategy and method of investigation (Gundersen et al., 1988a, 
Gundersen et al., 1988b). During all steps of sampling uniform random sampling pro-
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cedures should be applied. This guarantees that the partial quantity chosen for inves-
tigation is statistically representative (Gundersen and Jensen, 1987, Howard and 
Reed, 2004). It is imperative that the whole reference compartment containing the 
structure of interest is available for sampling and moreover, that the total volume 
thereof can be accurately determined, since absolute parameters like total volumes, 
surface areas, lengths, and object numbers are in general obtained by calculation 
from their corresponding relative parameters (volume-, surface-, length-, or numerical 
densities of the structures of interest within their reference compartments) (Tschanz 
et al., 2014). 
 
For details on the methodology of quantitative stereological analyses, the reader is 
referred to standard textbooks (Weibel, 1979b, Howard and Reed, 1998, Haschek et 
al., 2013), a steadily growing number of excellent reviews and publications (Weibel, 
1979a, Nyengaard, 1999, Dorph-Petersen et al., 2001, Albl et al., 2016, Blutke et al., 
2016, Matenaers et al., 2018), and, also to the descriptions provided in the methods 
section of the publication in the present thesis (see pages 38-40). 
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Abstract
During nephrogenesis, POU domain class 3 transcription factor 3 (POU3F3 aka BRN1) is
critically involved in development of distinct nephron segments, including the thick ascend-
ing limb of the loop of Henle (TAL). Deficiency of POU3F3 in knock-out mice leads to under-
development of the TAL, lack of differentiation of TAL cells, and perinatal death due to renal
failure. Pou3f3L423Pmutant mice, which were established in the Munich ENUMouse Muta-
genesis Project, carry a recessive point mutation in the homeobox domain of POU3F3.
Homozygous Pou3f3L423Pmutants are viable and fertile. The present study used functional,
as well as qualitative and quantitative morphological analyses to characterize the renal phe-
notype of juvenile (12 days) and aged (60 weeks) homo- and heterozygous Pou3f3L423P
mutant mice and age-matched wild-type controls. In both age groups, homozygous mutants
vs. control mice displayed significantly smaller kidney volumes, decreased nephron num-
bers and mean glomerular volumes, smaller TAL volumes, as well as lower volume densi-
ties of the TAL in the kidney. No histological or ultrastructural lesions of TAL cells or
glomerular cells were observed in homozygous mutant mice. Aged homozygous mutants
displayed increased serum urea concentrations and reduced specific urine gravity, but no
evidence of glomerular dysfunction. These results confirm the role of POU3F3 in develop-
ment and function of the TAL and provide new evidence for its involvement in regulation of
the nephron number in the kidney. Therefore, Pou3f3L423P mutant mice represent a valu-
able research model for further analyses of POU3F3 functions, or for nephrological studies
examining the role of congenital low nephron numbers.
PLOSONE | DOI:10.1371/journal.pone.0158977 July 15, 2016 1 / 31
a11111
OPEN ACCESS
Citation: Rieger A, Kemter E, Kumar S, Popper B,
Aigner B, Wolf E, et al. (2016) Missense Mutation of
POU Domain Class 3 Transcription Factor 3 in
Pou3f3
L423P Mice Causes Reduced Nephron Number
and Impaired Development of the Thick Ascending
Limb of the Loop of Henle. PLoS ONE 11(7):
e0158977. doi:10.1371/journal.pone.0158977
Editor: Shree Ram Singh, National Cancer Institute,
UNITED STATES
Received: April 19, 2016
Accepted: June 25, 2016
Published: July 15, 2016
Copyright: © 2016 Rieger et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: AR recieved a PhD scholarship from the
Hanns-Seidel-Stiftung e. V., Munich, Germany.
Competing Interests: The authors have declared
that no competing interests exist.
35
Introduction
Members of the POU domain transcription factor family are crucially involved in the regula-
tion of a variety of developmental processes in diverse organs and tissues [1]. Amongst others,
the transcription factor POU3F3 (BRN1) plays an important role in the embryonic develop-
ment of the brain and the kidney, where it participates in regulation of cerebro-cortical neuron
migration [2,3] and renal distal tubule formation [4–7]. In the developing brain, POU3F3 acts
in concert with another POU domain transcription factor, POU3F2 (BRN2), and loss of func-
tion of either one can partially be compensated by the other [2]. However, in the developing
kidney only POU3F3 is expressed, largely restricted to parts of the nephron that develop into
the thick ascending limb (TAL) and the macula densa (MD) of the loop of Henle and the distal
tubule [5].
In the mature kidney, the TAL is functionally important for the urinary concentrating
mechanism via the countercurrent multiplier system, the regulation of the extracellular fluid
volume and pH, as well as for the homeostasis of calcium and magnesium, and of bicarbonate
and ammonium. For this, the TAL is equipped with several, partially energy dependent, spe-
cialized ion transporters, such as NKCC2, ROMK, NHE3, CLC-K1/2 and KCC4 [8]. The TAL
is also the origin of the abundant urine glycoprotein uromodulin (UMOD), also known as
Tamm-Horsfall protein [9,10]. The MD in the juxtaglomerular wall of the distal TAL is cru-
cially involved in regulation of the glomerular blood flow and the glomerular filtration rate
(GFR). In response to the intra-tubular sodium chloride concentration, the MD controls the
release of renin from juxtaglomerular cells, thereby regulating the renin–angiotensin–aldoste-
rone system (RAAS) dependent tubular reabsorption of sodium and water in the kidneys [11].
In 2003, Nakai and colleagues reported generation of Pou3f3 knock-out mice [5]. Homozy-
gous knock-outs displayed increased plasma urea and potassium levels and renal hypoplasia
with severe malformations of distinct tubular nephron segments. In particular, elongation and
differentiation of the TAL and development of MD cells were impaired, and homozygous
Pou3f3 knock-out mice died within 24 hours after birth due to renal failure [5].
Mammalian nephrogenesis is a complex process involving the spatially and timely coordi-
nated interaction of several transcription and growth factors, from initial interaction of the
metanephric mesenchyme and the ureteric bud (i.e., nephron induction), to the final formation
of the different tubular segments of the mature nephron and the collecting duct (CD) system
(i.e., nephron differentiation or nephron patterning) [4,6,7]. In mice, nephron endowment is
completed by postnatal day 7–10 [12–14]. The transcription factor POU3F3 is involved in con-
trol of this complex nephron patterning, however its role is yet not completely understood, and
analysis of POU3F3 function in postnatal renal development in knock-out mice is limited by
the neonatal death of the animals.
Recently, we reported generation and phenotypical characterization of a Pou3f3mutant
mouse line on C3H genetic background in the Munich ethyl-N-nitrosourea (ENU) mouse
mutagenesis project [15,16]. These Pou3f3L423P mutant mice harbor a recessive T!C point
mutation, leading to an amino acid exchange from leucine to proline in the conserved
homeobox domain of the protein at amino acid position 423 [16]. In contrast to Pou3f3 knock-
out mice, hetero- and homozygous Pou3f3L423P mutant mice are viable and fertile. They display
increased plasma urea levels, reduced body and kidney weights, as well as neurological deficits,
impaired hearing, malformation of the semicircular canals of the vestibular organ, and several
metabolic changes associated with renal dysfunction [16].
In the present study, the renal phenotype of juvenile and aged homo- and heterozygous
Pou3f3L423P mutant mice was characterized in detail using comprehensive quantitative mor-
phological and functional analyses. State-of-the-art design-based quantitative stereological
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methods were applied to identify the effects of the Pou3f3mutation on development, growth,
and cellular composition of different nephron segments, including the TAL and glomeruli. The
results of these analyses provide new insights into the role of POU3F3 in pre- and postnatal
kidney development and provide the basis for using Pou3f3L423P mutant mice as an animal
model in nephrological research.
Materials and Methods
Ethics statement and animal housing
All experiments were approved by the responsible animal welfare authority (Regierung von
Oberbayern) and were carried out in accordance with the German Animal Protection Law,
conforming to international guidelines on the ethical use of animals.
Mice
Pou3f3L423P mutant mice were originally generated in the Munich ENUmouse mutagenesis
project and maintained on the genetic background of C3HeB/FeJ inbred mice [16]. All mice
investigated in the present study were kept under specified pathogen-free conditions in a closed
barrier system on a 12:12 hour light-dark cycle and had free access to a standard rodent diet
(V1534; Ssniff, Soest, Germany) and drinking water [16]. Genotyping of mice was performed
by allele-specific PCR restriction fragment length polymorphism (RFLP) analysis, as described
previously [16]. Mice were examined at 12 days of age and at 60 weeks of age. If not stated oth-
erwise, the following numbers of mice were analyzed at 12 days of age: non-mutant control
mice (CON), male: n = 6, female: n = 11; heterozygous Pou3f3L423P-mutant mice (HET), male:
n = 15, female: n = 15; homozygous Pou3f3L423P-mutant mice (HOM), male: n = 7, female:
n = 5; and at 60 weeks of age: CON, male and female: n = 7; HET, male: n = 8, female: n = 7;
HOM, male and female: n = 6.
Blood pressure, serum, and urine analyses
Blood pressure was noninvasively measured by regular tail cuff plethysmography (CODA Sys-
tem, Kent Scientific, Torrington, CT) in 60-week-old mice, as previously described [17]. To
this, mice were trained daily to accustom them to the blood pressure measuring procedure over
a period of two weeks (at least four times per week). Blood pressure data were averaged from
valid readings of ten consecutive measurements per mouse. Spot urine samples from 12-day-
old mice and from 60-week-old mice, and serum from tail vein blood specimen from 60-week-
old mice were collected and stored at -80°C until assayed. The serum concentrations of urea
and sodium were determined using a COBRAS INTEGRA1 400 plus analyzer (Roche Diag-
nostics, Germany). Serum cystatin C concentrations were measured by an enzyme linked
immunosorbent assay (Mouse Cystatin C ELISA-kit RD291009200R, BioVendor GmbH,
Germany).
Urine albumin concentrations were determined in spot urine samples of 12-day-old and of
60-week-old mice using the mouse albumin ELISA-kit Bethyl E90-134 (Bethyl, USA). Addi-
tionally, the specific gravity of the urine and the urinary creatinine concentrations were deter-
mined in spot urine samples of 60-week-old mice. Urine creatinine concentrations were
measured using a Hitachi automated analyzer (Merck, Germany). Subsequently, urine albu-
min-to-creatinine ratios (UACR) were calculated from corresponding urine albumin and cre-
atinine concentrations. The specific gravity of the urine samples was determined by
refractometry (MHRS-10-ATC, Müller Optronic, Germany).
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For SDS-PAGE urine protein analysis, individual spot urine samples of non-mutant control
mice (male: n = 6, female: n = 11), heterozygous Pou3f3L423P-mutant mice (male: n = 15,
female: n = 15), and homozygous Pou3f3L423P-mutant mice (male: n = 7, female: n = 5) were
diluted to a creatinine content of 1.5 mg/dl. Urine proteins were temperature denatured (Ther-
moblock TB1, Biometra, Germany) and separated using 12% SDS-PAGE gels (Protean III, Bio-
Rad, Munich, Germany) together with a broad molecular weight standard (Bio-Rad) and a
mouse albumin standard (Biotrend, Cologne, Germany), as previously described [17]. In all
gels, individual urine samples of male and female homozygous and heterozygous Pou3f3L423P-
mutant mice and non-mutant controls were loaded. After electrophoresis, the gels were stained
with Coomassie blue.
Body and kidney weight, kidney processing, histology and electron
microscopy
After determination of body weight at 12 days and at 60 weeks of age, respectively, mice were
killed by cervico-cranial dislocation. After removal of the left kidney, mice were perfused with
neutrally buffered 2.5% glutaraldehyde solution through the heart, as previously described
[17,18]. After in situ immersion fixation in 2.5% glutaraldehyde solution, the right kidney was
carefully separated from adjacent tissues and blotted dry. The kidneys were weighed to the
nearest mg and cut perpendicular to the longitudinal axis in ~1 mm thick slices, using a preci-
sion tissue slicing device [19]. The slices of the left kidney were fixed in neutrally buffered 4%
formaldehyde solution and routinely embedded in paraffin for immunohistochemical analyses.
The slices of the right, perfusion-fixed kidney (6.9 ± 0.5 slices in 12-day-old mice and
11.5 ± 0.9 slices in 60-week-old mice) were routinely processed and embedded in plastic for
light microscopy and transmission electron microscopy (TEM) as previously described [20,21].
For TEM, three 1 mm3 samples of the renal cortex per animal were selected by systematic ran-
dom sampling [22], postfixed in 1% osmium tetroxide and embedded in Epon-resin. From
each Epon block, ten consecutive 0.5 μm thick semi-thin sections were cut and stained with
toluidine blue O and safranin. Ultrathin sections (70–80 nm) were cut, contrasted with uranyl
citrate and lead citrate and examined with a TEM (EM10, Zeiss, Eching, Germany). The
remaining kidney slices were embedded in plastic, containing hydroxymethylmethacrylate and
methylmethacrylate (GMA/MMA, Sigma-Aldrich Laborchemikalien GmbH, Seelze, Ger-
many), as described previously [20]. For qualitative and quantitative morphological analyses,
plastic sections with a nominal section thickness of 1.0 μm were cut on a Reichert-Jung 2050
rotary microtome (Leica, Wetzlar, Germany) and stained with hematoxylin and eosin, periodic
acid Schiff (PAS), and periodic acid silver methenamine (PASM). For quantitative stereological
analyses, ~100 consecutive sections with a nominal section thickness of 1 μmwere additionally
cut from each GMA/MMA block per case. From each section series, every 20th section was sys-
tematically randomly selected (5 ± 1 sections per case) and stained with PAS.
Immunohistochemistry
Immunohistochemical analyses were performed on sections of paraffin embedded kidney tis-
sue. The following primary antibodies were used: rabbit polyclonal anti human uromodulin
antibody (H-135; sc-20631, Santa Cruz Biotechnology, Heidelberg, Germany, dilution 1:1000)
[23], monoclonal rat anti mouse uromodulin IgG antibody (MAB5175, R&D Systems, Abing-
don, UK, dilution 1:250), polyclonal rabbit anti mouse AQP2 IgG antibody (A7310, Sigma-
Aldrich, Munich, Germany, dilution 1:450) and guinea pig anti mouse BRN1 IgG antibody
(gp56, by courtesy of Prof. Dr. Wegner, Institute of Biochemistry, Emil Fischer Center, Univer-
sity Erlangen-Nuremberg, Germany, dilution 1:600). As secondary antibodies, biotinylated
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goat anti rabbit IgG antibody (BA-1000, Vector, Peterborough, UK, dilution 1:200), horserad-
ish peroxidase labeled goat anti rabbit IgG antibody (P0448, DAKO, Hamburg, Germany, dilu-
tion 1:150), horseradish peroxidase labeled rabbit anti guinea pig IgG antibody (P0141, DAKO,
Hamburg, Germany, dilution 1:150), and alkaline phosphatase labeled goat anti rat IgG anti-
body (112-055-167, Jackson ImmunoResearch, Newmarket, UK, dilution 1:300) were used.
Immunoreactivity was visualized using 3,3-diaminobenzidine tetrahydrochloride dihydrate
(DAB) or a combination of nitro blue tetrazolium chloride (NBT) and 5-bromo-4-chloro-
3-indolyl phosphate (BCIP). Kidney sections stained with buffer instead of the primary anti-
body were used as negative control.
Quantitative-stereological investigations of the kidney
Plastic resin-embedded samples of kidney tissue were used for quantitative stereological analy-
ses, using design-based stereological methods, such as the physical disector and point counting
[24,25], essentially carried out as described previously in detail [26]. Quantitative stereological
estimates were corrected for embedding-related tissue shrinkage.
Total volumes of the kidney, renal zones, glomeruli. The kidney volume was obtained
by dividing the weight of the glutaraldehyde-fixed right kidney by the density of perfusion-
fixed murine kidney tissue (1.05 g/cm3) [27]. The cross-sectional areas of the kidney (Kid) as
well as the cortex and the medulla (Med) of the kidney [28,29], were planimetrically deter-
mined in micrographs of PASM-PAS stained GMA/MMA kidney sections (9 ± 2 per case),
using a VideoplanTM image analysis system (Zeiss-Kontron, Eching, Germany). The volume
fractions of the cortex (VV(Cortex/Kid)) and the medulla (VV(Med/Kid)) were calculated according
to the principle of Delesse [24]. The absolute volumes of the individual renal zones (V(Cortex,
Kid), V(Med, Kid)) were calculated by multiplication of the volume fractions of the respective
zones in the kidney with the total kidney volume. The fractional volume of the glomeruli in the
cortex (VV(Glom/Kid)) was determined by point counting (1029 ± 115 points per case) [30] in
systematically randomly selected areas [22] of PASM-PAS stained GMA/MMA sections, as
principally described earlier [21]. The absolute volume of the glomeruli in the perfusion-fixed
(right) kidney (V(Glom, Kid)) was calculated from the volume fraction of the glomeruli in the
cortex and the absolute cortex volume. The volume fractions of the TAL in the kidney (VV(TAL/
Kid)) were determined by point counting (3713 ± 1646 points per case) in systematically ran-
domly selected areas of paraffin embedded kidney sections immunostained for uromodulin
(UMOD, section 2.6). The absolute volume of the TAL in the kidney (V(TAL, Kid)) was calcu-
lated from the volume fraction of the TAL cells in the kidney and the absolute volume of the
kidney.
Mean glomerular volume and total number of glomeruli. The mean glomerular volume
(v ðGlomÞ) and the total number of nephrons (glomeruli) in the right kidney (N(Glom, Kid)) were esti-
mated, using the physical disector method [24,25], in combination with systematic point counting,
as described in previous publications of our group [17,21,27]. Per case, 5 ± 1 PAS stained GMA/
MMA section pairs with 20 μm distance (disector height) were systematically randomly selected.
Using an automated stereology system (VIS-Visiopharm Integrator SystemTMVersion 3.4.1.0 with
newCASTTM software, Visiopharm A/S, Denmark), corresponding locations of the renal cortex
were then systematically randomly sampled at 40x final magnification in both sections, automati-
cally congruently aligned, and digitally superimposed with unbiased counting frames (344017 μm2
area) and 9 x 9 point test grids. The sectional area of cortical kidney tissue present within each
sampled counting frame (A(Cortex)) was determined by point counting. In the subsequent disector
analyses, 67 ± 18 Q- (glomeruli) were counted per case. The numerical volume density of glomeruli
in the renal cortex of the right kidney was calculated as: NV(Glom/Kid) = (∑Q
-
(Glom)/h x ∑A(Cortex)) x
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fs
3with fs = linear tissue shrinkage factor for GMA/MMA-embedded murine kidney tissue (0.91)
[31]. The number of glomeruli in the right kidney N(Glom, Kid)was then calculated as the product
of NV(Glom/Kid) and V(Cortex, Kid). Subsequently, the mean glomerular volume was estimated as
vðGlomÞ = VV(Glom/Kid)/ NV(Glom, Kid).
To validate the precise disector heights used for calculation of the numerical volume densi-
ties of glomeruli in the kidney and glomerular cells in the glomeruli, the thicknesses of GMA/
MMA and Epon sections were controlled, using an orthogonal resectioning technique, as pre-
viously described [21,27]. Since the measured thickness of GMA/MMA sections and Epon sec-
tions was 1.028 ± 0.031 and 0.501 ± 0.005, respectively, a section thickness of 1.0 μm for GMA/
MMA sections and 0.5 μm for Epon sections was consistently used for the calculation of the
disector volumes.
Number and volumes of glomerular cells. The mean numbers of distinct glomerular cell
types per glomerulus (C: all glomerular cells; Pod: podocytes, M-E: mesangial and endothelial
cells), and the mean podocyte volume were unbiasedly determined, applying the physical disector
method [24,25], principally as described above. For this, the numerical volume density of glomer-
ular cells in the glomerulus was unbiasedly determined in consecutive serial semi-thin sections of
Epon-embedded cortical kidney tissue samples: per section series, 2–3 pairs of sections with
1.5 μm distance were systematically randomly sampled [24]. Per case, the corresponding profiles
of 10 ± 1 systematically randomly sampled glomeruli were photographed at 400x magnification
in both sections of a section pair, using a Leica DFC 320 camera (Leica, Germany) connected to a
microscope (Orthoplan, Leitz, Germany). Images including a size ruler were printed and overlaid
with a plastic transparency with 576 equally spaced test points. The areas of the glomerular
cross-sections (A(Glom)) were planimetrically measured, using a Videoplan image analysis system
(Zeiss-Kontron, Germany). The volume fraction of podocytes per glomerulus VV(Pod/Glom) was
estimated from the fraction of points hitting podocyte section profiles, and points hitting the cor-
responding glomerular cross-section profile [24]. On the average, 681 ± 206 points were counted
per case. All glomerular cell nuclei profiles (C, Pod, M-E) sampled within a glomerular cross-sec-
tion in the first (reference) section, which were not present in the corresponding glomerular sec-
tion profile in the second (look-up) section, were counted (Q−). The operation was then repeated
by interchanging the roles of the look-up section and the reference section, increasing the effi-
ciency of cell nuclei counting by factor two. On the average, 250 ± 47 glomerular cell (C) nuclei
(Q−) were counted per case (Pod: 72 ± 9; M-E: 181 ± 39). The numerical volume density of glo-
merular cells in the glomerulus (NV(C/Glom), NV(Pod/Glom), NV(M-E/Glom)) was calculated from the
number of Q- counted per cell type and the respective disector volume, defined by the cumulative
areas of analyzed glomerular section profiles and the distance (disector height = 1.5 μm) between
the examined section pairs: NV(X/Glom) = (∑Q
-
(X)/h x ∑A(Glom)) x fs
3 with X = C, or Pod, or M-E;
h = disector height (1.5 μm) and fs = linear tissue shrinkage factor for Epon-embedded murine
kidney tissue (0.95) [17]. The mean number of cells per glomerulus (N(C, Glom)) and of podocytes
per glomerulus (N(Pod, Glom)) was calculated by multiplying the numerical volume density of the
respective glomerular cells in the glomerulus with the mean glomerular volume. The mean podo-
cyte volume (v ðPodÞ) was calculated dividing VV(Pod/Glom) by NV(Pod/Glom).
Volume of the mesangium and glomerular capillaries. The volume densities of capillar-
ies, and of the mesangium within the glomeruli (VV(Cap/Glom) and VV(Mes/Glom)) were determined
by point counting (fraction of points hitting capillary section profiles, or the mesangial area in
PAS stained sections, respectively, and points hitting the glomerular section profile) in 51 ± 6 sys-
tematically randomly sampled glomerular profiles in PAS stained GMA/MMA sections at 200x
magnification. Per case, 932 ± 256 points were counted. The mean mesangial and capillary vol-
umes per glomerulus (V(Mes, Glom) and V(Cap, Glom)) were calculated as the product of the
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respective volume density in the glomerulus and the mean glomerular volume (vðGlomÞ). The total
volume of glomerular capillaries in the kidneys was calculated as V(Glom-cap, Kid) = VV(Cap/Glom) x
V(Glom, Kid).
Length of glomerular capillaries. The mean length of the capillaries per glomerulus (L(Cap,
Glom)) was determined in the same glomerular profiles sampled in the serial semi-thin Epon sec-
tions used for estimation of glomerular cell numbers. The number of glomerular capillary section
profiles (SQ(Cap) = 1261 ± 122 per case) present within the examined glomerular section profiles
was counted. The cumulative glomerular tuft profile area of all examined glomerular section pro-
files (SA(Glom)) was measured planimetrically, as described above. The length density of capillar-
ies in the glomeruli was calculated as LV(Cap/Glom) = 2 x QA(Cap/Glom) x fs
2, with QA(Cap/Glom) =
SQ(Cap)/SA(Glom) and fs = 0.95. L(Cap, Glom) was then obtained as: L(Cap, Glom) = LV(Cap/Glom) x
vðGlomÞ [22,24]. The total length of the glomerular capillaries in the kidney (L(Glom-cap, Kid)) was
calculated as: L(Glom-cap, Kid) = LV(Cap, Glom) x V(Glom, Kid).
Glomerular basement membrane (GBM) thickness and filtration slit frequency (FSF).
The thickness of the GBM was determined by the orthogonal intercept method as described
earlier [17,32,33]. Per case, eight glomeruli were sampled from semi-thin sections, as described
earlier [34]. Ultrathin sections of these glomeruli were prepared for TEM, and peripheral glo-
merular capillary loops were photographed (9 ± 2 pictures per case) in a predetermined man-
ner (by half turns of the stage handle). Photographs were developed to a final print
magnification of 54324 x, and covered by a transparent 1.5-cm2 grid. Where gridlines tran-
sected the GBM, the shortest distance between the endothelial cell membrane and the outer lin-
ing of the lamina rara externa underneath the cell membrane of the epithelial foot processes
was measured, using a logarithmic ruler template with dimensions and midpoints, as described
earlier in detail [33]. The true harmonic mean thickness (Th(GBM)) of the GBM was estimated
as: Th(GBM) = (8/3π) x (10
6/M) x lh(GBM), with lh(GBM) (apparent harmonic mean GBM thick-
ness) = ∑ Number of observations / ∑ (Midpoints x number of observations), and M = final
print magnification. On the average, 1379 ± 264 (range: 938–2204) intercepts per animal were
measured. The FSF was determined in the same electron micrographs, by counting the number
of epithelial filtration slits divided by the length of the peripheral capillary wall at the epithelial
interface, as described earlier [32]. On the average, 1890 ± 667 filtration slits (range: 922–3372)
were counted per animal.
Renal POU3F3 mRNA and protein abundance
Quantitative RT-real time PCR (RT-qPCR) analyses. The renal Pou3f3mRNA expres-
sion abundances in 60-week-old mice were examined by RT-qPCR analyses (n = 7/7 (male/
female) non-mutant controls, 8/6 heterozygous mutants, and 5/6 homozygous mutants).
RNA-isolation was performed, using Trizol1 (Invitrogen, CA, USA). The integrity of RNA
was assessed by agarose gel electrophoresis. RNA quantity and purity were determined using a
NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, Germany). Following DNase
digestion (Thermo Scientific dsDNase, Thermo Fisher Scientific, Germany), on the average
2.9 ± 0.4 μg of total RNA per case were reverse transcribed using the RNA to cDNA EcoDryTM
Premix (Clontech, CA, USA). RT-qPCR analyses were performed on an Applied Biosystems
StepOne Real-Time PCR System (Applied Biosystems, Germany) using Power SYBR1 Green
PCRMaster Mix (Applied Biosystems, UK) and primers for amplification of mouse Pou3f3
[35] (accession N°: NM_008900.2, forward primer: 5’-GGT ACC CAC CTG CGA GTA GA-3’;
reverse primer: 5’-CAG CCT ACA GCT GGA AAA GG-3’; amplicon length: 127 bp), uromo-
dulin (Umod) [36] (accession N°: NM_001278605.1, forward primer: 5’-gga aag cag aaa acc tgg
tg-3’; reverse primer: 5’-gag aca ggg ctt cat aca-3’; amplicon length: 205 bp), and
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glyceraldehyde-3-phosphate dehydrogenase (Gapdh) [37] (accession N°: NM_001289726.1, for-
ward primer: 5’-TGT GTC CGT CGT GGA TCT GA-3’; reverse primer: 5’-CCT GCT TCA
CCA CCT TCT TGA T-3’; amplicon length: 77 bp). Primer sequences were queried by NCBI
Blast software and the comparability of amplification efficiencies of the single primers was con-
firmed by performance of RT-qPCR-based standard curve analyses. All RT-qPCR measure-
ments were performed in duplicates and included no template controls and RT-minus controls
(DNase-digested RNA). The expression abundances of Pou3f3, and Umod were calculated in
relation to the expression of Gapdh as internal reference, as well as the abundance of Pou3f3 in
relation to Umod using the 2-ΔCT method [38]. The relative mRNA abundances were then nor-
malized to the respective mean relative mRNA abundance of non-mutant control mice.
Western-blot analyses. Renal protein abundances of POU3F3 and GAPDH in 60-week-
old mice were examined byWestern-blot analyses (n = 6/6 (male/female) non-mutant controls,
6/6 heterozygous mutants, and 6/6 homozygous mutants). For protein extraction, kidney tissue
samples were homogenized in protein extraction buffer (10 mm Na2HPO4 at pH 7.0; 0.2% (wt/
vol) sodium dodecyl sulfate solution; 10% (vol/vol) glycerine; adjusted to pH 7.0), heated to
95°C for 5 minutes and cooled on ice for 5 minutes. After centrifugation (18,000 g, 5 min, 4°C),
protein contents were quantified using the bicinchoninic acid method [39]. For Western-blot
analyses, 30 micrograms of denatured protein were loaded per lane on 12% sodium dodecyl
sulfate-polyacrylamide gels and separated by electrophoresis (SDS–PAGE) together with a pre-
stained protein ladder (PageRuler, Thermo Scientific, Germany). After electrophoresis, sepa-
rated proteins were blotted to polyvinylidene difluoride (PVDF) membranes (Thermo Fisher
Scientific, Germany). For detection of POU3F3 and GAPDH, the following antibodies (diluted
in 5% dry milk) were used after blocking of the membranes: Guinea pig-anti-Brn1 antibody,
diluted 1:2500 [40]; and Rabbit-anti-GAPDH (D16H11) mAb (#51741, Cell Signaling, New
England Biolabs GmbH, Germany), diluted 1:2000. Incubation with primary antibodies was
carried out overnight at 4°C. After washing of the membranes, incubation with appropriate
horseradish-peroxidase coupled secondary antibodies (HRP-goat anti-rabbit IgG (#7074), Cell
Signaling, New England Biolabs GmbH, Germany), diluted 1:2000; Donkey anti-guinea pig
IgG HRP conjugated (43R-ID039hrp, Fitzgerald Industries International Inc., Bioleague
GmbH & Co.KG, Germany), diluted 1:5000) and final washing steps, bound antibodies were
visualized using Amersham ECLWestern blotting detection reagent and Amersham ECL
Hyperfilms (GE Healthcare Life Sciences, Germany). After detection of POU3F3, the mem-
branes were stripped in stripping buffer (37.5 ml of 250 mM TRIS buffer at pH 6.7; 30 ml of
10%; 82.5 ml H2O; 1050 μl ß-mercaptoethanol) for 40 minutes at 70°C and then used for
detection of GAPDH.
Statistical analyses
All data are presented as means ± SD. To determine genotype effects data were analyzed by
one-way ANOVA with Gabriel’s post hoc tests. Gender specific differences were analyzed by
comparison of male vs. female mice of identical genotypes by using an unpaired Student's t-test
(IBM SPSS Statistics, Version 18). P-values<0.05 were considered significant. For all examined
parameters, the exact p-values of all comparisons are provided in the Supporting Information
(S1 and S2 Tables).
Results
Body weights, absolute and relative kidney weights, and kidney volumes
In juvenile mice of 12 days of age, the body weights of male and female homozygous Pou3f3L423P
mutant mice tended to be reduced as compared to heterozygous mutants and control mice (Fig 1),
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reaching statistical significance in male homozygous vs. heterozygous mutants (p<0.05). Homozy-
gous Pou3f3L423P-mutant mice consistently displayed significantly lower absolute (p<0.01) and
relative kidney weights (p<0.05) and kidney volumes (p<0.01) than heterozygous mutants or
non-mutant control mice. However these parameters were not significantly different between het-
erozygous mutants and control mice (Table 1, Fig 1). At 60 weeks of age, the body weights of male
homozygous Pou3f3L423Pmutant mice were significantly smaller, as compared to heterozygous
mutants (male p<0.01) or non-mutant control mice (male p<0.01, female p<0.01). Furthermore
Fig 1. Body weight (A, B) and volume of the perfusion-fixed right kidney (C, D) of 12-day-old (A, C) and of 60-week-old (B, D) Pou3f3L423P
mutant mice and non-mutant control mice. The numbers of animals examined are given in parentheses. Data are means ± SD. Significant differences
between homozygous and heterozygous mutants and non-mutant control mice are indicated by asterisks. *: p < 0.05, **: p < 0.01, ***: p < 0.001.
Significant differences between male and female mice of identical genotypes are indicated by crosses. +: p < 0.05, ++: p < 0.01, +++: p < 0.001.
doi:10.1371/journal.pone.0158977.g001
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the reduction of the absolute kidney weights, as well as the kidney volumes of homozygous
Pou3f3L423Pmutant mice of both sexes was highly significant (p<0.001). In contrast, the body
weights, absolute and relative kidney weights, and kidney volumes were not significantly different
between heterozygous mutants and non-mutant control mice (Table 2, Fig 1).
Blood pressure, serum, and urine analyses
The mean blood pressures of 60-week-old homo- and heterozygous Pou3f3L423P mutants and
of non-mutant control mice of the same sex did not display statistically significant differences.
Comparing male and female mice of identical genotypes, however, male non-mutant control
mice displayed significantly higher (p<0.05) mean blood pressures than female mice (Fig 2).
For characterization of the renal function in 60-week-old mice, the serum concentrations of
urea, sodium, and cystatin C, as well as the urine concentrations of albumin and creatinine, and
the specific gravities of spot urine samples were determined. Homozygous mutants displayed
Table 1. Absolute and relative kidney weights and urine albumin concentrations in homozygous (HOM) and heterozygous (HET) Pou3f3L423P
mutant mice and control (CON) mice at 12 days of age.
Parameter Sex CON (6/11) HET (15/15) HOM (7/5) Statistical significance*
CON vs. HET CON vs. HOM HET vs. HOM
Kidney weight [mg] M 63 ±11 60 ±11 42 ±3 n.s. p<0.01 p<0.01
F 62 ±11 62 ±8 46 ±8 n.s. p<0.01 p<0.01
Relative kidney weight [% of body weight] M 1.8 ±0.2 1.7 ±0.1 1.5 ±0.1 n.s. p<0.05 p<0.05
F 1.8 ±0.1 1.8 ±0.2 1.5 ±0.1 n.s. p<0.05 p<0.05
Urine albumin concentration [μg/ml] M 25 ±9 18 ±6 18 ±8 n.s. n.s. n.s.
f 19 ±3 21 ±7 15 ±4 n.s. n.s. n.s.
Numbers of animals examined are given in brackets (male/female). Data are means ± SD.
* 1-way ANOVA with Gabriel’s post hoc test. n.s. not significant.
doi:10.1371/journal.pone.0158977.t001
Table 2. Absolute and relative kidney weights, serum sodium levels, and urine albumin and creatinine concentrations in homozygous (HOM) and
heterozygous (HET) Pou3f3L423Pmutant mice and control (CON) mice at 60 weeks of age.
Parameter Sex CON (7/7) HET (8/7) HOM (6/6) Statistical significance*
CON vs. HET CON vs. HOM HET vs. HOM
Kidney weight [mg] m 365 c ±23 399 b ±55 229 b ±31 n.s. p<0.001 p<0.001
f 198 c ±23 219 b ±33 112 b ±11 n.s. p<0.001 p<0.001
Relative kidney weight [% of body weight] m 0.9 c ±0.1 1.0 a ±0.1 0.9 b ±0.1 n.s. n.s. p<0.05
f 0.5 c ±0.1 0.7 a ±0.2 0.5 b ±0.0 n.s. n.s. p<0.05
Serum sodium concentration [mmol/l] m 146 ±5 146 ±4 147 ±4 n.s. n.s. n.s.
f 141 ±6 143 ±1 144 ±10 n.s. n.s. n.s.
Urine albumin concentration [μg/ml] m 50 ±20 57 ±22 25 ±24 n.s. n.s. p<0.05
f 125 ±81 38 ±22 11 ±8 n.s. p<0.01 n.s.
Urine creatinine concentration [mg/ml] m 0.21 ±0.05 0.16 ±0.05 0.14 ±0.11 n.s. n.s. n.s.
f 0.19 ±0.04 0.16 ±0.04 0.10 ±0.03 n.s. p<0.05 n.s.
UACR [μg/mg] m 253.3 ±67.0 337.8 ±121.9 183.9 ±48.6 n.s. n.s. n.s.
f 642.4 ±433.3 258.5 ±140.1 114.9 ±76.7 n.s. p<0.05 n.s.
Numbers of animals examined are given in brackets (male/female). UACR: Urine albumin-to-creatinine ratio. Data are means ± SD.
*1-way ANOVA with Gabriel’s post hoc test.
a,b,c: Statistically significant differences (a: p0.05, b: p0.01, c: p0.001) between male and female mice of the identical genotype; n.s. not significant.
doi:10.1371/journal.pone.0158977.t002
Renal Alterations in Pou3f3L423P Mutant Mice
PLOS ONE | DOI:10.1371/journal.pone.0158977 July 15, 2016 10 / 31
44
significantly, on average two-fold higher serum urea concentrations than non-mutant control
mice and heterozygous mutants (male mice: p<0.01, female mice: p<0.05), whereas the serum
urea levels between heterozygous mutants and control mice were not significantly different (Fig
2A).
The serum concentrations of sodium (Table 2) and of cystatin C (Fig 2B), an endogenous
marker of glomerular filtration [41], were also not significantly different between the different
groups of mice.
Urine analyses results revealed no evidence of albuminuria in Pou3f3L423P mutant mice. At
12 days of age, the urine albumin concentrations were not significantly different between
homo- and heterozygous Pou3f3L423P mutants and control mice (Table 1). At 60 weeks of age,
the urine albumin concentrations were even significantly lower in female homozygous mutants
vs. non-mutant controls (p<0.01), as well as in male homo- vs. heterozygous mutants
(p<0.05) (Table 2). Moreover, 60-week-old homozygous Pou3f3L423P mutant mice also consis-
tently displayed lower urine creatinine concentrations, urinary albumin-to-creatinine ratios,
and urine specific gravities than heterozygous Pou3f3L423P mutants and non-mutant control
mice. Here, the specific urine gravity (Fig 2D) in homozygous mutants was significantly lower
than in heterozygous mutants and control mice (male mice: p<0.01, female mice: p<0.05). as
well, the urine creatinine concentrations and the urine albumin-to-creatinine ratios (UACR)
(Table 2) of female homozygous mutants were also statistically significantly lower as compared
to control mice (p<0.05). In contrast, the specific urine gravities (Fig 2D), the urine creatinine
concentrations and the UACRs (Table 2) were not significantly different between heterozygous
mutants and non-mutant controls mice (Fig 2). Corresponding to these quantitative findings,
SDS-PAGE based urine protein analyses did also not demonstrate signs of albuminuria in
homo- or heterozygous Pou3f3L423P mutants (Fig 3).
Qualitative histological, immunohistochemical and ultrastructural kidney
findings
Histological evaluation revealed an obvious decrease in the number of glomerular profiles in
kidney sections of 60-week-old homozygous Pou3f3L423P mutant mice, as compared to hetero-
zygous mutants and non-mutant control mice. Moreover, the glomerular section profiles of
homozygous Pou3f3L423P mutants appeared strikingly smaller than in heterozygous
Pou3f3L423P mutants or control mice (Fig 4). In contrast, histological examination of kidney
sections revealed no conspicuous differences between heterozygous Pou3f3L423P mutants and
control mice (Fig 4).
Apart from the apparently diminished size of glomeruli in 60-week-old homozygous
Pou3f3L423P mutants, which was more prominent than in 12-day-old mutant mice, no qualita-
tive histopathological or ultrastructural glomerular alterations were present in either homo- or
heterozygous mutants at 12-days and at 60-weeks of age (Figs 4 and 5). Histological and ultra-
structural analysis also showed no conspicuous morphological alterations of the epithelial cells
of the thick ascending limb (TAL) of the loop of Henle of 12-day-old, or of 60-week-old homo-
and heterozygous Pou3f3L423P mutant mice (Figs 4 and 5).
The abundance pattern of POU3F3 in different nephron segments and tubular compart-
ments of homozygous Pou3f3L423P mutant mice and non-mutant controls, were demonstrated
by immunohistochemical detection of POU3F3, and co-localization with the TAL marker uro-
modulin (UMOD), and the CD marker aquaporin 2 (AQP2). Immunohistochemical detection
of UMOD in the kidneys of non-mutant controls revealed a diffuse homogeneous cytoplasmic
and distinct apical membrane staining pattern in epithelial cells of the TAL. In contrast, homo-
zygous Pou3f3L423P mutant mice of 12 days of age (data not shown) and of 60 weeks of age
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showed a less dense immunohistochemical UMOD staining pattern of individual TAL section
profiles in the kidney, as compared to age and sex-matched heterozygous mutants and non-
mutant control mice (Fig 6).
Immunohistochemical detection of POU3F3 revealed a nuclear staining pattern in epithelial
cells of the TAL, the MD, and the CDs in homo- and heterozygous mutants and non-mutant
control mice (Fig 6), as demonstrated by co-localization with the TAL marker UMOD and the
Fig 2. Serum urea concentration (A), serum cystatin C concentration (B), mean blood pressure (C), and urine specific gravity of 60-week-old
Pou3f3L423Pmutant mice and non-mutant control mice (D). The numbers of animals examined are given in parentheses. Data are means ± SD.
Significant differences between homozygous and heterozygous mutants and non-mutant control mice are indicated by asterisks. *: p < 0.05, **: p < 0.01,
***: p < 0.001. Significant differences between male and female mice of identical genotypes are indicated by crosses. +: p < 0.05, ++: p < 0.01, +++:
p < 0.001.
doi:10.1371/journal.pone.0158977.g002
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CDmarker AQP2. In contrast, POU3F3 staining was not detectable in glomerular cells. Simul-
taneous detection of UMOD and POU3F3 by double-immunohistochemistry proved the co-
Fig 3. SDS-PAGE urine protein analysis of 60-week-old homozygous (HOM) and heterozygous (HET)
Pou3f3L423P mutant mice and non-mutant control (CON) mice. A representative gel of individual spot
urine samples of three male and female HOM, HET and CONmice diluted to identical creatinine
concentrations is shown. Molecular weight marker (M), murine serum albumin (ALB). Mice of all examined
genotypes display discrete albumin bands (arrow) at approximately 67 kDa. The intensity of the major urinary
protein (MUP) bands at approximately 18–25 kDa in male mice is stronger than in female mice.
doi:10.1371/journal.pone.0158977.g003
Fig 4. Kidney histology of 12-day-old and of 60-week-old homozygous (HOM) and heterozygous (HET) Pou3f3L423P mutant mice and non-
mutant control mice (CON).GMA/MMA sections, HE staining. Bars = 100 μm, in insets = 50 μm.
doi:10.1371/journal.pone.0158977.g004
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expression of both proteins in cells of the TAL (Fig 6). Likewise, the co-expression of POU3F3
and AQP2 in CD cells was shown by immunohistochemical detection of these proteins in con-
secutive sections of kidney tissue (Fig 6).
Quantitative morphological findings
Quantitative morphological data of the renal cortex and the medulla. Corresponding to
the significantly decreased kidney volumes, the total volumes of the renal cortex and of the
Fig 5. Ultrastructural morphology of TAL cells (A, B), podocytes and peripheral glomerular capillary walls (C, D) in
60-week-old, male, homozygous Pou3f3L423Pmutant mice (HOM) and non-mutant control mice (CON). Tubular lumen (l),
tubular basement membrane (TBM), podocyte (p), glomerular capillary (c), podocyte foot processes (FP), glomerular basement
membrane (GBM), Transmission electron microscopy. Bars = 2.5 μmA-D, and = 0.5 μm in insets to C, D.
doi:10.1371/journal.pone.0158977.g005
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Fig 6. Immunohistochemical detection of uromodulin (UMOD, a-d), POU3F3 (e-l), and Aquaporin 2 (AQP2,m-r) in kidney
sections of 60-week-old homozygous Pou3f3L423P mutant mice (HOM) and non-mutant control mice (CON). Positive
immunoreactivity (UMOD, POU3F3, AQP2 in a-h and m-r) is indicated by brown color (chromogen: DAB). In the double-
immunohistochemical detection (i-l), UMOD immunoreactivity is indicated by blue color (chromogen: NBT/BCIP) and POU3F3 by
brown color (DAB). Arrows mark the TAL and the MD, CDs are indicated by hashs, and asterisks mark glomeruli. Black rectangles
indicate the positions of the detail enlargements. Positive UMOD immunoreactivity with a diffuse cytoplasmic and distinct apical
membrane staining pattern is present in epithelial cells of the TAL, POU3F3 immunoreactivity is present in the TAL, the MD and the
CDs (nuclear staining pattern), and CD cells display a cytoplasmic staining pattern for the CDmarker AQP2. Paraffin sections.
Nuclear counterstain: Hemalum. Bars = 1 mm (left row), = 50 μm (middle and right row).
doi:10.1371/journal.pone.0158977.g006
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medulla in 12-day-old and in 60-week-old homozygous Pou3f3L423P mutant mice were consis-
tently, on average one third, smaller than in age- and sex-matched heterozygous mutants and
non-mutant control mice. In contrast, the total cortical and medullary volumes of heterozy-
gous mutants and non-mutant control mice did not differ significantly (Tables 3 and 4). At 12
days of age, male and female mice of identical genotypes displayed approximately equal total
volumes of the renal cortex and of the medulla (Table 3).
At 60 weeks of age, however, the total cortical volumes of female animals were significantly
smaller than in male homozygous (p<0.01) and heterozygous mutants (p<0.001). Corre-
spondingly they also showed consistently significantly smaller total medullary volumes
(p<0.01) than male mice (Table 4).
Quantitative morphological data of the TAL. In juvenile and aged homozygous
Pou3f3L423P mutant mice, the total volume of the TAL of the loop of Henle (V(TAL, Kid)), as well
as the volume density of the TAL in the kidney (VV(TAL/Kid)), were consistently significantly
reduced (on average by 53% and 30% respectively), as compared to age- and sex-matched non-
Table 3. Fractional and absolute volumes of cortex andmedulla in the kidney of homozygous (HOM) and heterozygous (HET) Pou3f3L423P mutant
mice and control (CON) mice at 12 days of age.
Parameter Sex CON (6/11) HET (15/15) HOM (7/5) Statistical significance*
CON vs. HET CON vs. HOM HET vs. HOM
VV(Cortex/Kid) m 0.65 ±0.05 0.66 ±0.04 0.69 ±0.04 n.s. n.s. n.s.
f 0.65 ±0.06 0.66 ±0.04 0.71 ±0.10 n.s. n.s. n.s.
V(Cortex, Kid) [mm
3] m 42.9 ±7.4 39.9 ±8.4 29.5 ±4.7 n.s. p<0.05 p<0.01
f 44.4 ±10.1 40.1 ±6.4 32.3 ±7.2 n.s. p<0.05 n.s.
VV(Med/Kid) m 0.35 ±0.05 0.34 ±0.04 0.31 ±0.04 n.s. n.s. n.s.
f 0.35 ±0.06 0.34 ±0.04 0.29 ±0.10 n.s. n.s. n.s.
V(Med, Kid) [mm
3] m 22.6 ±4.2 19.9 ±3.1 13.4 ±2.9 n.s. p<0.01 p<0.01
f 23.8 ±5.7 20.8 ±5.5 13.0 ±4.8 n.s. p<0.01 n.s.
Numbers of animals examined are given in brackets (male/female). Data are means ± SD.
*1-way ANOVA with Gabriel’s post hoc test; n.s. not significant. Male and female mice of the identical genotype did not display statistically significant
differences in the listed parameters.
doi:10.1371/journal.pone.0158977.t003
Table 4. Fractional and absolute volumes of cortex andmedulla in the kidney of homozygous (HOM) and heterozygous (HET) Pou3f3L423P mutant
mice and control (CON) mice at 60 weeks of age.
Parameter Sex CON (7/7) HET (8/7) HOM (6/6) Statistical significance*
CON vs. HET CON vs. HOM HET vs. HOM
VV(Cortex/Kid) m 0.72
b
±0.03 0.72 ±0.04 0.71 ±0.04 n.s. n.s. n.s.
f 0.64 b ±0.05 0.70 ±0.05 0.75 ±0.07 n.s. p<0.01 n.s.
V(Cortex, Kid) [mm
3] m 292.9 c ±70.7 271.8 c ±44.4 184.0 b ±27.7 n.s. p<0.01 p<0.05
f 150.8 c ±30.0 155.9 c ±34.1 96.8 b ±27.7 n.s. p<0.05 p<0.01
VV(Med/Kid) m 0.28
a
±0.03 0.28 ±0.04 0.29 ±0.04 n.s. n.s. n.s.
f 0.36 a ±0.05 0.30 ±0.05 0.25 ±0.07 n.s. p<0.05 n.s.
V(Med, Kid) [mm
3] m 112.3 ±25.6 106.3 b ±25.6 77.4 b ±24.6 n.s. n.s. n.s.
f 86.3 ±27.4 65.5 b ±18.3 30.8 b ±5.8 n.s. p<0.05 p<0.05
Numbers of animals examined are given in brackets (male/female). Data are means ± SD.
*:1-way ANOVA with Gabriel’s post hoc test.
a,b,c: Statistically significant differences (a: p0.05, b: p0.01, c: p0.001) between male and female mice of the identical genotype; n.s. not significant.
doi:10.1371/journal.pone.0158977.t004
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mutant control mice (p<0.001 at 12 days of age; p<0.01 at 60 weeks of age) (Fig 7). Compared
to heterozygous mutants the V(TAL, Kid) as well as the VV(TAL/Kid) were also significantly smaller
in 12-day-old homozygous mutants (p<0.001). In 60-week-old animals the V(TAL, Kid) was sig-
nificantly smaller in both male (p<0.05) and female (p<0.01) homozygous Pou3f3L423P
mutants, whereas the VV(TAL/Kid) was only significantly reduced in female mice (p<0.05). In
contrast, the total TAL volume and the volume density of the TAL in the kidney of
Fig 7. Volume density of TAL cells in the kidney and absolute TAL volumes in 12-day-old (A, C) and 60-week-old (B, D) Pou3f3L423Pmutant
mice and non-mutant control mice. The numbers of animals examined are given in parentheses. Data are means ± SD. Significant differences
between homozygous and heterozygous mutants and non-mutant control mice are indicated by asterisks. *: p < 0.05, **: p < 0.01, ***: p < 0.001.
Significant differences between male and female mice of identical genotypes are indicated by crosses. +: p < 0.05, ++: p < 0.01, +++: p < 0.001.
doi:10.1371/journal.pone.0158977.g007
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heterozygous mutants and controls were not significantly different, except for the VV(TAL/Kid)
in male 12-day-old mice (p<0.001) (Fig 7).
Quantitative morphological data of the glomeruli. For quantitative characterization of
glomerular alterations, the volume density of the glomeruli in the kidney (VV(Glom/Kid)), the
total volume (V(Glom, Kid)), and the number of nephrons (glomeruli) in the kidney (N(Glom,
Kid)), and the mean glomerular volume (v ðGlomÞ) were determined in both 12-day-old, and in
60-week-old mutant mice and non-mutant controls (Tables 5 and 6; Fig 8). In 60-weeks-old
Pou3f3L423P mutant mice and non-mutant controls, additional quantitative parameters of glo-
merular morphology were determined, including the mean mesangium volume per glomerulus
(V(Mes, Glom)), the mean capillary volume per glomerulus (V(Cap, Glom)), the average length of
the capillaries per glomerulus (L(Cap, Glom)), the number of cells per glomerulus (N(C, Glom)), the
mean podocyte volume (v ðPodÞ), the filtration slit frequency (FSF), and the thickness of the glo-
merular basement membrane (GBM) (Tables 5–7; Fig 8).
Volume density of the glomeruli in the kidney, total and relative glomerular volume.
At 12 days of age, the volume densities of the glomeruli in the kidney were not significantly dif-
ferent between homo- and heterozygous mutants and control mice (Table 5). The total volume
of the glomeruli, however, was consistently smaller in homozygous mutants vs. control mice,
as well as in homo- vs. heterozygous mutants, with statistically significant differences in female
homozygous mutants vs. controls and in male homo- vs. heterozygous mutants (p<0.05). The
total glomerular volumes of heterozygous mutants and control mice were not significantly dif-
ferent (Table 5).
The relative total glomerular volume (total glomerular volume in the kidney in relation to
body weight, V(Glom, Kid)/BW) was not significantly different between 12-day-old homo- and
heterozygous Pou3f3L423P mutant mice and non-mutant controls of both sexes (Table 5).
At 60 weeks of age, however, both the volume densities of the glomeruli in the kidney
(p<0.05) and the total volume of the glomeruli (male p<0.01, female p<0.001) in homozygous
mutant mice were significantly lower as compared to non-mutant control mice. Except for the
Table 5. Quantitative stereological data of glomeruli in homozygous (HOM) and heterozygous (HET) Pou3f3L423Pmutant mice and control (CON)
mice at 12 days of age.
Parameter Sex CON (6/11) HET (15/15) HOM (7/5) Statistical significance*
CON vs. HET CON vs. HOM HET vs. HOM
VV(Glom/Kid) m 0.04 ±0.00 0.04 ±0.01 0.04 ±0.01 n.s. n.s. n.s.
f 0.04 ±0.01 0.04 ±0.00 0.04 ±0.01 n.s. n.s. n.s.
V(Glom, Kid) [mm
3] m 1.68 ±0.30 1.68 ±0.37 1.23 ±0.25 n.s. n.s. p<0.05
f 1.85 ±0.32 1.70 ±0.37 1.33 ±0.32 n.s. p<0.05 n.s.
V(Glom, Kid)/body weight [10
3 x mm3/g] m 117 ±15 117 ±16 108 ±18 n.s. n.s. n.s.
f 131 ±15 121 ±22 110 ±8 n.s. n.s. n.s.
NV(Glom/Kid) [n/mm
3] m 390 ±99 358 ±66 306 ±38 n.s. n.s. n.s.
f 334 ±78 317 ±26 295 ±33 n.s. p<0.05 n.s.
N(Glom,Kid) /BW [n/g] m 176 ±33 148 ±40 122 ±19 n.s. p<0.05 n.s.
f 189 ±40 157 ±20 120 ±25 p<0.05 p<0.001 p<0.05
v ðGlomÞ/BW [10
3
μm3/g] m 22.6 ±1.8 20.7 ±4.1 20.8 ±3.9 n.s. n.s. n.s.
f 21.0 ±2.6 21.2 ±2.4 20.3 ±4.0 n.s. n.s. n.s.
Numbers of examined animals are given in brackets (male/female). Data are means ± SD.
*:1-way ANOVA with Gabriel’s post hoc test; n.s. not significant. Male and female mice of the identical genotype did not display statistically significant
differences in the listed parameters.
doi:10.1371/journal.pone.0158977.t005
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glomerular volume density in the kidneys of female mice, the total glomerular volumes (p<0.01)
and glomerular volume densities (p<0.05) in the kidney of homozygous mutants were also sig-
nificantly reduced as compared to heterozygous mutant mice. In contrast, VV(Glom/Kid) and
V(Glom, Kid) were not statistically significantly different between heterozygous Pou3f3
L423Pmutant
mice and non-mutant controls (Table 6). In contrast to 12-day-old mice, the relative total glo-
merular volumes in 60-week-old homozygous Pou3f3L423Pmutants were markedly reduced, as
compared to heterozygous mutant mice and non-mutant control mice, with a statistically signifi-
cant difference in male homozygous mutants vs. controls (p<0.05). In contrast, the relative total
glomerular volumes of 60-week-old heterozygous mutants and control mice were not signifi-
cantly different (Table 6).
Total and relative nephron number, mean glomerular volume, and relative mean glo-
merular volume. Quantitative stereological analyses revealed a marked reduction of the
numbers of nephrons (glomeruli) in juvenile and aged homozygous Pou3f3L423P mutants as
compared to heterozygous mutants and non-mutant controls, being highly significant in both
sexes at 12 days of age (p<0.001). At 60 weeks of age, nephron numbers were also significantly
lower in homozygous mutants as compared to heterozygous (p<0.05) and non-mutant con-
trols (male p<0.001, female p<0.05). On average, male and female homozygous mutants
showed 40% lower nephron numbers than age and sex-matched, non-mutant controls.
Whereas at 12 days of age, heterozygous mutants displayed also significantly lower nephron
numbers than non-mutant controls (p<0.05), the nephron numbers in 60-week-old heterozy-
gous mutants and controls did not differ significantly (Fig 8). There were no statistically signifi-
cant differences between the number of glomeruli in 12-day-old mice and 60-week-old mice of
identical genotype and gender.
In addition to the significantly lower total number of nephrons, the relative nephron num-
bers (total nephron number per body weight, N(Glom,Kid)/BW) were reduced, reaching statisti-
cal significance in 12-day-old male (p<0.05) and female (p<0.001) homozygous mutants, as
well as in male homozygous mutants of 60 weeks of age (p<0.05) compared to non-mutant
control mice (Tables 5 and 6). The relative nephron numbers of homozygous vs. heterozygous
mutants and of heterozygous mutants vs. control mice were only significantly reduced in
female mice of 12 days of age (p<0.05), but not in 12-day-old male mice, or in mice of 60
weeks of age (Tables 5 and 6).
Confirming the qualitative histological findings, the stereologically determined mean glo-
merular volumes of homozygous Pou3f3L423P mutants were significantly reduced as compared
to control mice in both juvenile (male p<0.01, female p<0.05) and aged animals (male
p<0.01, female p<0.001) (Fig 8). On average, male and female homozygous mutants of both
examined age groups displayed 27% smaller mean glomerular volumes than their age- and sex-
matched controls. In both examined age groups, a statistically significant difference between
the lower mean glomerular volumes in homo- vs. heterozygous mutant mice was only present
in male mice (p<0.05). The mean glomerular volumes in heterozygous mutants and in control
mice were not significantly different between both examined stages of age (Fig 8). In contrast
to the striking reduction of the mean glomerular volumes, the relative mean glomerular vol-
umes (related to body weight) did not display statistically significant differences between
homo- and heterozygous mutants and non-mutant control mice of 12 days or 60 weeks of age
(Tables 5 and 6).
Additional quantitative parameters of glomerular morphology of 60-week-old mice. In
60-week-old mice, the volume densities of the mesangium in the glomeruli were similar in all
examined genotype groups. Corresponding to their lower mean glomerular volume, homozy-
gous Pou3f3L423P mutant mice also displayed lower mean mesangial volumes per glomerulus
(V(Mes, Glom)) than heterozygous mutants and control mice, and heterozygous mutants
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Table 6. Quantitative stereological data of glomeruli and glomerular subcompartments in homozygous (HOM) and heterozygous (HET)
Pou3f3L423P mutant mice and control (CON) mice at 60 weeks of age.
Parameter Sex CON (7/7) HET (8/7) HOM (6/6) Statistical significance*
CON vs. HET CON vs. HOM HET vs. HOM
VV(Glom/Kid) m 0.018
c
±0.004 0.017 c ±0.003 0.013 c ±0.002 n.s. p<0.05 p<0.05
f 0.030 c ±0.003 0.026 c ±0.005 0.023 c ±0.004 n.s. p<0.05 n.s.
V(Glom, Kid) [mm
3] m 5.35 ±1.57 4.69 ±0.97 2.28 ±0.59 n.s. p<0.01 p<0.01
f 4.44 ±0.89 4.00 ±0.81 2.27 ±0.82 n.s. p<0.001 p<0.01
V(Glom, Kid)/body weight [10
3 x mm3/g] m 136 ±41 121 ±21 85 ±17 n.s. p<0.05 n.s.
f 120 ±27 136 ±61 98 ±28 n.s. n.s. n.s.
NV(Glom/ Kid) [n/mm
3] m 72 b ±20 62 b ±10 59 b ±9 n.s. n.s. n.s.
f 114 b ±27 110 b ±38 130 b ±20 n.s. n.s. n.s.
N(Glom, Kid) /BW [n/g] m 386 ±43 341 ±70 301
a
±38 n.s. p<0.05 n.s.
f 344 ±85 409 ±131 403 a ±75 n.s. n.s. n.s.
v ðGlomÞ/BW [10
3
μm3/g] m 7.9 ±1.9 6.6 ±1.2 6.0 ±0.7 n.s. p<0.05 n.s.
f 6.9 ±0.9 7.9 ±2.8 6.1 ±1.2 n.s. n.s. n.s.
VV(Mes/Glom) m 0.28 ±0.04 0.23 ±0.02 0.26 ±0.08 n.s. n.s. n.s.
f 0.25 ±0.04 0.25 ±0.04 0.26 ±0.07 n.s. n.s. n.s.
V(Mes, Glom) [x10
3
μm3] m 86 a ±18 58 ±12 40 ±8 p<0.01 p<0.001 n.s.
f 66 a ±9 57 ±11 35 ±6 n.s. p<0.01 p<0.05
VV(Cap/Glom) m 0.44
b
±0.03 0.51 ±0.02 0.47 ±0.05 p<0.01 n.s. n.s.
f 0.50 b ±0.04 0.50 ±0.06 0.44 ±0.06 n.s. n.s. n.s.
V(Cap, Glom) [x10
3
μm3] m 137 ±42 130 ±30 76 ±18 n.s. p<0.05 p<0.05
f 139 ±37 114 ±15 63 ±21 n.s. p<0.01 n.s.
VV(Pod/Glom) m 0.28 ±0.02 0.26 ±0.01 0.27 ±0.04 n.s. n.s. n.s.
f 0.26 ±0.04 0.26 ±0.04 0.29 ±0.03 n.s. n.s. n.s.
v ðPod; GlomÞ [x10
3
μm3] m 87 ±23 67 ±18 44 ±12 n.s. p<0.01 n.s.
f 71 ±22 60 ±15 41 ±12 n.s. p<0.05 n.s.
LV(Cap/Glom) [mm/mm
3] m 0.014 ±0.003 0.018 ±0.003 0.019 ±0.004 n.s. n.s. n.s.
f 0.017 ±0.003 0.020 ±0.003 0.020 ±0.004 n.s. n.s. n.s.
L(Cap, Glom) [mm] m 4.2 ±0.5 4.3 ±0.4 3.0 ±0.4 n.s. p<0.001 p<0.001
f 4.5 ±0.6 4.7 ±0.5 2.8 ±0.5 n.s. p<0.05 p<0.05
L(Glom-cap, Kid) [m] m 72 ±12 81 ±14 42 ±9 n.s. p<0.05 p<0.01
f 76 ±13 81 ±16 45 ±11 n.s. p<0.05 p<0.01
NV(C/Glom) [n/10
5
μm3] m 95 ±12 101 ±11 105 a ±7 n.s. n.s. n.s.
f 108 ±16 111 ±6 128 a ±16 n.s. n.s. n.s.
N(C, Glom) m 277 ±45 258 ±66 168 ±20 n.s. p<0.01 p<0.05
f 295 ±65 252 ±24 175 ±36 n.s. p<0.01 n.s.
NV(M-E/Glom) [n/10
5
μm3] m 58 ±8 61 ±14 57 a ±4 n.s. n.s. n.s.
f 68 ±13 66 ±2 74 a ±16 n.s. n.s. n.s.
N(M-E,Glom) m 173 ±43 159 ±63 91 ±16 n.s. p<0.05 n.s.
f 189 ±70 153 ±22 104 ±36 n.s. p<0.01 n.s.
NV (Pod/Glom) [n/10
5
μm3] m 37 ±8 41 ±8 48 ±6 n.s. n.s. n.s.
f 40 ±10 44 ±6 54 ±13 n.s. n.s. n.s.
N(Pod,Glom) m 104 ±5 100 ±9 76 ±5 n.s. p<0.001 p<0.01
f 106 ±7 100 ±3 72 ±7 n.s. p<0.001 p<0.01
v ðPodÞ m 811 ±204 675 ±161 574 ±122 n.s. n.s. n.s.
f 602 ±141 594 ±161 572 ±165 n.s. n.s. n.s.
Numbers of animals examined are given in brackets (male/female). Data are means ± SD.
*:1-way ANOVA with Gabriel’s post hoc test.
a,b,c: Statistically significant differences (a: p0.05, b: p0.01, c: p0.001) between male and female mice of the identical genotype; n.s. not significant.
doi:10.1371/journal.pone.0158977.t006
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displayed lower mean mesangial volumes per glomerulus than control mice (Table 6). These
differences reached statistical significance in homozygous vs. control mice (male p<0.001,
female p<0.01), female homozygous vs. heterozygous mutant mice (p<0.05), and male hetero-
zygous mutants vs. control mice (p<0.01).
The mean capillary volume per glomerulus (V(Cap, Glom)) of homozygous Pou3f3
L423P
mutant mice of both sexes was significantly lower as compared to non-mutant controls
(p<0.05). Compared to heterozygous mutants only male homozygous mutants showed a
Fig 8. Number of glomeruli per kidney andmean glomerular volumes in 12-day-old (A, C) and 60-week-old (B, D) Pou3f3L423P mutant mice and
non-mutant control mice. The numbers of examined animals are given in parentheses. Data are means ± SD. Significant differences between
homozygous and heterozygous mutants and non-mutant control mice are indicated by asterisks. *: p < 0.05, **: p < 0.01, ***: p < 0.001. Significant
differences between male and female mice of identical genotypes are indicated by crosses. +: p < 0.05, ++: p < 0.01, +++: p < 0.001.
doi:10.1371/journal.pone.0158977.g008
Renal Alterations in Pou3f3L423P Mutant Mice
PLOS ONE | DOI:10.1371/journal.pone.0158977 July 15, 2016 21 / 31
55
statistical significant reduction (p<0.05). The mean length of the capillaries per glomerulus
(L(Cap, Glom)) was significantly reduced in homozygous mutants as compared to both heterozy-
gous mutants and non-mutant controls (male p<0.001, female 0.05). Concordingly the total
length of the glomerular capillaries in the kidney (L(Glom-cap, Kid)) in homozygous Pou3f3
L423P
mutant mice was consistently significantly lower than in heterozygous mutants (p<0.01) and
non-mutant control mice (p<0.05). In contrast, these parameters were not significantly differ-
ent between heterozygous mutant mice and controls (Table 6).
Corresponding to their smaller mean glomerular volumes, male and female homozygous
Pou3f3L423P mutant mice exhibited significantly lower numbers of cells per glomerulus than
sex-matched control mice (p<0.01, on average -37%). Compared to sex-matched heterozygous
mutant mice, male, but not female homozygous mutant mice also displayed a significantly
lower total number of cells per glomerulus (p<0.05). In contrast, the total number of cells per
glomerulus was not significantly different between heterozygous mutants and control mice of
both sexes (Table 6). Concordantly, homozygous Pou3f3L423P mutant mice exhibited signifi-
cantly reduced numbers of podocytes (p<0.001) and of mesangial and endothelial cells per glo-
merulus as compared to control mice (male p<0.05, female p<0.01). Except for the
significantly reduced number of podocytes per glomerulus in male homo- vs. heterozygous
mutants (p<0.01), heterozygous mutant mice did not display significantly different podocyte
or mesangial and endothelial cell numbers per glomerulus as compared to homozygous
mutants or non-mutant control mice (Table 6). The mean podocyte volumes were not signifi-
cantly different between mice of the three examined genotypes (Table 6). The true harmonic
mean thickness of the GBM of homozygous Pou3f3L423P mutant mice of both sexes was signifi-
cantly smaller (about -20%) than in heterozygous mutants (p<0.05), whereas there were no
significant differences in GBM thickness between homozygous mutants and controls, or
between heterozygous mutants and control mice (Table 7). The number of filtration slits
between adjacent podocyte foot processes per length of the GBM was virtually equal in all
examined groups of mice (Table 7).
Renal POU3F3 mRNA and protein abundance
Quantitative RT-real time PCR (RT-qPCR) analyses (Fig 9A and 9B) did not reveal statistically
significantly different relative renal Pou3f3mRNA abundances (relative to Gapdh) in homozy-
gous and heterozygous Pou3f3L423P mutant mice and non-mutant control mice. The relative
renal mRNA abundances of Umod (relative to Gapdh), however, were significantly lower in
homozygous Pou3f3L423P mutant mice than in non-mutant control mice (p<0.05), and in male
homo- vs. heterozygous mutants (p<0.05). Correspondingly, homozygous Pou3f3L423P mutant
Table 7. True harmonicmean thickness of the glomerular basement membrane (GBM) and filtration slit frequency (FSF) in homozygous (HOM)
and heterozygous (HET) Pou3f3L423P mutant mice and control (CON) mice at 60 weeks of age.
Parameter Sex CON (7/7) HET (8/7) HOM (6/6) Statistical significance*
CON vs. HET CON vs. HOM HET vs. HOM
Th(GBM) [nm] m 178 ±12 185 ±11 156 ±13 n.s. n.s. p<0.05
f 164 ±6 178 ±12 146 ±4 n.s. n.s. p<0.05
FSF [n/mm GBM] m 2504 ±194 2568 ±179 2573 ±67 n.s. n.s. n.s.
f 2560 ±189 2517 ±61 2631 ±158 n.s. n.s. n.s.
Numbers of animals examined are given in brackets (male/female). Data are means ± SD.
*:1-way ANOVA with Gabriel’s post hoc test.
a,b,c: Statistically significant differences (a: p0.05, b: p0.01, c: p0.001) between male and female mice of the identical genotype; n.s. not significant.
doi:10.1371/journal.pone.0158977.t007
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mice displayed significantly higher relative renal Pou3f3mRNA abundances (relative to Umod)
than heterozygous mutants (p<0.001) and non-mutant control mice (p<0.001). By Western-
blot analysis, renal POU3F3 protein was detectable in total kidney protein lysates of homozy-
gous and heterozygous Pou3f3L423P mutant mice, as well as in non-mutant control mice (Fig
9C and 9D).
Discussion
In the mammalian kidney, development of functioning nephrons in adequate numbers (i.e.,
nephron endowment) depends on the proper induction of nephrons in the embryonic meta-
nephros, the subsequent transition of the renal vesicles into segmented nephrons (nephron
patterning), and the maturation of the different nephron segments. These processes are
Fig 9. RT-qPCR (A, B) andWestern blot analyses (C, D) of relative POU3F3 abundances in the kidneys of 60-week-old (B, D) homozygous
(HOM) and heterozygous (HET) Pou3f3L423P mutant mice and non-mutant control mice (CON). The relative mRNA abundances (Pou3f3 vs.
Gapdh, Umod vs.Gapdh, and Pou3f3 vs. Umod) were normalized to the corresponding mean relative mRNA abundances of non-mutant control
mice. The numbers of animals examined are given in parentheses. Data are means ± SD. Significant differences between homozygous and
heterozygous mutants and non-mutant control mice are indicated by asterisks. *: p < 0.05, **: p < 0.01, ***: p < 0.001.
doi:10.1371/journal.pone.0158977.g009
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controlled by complex, temporally and spatially coordinated interaction networks of several
different transcription- and growth factors, receptors, and signaling molecules/cascades that
regulate nephro-nephronogenesis by activation or repression of genes in specific cell types
[4,6,7]. The early fetal induction of ureteric bud branching, the accurate signaling between the
tips of the developing ureteric bud and the surrounding metanephric mesenchyme leading to
formation the renal vesicle (nephron induction), the subsequent metanephric mesenchymal to
epithelial transformation in the renal vesicle and its conversion to primitive nephrons
(comma- and S-shaped bodies) is controlled by transcriptional pathways, inter alia involving
the glial-derived neurotrophic factor (GDNF) and CRET (ret proto-oncogene) signaling path-
way, the WNT-beta-catenin cascade, and transcription- and inducing factors as EYA1 (eyes
absent homolog 1 transcriptional coactivator and phosphatase 1), LIF (leukemia inhibitory fac-
tor), FGF2 (fibroblast growth factor 2), and TGFB2 (transforming growth factor beta 2) [4,6,7].
The subsequent patterning of the nephron, i.e., the formation of distinct differentiated tubular
segments along the proximal–distal nephron axis, and the invasion of capillaries and further
differentiation to immature glomeruli is governed by transcription factors such as WT1
(Wilms’ tumor 1), LHX1 (LIM homeobox 1), POU3F3, and DLL1 (delta-like 1). Here, Notch–
Delta pathway signaling particularly determines the patterning of proximal tubular nephron
segments, whereas the fate of the distal nephron is specified by POU3F3 and IRX (iroquois
homeobox) transcription factors [4,6,7]. However, the exact functions, the manifold interac-
tions, and the regulatory hierarchies of all different factors involved in nephro-nephronogen-
esis are not yet fully clarified. In mice, the final maturation of the glomeruli, different tubular
nephron segments, and the CDs is completed around postnatal day 7–10 [42].
The putative functions of several nephrogenetic factors were discovered and studied in
genetically modified rodent models, where the complete or partial loss of function of a single
growth or transcription factor led to a distinct phenotype, as, e.g., a typical malformation of the
entire kidney, or of a distinct nephron segment [43–45]. Likewise, the important role of
POU3F3 in nephron patterning during nephrogenesis, particularly for formation, differentia-
tion, elongation, and maturation of the thick ascending limb (TAL) of the loop of Henle and
the differentiation of the macula densa (MD) was discovered in Pou3f3 knock-out mice and
reported by Nakai et al. in 2003 [5]. In the developing nephron, Pou3f3 expression was detected
in distal renal vesicles, S-shaped bodies, and nephron regions that develop into the TAL, the
MD, and the distal convoluted tubule, where Pou3f3 expression also persists in the mature
nephron. In the kidneys of homozygous Pou3f3 knock-out mice, the TAL is largely absent at
birth [5]. New-born homozygous Pou3f3 knock-out mice exhibit increased plasma urea and
potassium levels and die from renal failure within 24 hours after birth [5].
Possible mechanisms how POU3F3 deficiency triggers underdevelopment of the TAL
include reduced cell proliferation and early onset of apoptosis in the primitive nephron loops
of homozygous Pou3f3 knock-out embryos [5].
Indicating a gene-dosage dependent role of POU3F3 in regulation of gene expression in the
TAL, adult heterozygous Pou3f3 knock-out mice display reduced expression levels of genes
normally expressed in the TAL (including Umod, Nkcc2, and different K+ and Cl- channels).
However, there is no evidence for an altered cellular morphology or limitation of normal TAL
function heterozygous knock-out mice, as shown by histological and ultrastructural analyses
and by unaltered blood/serum levels of urea, creatinine, Na+, K+, Cl-, and normal urine osmo-
lality and volumes [5].
The present study analyzed Pou3f3L423P-mice, a mutant mouse line that was recently gener-
ated in the Munich ENU-Mouse-Mutagenesis project [15,16]. The point mutation in the
Pou3f3 gene is not lethal and, in contrast to homozygous Pou3f3-knock-out mice, homozygous
Pou3f3L423P mutant mice are viable and fertile [16] and thus can be used to study the effects of
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the POU3F3 mutation on renal development, morphology, and function in the postnatal life.
Adult homozygous Pou3f3L423P mutant mice have previously been shown to display increased
plasma urea levels, along with several other metabolic changes, including increased creatinine,
chloride, and potassium serum levels, as well as a decreased bone mineral density and bone
mineral content, indicative for impaired renal function, [5,16].
To analyze both immediate developmental effects on the nephronogenesis as well as long-
term consequences of the Pou3f3L423P mutation on renal function and morphology, homo- and
heterozygous mutant mice and non-mutant controls were examined at 12 days, around com-
pletion of nephronogenesis [12], and at 60 weeks of age. For a comprehensive morphological
analysis of the development, growth and cellular composition of distinct nephron segments,
such as the TAL and the glomeruli, qualitative histological and ultrastructural examinations, as
well as unbiased, design-based quantitative stereological methods were applied [46–48]. The
results of these analyses confirmed the significant role of POU3F3 in nephrogenesis, and par-
ticularly in the development of the TAL, which is in line with the findings in Pou3f3 knock-out
mice reported by Nakai et al. [5]. Both 12-day-old and 60-week-old homozygous Pou3f3L423P
mutant mice displayed significantly smaller kidney weights and volumes than non-mutant
controls, as well as significantly lower total TAL volumes and volume densities of the TAL in
the kidney. Given the important function of the TAL in renal nitrogen metabolism [8,49], the
incomplete formation of the TAL might provide an explanation for the increased serum urea
concentrations detected in homozygous Pou3f3L423P mutants [5,16].
In further accordance with the findings by Nakai et al., the present study immunohisto-
chemically detected POU3F3 in the TAL and the MD of both juvenile and aged, mutant and
non-mutant mice, confirming the importance of POU3F3 in fetal development of the TAL,
and providing additional evidence for its putative role in maintenance of the function of the
TAL in the developed kidney [5]. Additionally, the present study detected a positive POU3F3
immunostaining in CD cell nuclei of the mature kidney, which has not been described in the
developing kidney [5].
Basically, a meaningful quantitative comparison of the effects of a complete POU3F3 defi-
ciency in Pou3f3 knock-out mice with the consequences of the Pou3f3L423P mutation on the
extent of TAL under-development is not possible, since mice of different ages and different
genetic backgrounds were investigated, and since the extent of TAL under-development was
only semiquantitatively assessed in the study of Nakai et al. [5]. However, marked alterations
of the cellular morphology and the ultrastructure of TAL cells, as observed in Pou3f3 knock-
out mice [5], were not present in homozygous Pou3f3L423P mutants examined in the present
study. In addition to the underdevelopment of the TAL, quantitative stereological analyses
revealed a striking, significant reduction of the absolute nephron numbers and the relative
numbers of nephrons per body weight, as well as a significant decrease of the mean glomerular
volume (but not of the relative mean glomerular volume per body weight) in the kidneys of
homozygous Pou3f3L423P mutants, present at 12 days of age. The same findings were also pres-
ent in aged, 60-week-old homozygous Pou3f3L423P mutant mice, except for the relative neph-
ron number, which was only significantly reduced in male, but not in female homozygous
mutants vs. control mice. In Pou3f3 knock-out mice, a comparable effect of abolished POU3F3
function on reduction of the numbers and sizes of glomeruli has not been reported, probably
because nephronogenesis and glomerular development are still in progress in newborn mice
[12], or due to application of a less accurate method for quantification and sizing of glomeruli.
Therefore, in addition to its known role in nephron patterning (i.e., development of the TAL),
the results of the present study show that POU3F3 is also involved in determination of the final
nephron number (nephron endowment) of the mature mouse kidney. In this context, the
reduction of the absolute nephron number in homozygous mutants vs. control mice actually
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appears to represent the decisive parameter, rather than alterations of the relative nephron
number. Studies in different mouse strains did reveal a correlation between kidney- and body
weight at birth and at adulthood, but not between the number of nephrons and body weight or
between nephron number and kidney size [50]. Therefore, the finding that a significant reduc-
tion of the relative nephron number, as observed in male and female 12-day-old homozygous
Pou3f3L423P mutants, was only present in male, but not in female homozygous mutants of 60
weeks of age does not contradict a role of POU3F3 for nephron endowment of the kidney.
Long-term consequences of the quantitative reduction of the TAL were essentially restricted
to functional alterations of the tubular system, like alterations in serum and urine parameters
(i.e., elevation of serum urea concentrations and decreased specific urine gravities), whereas no
further pathomorphological alterations of the tubular system were detected in the kidneys of
aged homozygous Pou3f3L423P mutants. In these mice, the Pou3f3mutation and the altered
TAL did also not exert detectable effects on glomerular function, as the serum cystatin C con-
centration, urine albumin excretion, and blood pressure were unaffected in aged mutant mice.
Apart from the reduced nephron number and the diminished size of the glomeruli, no func-
tional, qualitative or quantitative morphological alterations were detected in aged, 60-week-old
Pou3f3L423P mutant mice. Protein analyses of spot urine samples did not reveal any evidence
for an increased urinary albumin excretion in Pou3f3L423P mutant mice as compared to non-
mutant controls. These findings are in line with previously reported results of analyses of
24-hour urine samples, where the urinary albumin and total protein excretion per day was not
significantly different between homozygous Pou3f3L423P mutants and control mice of 15 weeks
of age [16]. Moreover, no evidence of histological or ultrastructural glomerular lesions was
present in Pou3f3L423P mutants, and quantitative morphological parameters, such as the GBM
thickness, or the mean podocyte volume, representing sensitive and early indicators of glomer-
ular damage [17,27,32] were similar in mutant mice and non-mutant controls. Thus, the
reduced nephron endowment in mutant mice did obviously not cause functionally relevant
alterations of the glomerular morphology.
In the present study, RT-qPCR and Western-blot analyses did not reveal evidence for a
reduced mRNA or protein abundance of POU3f3 in the kidneys of homozygous or heterozy-
gous Pou3f3L423P mutant mice, as compared to non-mutant control mice. A possible explana-
tion for the observed differences in Pou3f3 knock-out and Pou3f3L423P mutant mice, such as
the neonatal death in Pou3f3 knock-out mice, might lie in an altered, but not completely abol-
ished activity of the mutant POU3F3 protein. The Pou3f3L423P mutation is located in the con-
served homeobox domain of the protein and might therefore alter the transcriptional
regulation of all or a subset of POU3F3 target genes. Additionally, lack of distinct POU3F3
functions in homozygous mutant mice might partially be compensated by unknown other,
synergistically acting factors. Finally, the milder phenotype of heterozygous Pou3f3 knock-out
mice and of heterozygous Pou3f3L423P mutants can also be interpreted as a gene-dose depen-
dent effect [5]. However, further studies are necessary to clear the exact molecular mechanisms,
how POU3F3 participates in regulation of nephrogenesis and maintenance of TAL function in
the mature kidney, including the timely and spatially coordinated transcriptional control of its
target-genes, interaction with other factors, and potential modulation of different signaling
pathways regulating cell proliferation, differentiation, and apoptosis [5]. In these studies,
Pou3f3L423P mutant mice might prove a useful model system.
Finally, the observed reduction in the nephron number in homozygous Pou3f3L423P mutant
mice is of particular interest, since a low nephron endowment is considered as an important
individual risk factor for development of diverse chronic kidney diseases in humans [51–53].
Several studies in human beings and animal models have shown that low nephron numbers are
often associated with glomerular hypertrophy [43,54,55], a pathogenetic key lesion for
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development of glomerulosclerosis [56,57], and with hypertension [52,58–60]. In this context,
the a priori low number of nephrons is seen as a “first hit”, predisposing the kidney to a facili-
tated development of glomerular hypertrophy, promoting subsequent establishment of glomer-
ulosclerotic lesions, progressive loss of nephrons and renal function, and establishment of
hypertension, if challenged by a “second hit”, as e.g., a primary nephropathy, diabetes mellitus,
or obesity [53,61–63]. The exact pathomechanisms how a low nephron endowment may favor
the development of glomerular hypertrophy (e.g., by induction of compensatory glomerular
growth [43] mediated by glomerular growth factors [56,64]) or hypertension (e.g., by inappro-
priate activation of the renin angiotensin system, impaired tubular salt excretion causing salt
and volume retention, or by structural alterations of peritubular vessels) are, however, not
completely understood yet [43]. There are currently only few murine models of genetically
determined low nephron numbers, such as heterozygous Gdnf knock-out mice [43,65]. Com-
pared to non-mutant controls, these mice display approximately 33% lower nephron numbers,
while their body- and kidney weights are not altered [43,65]. However, apart from a higher
occurrence of unilateral renal agenesis in heterozygous Gdnf knock-out mice, the reduction of
nephron numbers also leads to development of a specific pattern of glomerular alterations,
such as glomerular hypertrophy with hyperplasia of endothelial and mesangial glomerular cells
and thickening of the glomerular basement membrane (GBM), predisposing the mice to devel-
opment of glomerular sclerosis [43]. In contrast, a comparable reduction of nephron numbers
in homozygous Pou3f3L423P mutant mice by 37% on the average was not associated with an
“own” pattern of pathological alterations of glomerular morphology and function, such as glo-
merular hypertrophy, glomerular mesangial and endothelial cell hyperplasia, thickening of the
GBM, or albuminuria. Correspondingly, the aged Pou3f3L423P mutant mice examined in the
present study, did also not display significantly elevated blood pressures or serum sodium con-
centrations, as compared to sex-matched non-mutant control mice. These findings are in line
with the results of a previous study [16], where the 24-hrs-urine-volumes, as well as the daily
urinary sodium excretion in homozygous Pou3f3L423P mutant mice were not significantly
lower than in non-mutant control mice. The lack of pathogenetically relevant morphological
glomerular alterations and the absence of evidence for altered renal sodium homeostasis or vol-
ume retention explain why Pou3f3L423P mutant mice do not display systemic hypertension
despite their significantly reduced nephron endowment. The lack of primary pathomorpholo-
gical glomerular lesions and hypertension in homozygous Pou3f3L423P mutant mice might
actually be advantageous, since it might allow for examination of the effects of reduced neph-
ron numbers independent of concomitant glomerular lesion patterns. This might be particu-
larly important, if Pou3f3L423P mutant mice are used as a model for a low nephron endowment
in experiments analyzing the role of reduced nephron numbers as a predisposing factor for
development of aggravated renal/glomerular lesions. Such an experimental approach could
comprise the comparison of a group of homozygous Pou3f3L423P mutant mice and a group of
mice with “normal” nephron numbers, both being challenged with an additional renal insult.
In summary, the results of the present study confirm the important function of POU3F3 in
nephron patterning, especially in development of the TAL. Additionally, we provide strong evi-
dence that POU3F3 is also involved in nephron induction, the determination of nephron num-
bers, and in nephron size in the murine kidney. The detailed characterization of the renal
morphology and function of Pou3f3L423P mutants provides the basis for their use as an experi-
mental animal model of low nephron numbers in nephrological research, as well as in further
studies examining the molecular and cellular functions of POU3F3 during nephrogenesis.
Renal Alterations in Pou3f3L423P Mutant Mice
PLOS ONE | DOI:10.1371/journal.pone.0158977 July 15, 2016 27 / 31
61
Supporting Information
S1 Table. Exact p values of statistically analyzed parameters of homozygous (HOM) and
heterozygous (HET) Pou3f3L423P mutant mice and control (CON) mice at 12 days of age.
Statistically significant differences between genotypes were determined by using a 1-way
ANOVA with Gabriel’s post hoc test, differences between male and female mice of the identical
genotype by Student’s t-test.
(DOCX)
S2 Table. Exact p values of statistically analyzed parameters of homozygous (HOM) and
heterozygous (HET) Pou3f3L423P mutant mice and control (CON) mice at 60 weeks of age.
UACR: Urine albumin-to-creatinine ratio. Statistically significant differences between geno-
types were determined by using a 1-way ANOVA with Gabriel’s post hoc test, differences
between male and female mice of the identical genotype by Student’s t-test.
(DOCX)
Acknowledgments
The authors thank Prof. Dr. Wegener (Institute of Biochemistry, Emil Fischer Center, Univer-
sity Erlangen-Nuremberg, Germany) for providing the BRN1 antibody, Lisa Pichl, Heike Sper-
ling, Claudia Mair and Heidrun Schöl (Institute of Veterinary Pathology at the Centre for
Clinical Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Germany),
and Tatjana Schröter, Kathrin Hedegger, Christine Hösl, and Franziska Kreß (Chair for Molec-
ular Animal Breeding and Biotechnology and Laboratory for Functional Genome Analysis,
Gene Center, Ludwig-Maximilians-Universität München, Munich, Germany) for excellent
technical support.
Author Contributions
Conceived and designed the experiments: AR EK SK BP BA EW RWAB. Performed the exper-
iments: AR EK BP AB. Analyzed the data: AR EK BP RW AB. Contributed reagents/materials/
analysis tools: AR EK SK BP BA EW RWAB. Wrote the paper: AR EK SK BP BA EW RWAB.
References
1. Ryan AK, Rosenfeld MG. POU domain family values: flexibility, partnerships, and developmental
codes. Genes Dev. 1997; 11: 1207–1225. PMID: 9171367
2. McEvilly RJ, de Diaz MO, Schonemann MD, Hooshmand F, Rosenfeld MG. Transcriptional regulation
of cortical neuron migration by POU domain factors. Science. 2002; 295: 1528–1532. PMID: 11859196
3. Sugitani Y, Nakai S, Minowa O, Nishi M, Jishage K, Kawano H, et al. Brn-1 and Brn-2 share crucial
roles in the production and positioning of mouse neocortical neurons. Genes Dev. 2002; 16: 1760–
1765. PMID: 12130536
4. El-Dahr SS, Aboudehen K, Saifudeen Z. Transcriptional control of terminal nephron differentiation. Am
J Physiol Renal Physiol. 2008; 294: F1273–1278. doi: 10.1152/ajprenal.00562.2007 PMID: 18287399
5. Nakai S, Sugitani Y, Sato H, Ito S, Miura Y, Ogawa M, et al. Crucial roles of Brn1 in distal tubule forma-
tion and function in mouse kidney. Development. 2003; 130: 4751–4759. PMID: 12925600
6. O'Brien LL, McMahon AP. Induction and patterning of the metanephric nephron. Semin Cell Dev Biol.
2014; 36: 31–38. doi: 10.1016/j.semcdb.2014.08.014 PMID: 25194660
7. Schedl A. Renal abnormalities and their developmental origin. Nat Rev Genet. 2007; 8: 791–802.
PMID: 17878895
8. Mount DB. Thick ascending limb of the loop of Henle. Clin J Am Soc Nephrol. 2014; 9: 1974–1986. doi:
10.2215/CJN.04480413 PMID: 25318757
9. Pennica D, Kohr WJ, KuangWJ, Glaister D, Aggarwal BB, Chen EY, et al. Identification of human uro-
modulin as the Tamm-Horsfall urinary glycoprotein. Science. 1987; 236: 83–88. PMID: 3453112
Renal Alterations in Pou3f3L423P Mutant Mice
PLOS ONE | DOI:10.1371/journal.pone.0158977 July 15, 2016 28 / 31
62
10. Tamm I, Horsfall FL Jr. Characterization and separation of an inhibitor of viral hemagglutination present
in urine. Proc Soc Exp Biol Med. 1950; 74: 106–108. PMID: 15430405
11. Burg MB. Thick ascending limb of Henle's loop. Kidney Int. 1982; 22: 454–464. PMID: 6296522
12. Lechner MS, Dressler GR. The molecular basis of embryonic kidney development. Mech Dev. 1997;
62: 105–120. PMID: 9152004
13. Little MH. Improving our resolution of kidney morphogenesis across time and space. Curr Opin Genet
Dev. 2015; 32: 135–143. doi: 10.1016/j.gde.2015.03.001 PMID: 25819979
14. Cullen-McEwen L, Sutherland MR, Black MJ (2016) The Human Kidney: Parallels in Structure, Spatial
Development, and Timing of Nephrogenesis. Kidney Development, Disease, Repair and Regeneration:
Elsevier. pp. 27–40.
15. Aigner B, Rathkolb B, Herbach N, Kemter E, Schessl C, Klaften M, et al. Screening for increased
plasma urea levels in a large-scale ENUmouse mutagenesis project reveals kidney disease models.
Am J Physiol Renal Physiol. 2007; 292: F1560–1567. PMID: 17264314
16. Kumar S, Rathkolb B, Kemter E, Sabrautzki S, Michel D, Adler T, et al.Generation and Standardized,
Systemic Phenotypic Analysis of Pou3f3L423PMutant Mice. PLoS One. 2016; 11: e0150472. doi: 10.
1371/journal.pone.0150472 PMID: 27003440
17. Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Goke B, et al.Diabetic kidney lesions of GIPRdn
transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy
and glomerulosclerosis. Am J Physiol Renal Physiol. 2009; 296: F819–829. doi: 10.1152/ajprenal.
90665.2008 PMID: 19211686
18. Wanke R, Wolf E, Brem G, HermannsW. [Role of podocyte damage in the pathogenesis of glomerulo-
sclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of pro-
gressive nephropathy]. Verh Dtsch Ges Pathol. 2001; 85: 250–256. PMID: 11894406
19. Albl B, Haesner S, Braun-Reichhart C, Streckel E, Renner S, Seeliger F, et al. Tissue Sampling Guides
for Porcine Biomedical Models. Toxicol Pathol. 2016; 44: 414–420. doi: 10.1177/0192623316631023
PMID: 26883152
20. HermannsW, Liebig K, Schulz LC. Postembedding immunohistochemical demonstration of antigen in
experimental polyarthritis using plastic embedded whole joints. Histochemistry. 1981; 73: 439–446.
PMID: 7035413
21. Hoeflich A, Weber MM, Fisch T, Nedbal S, Fottner C, Elmlinger MW, et al. Insulin-like growth factor
binding protein 2 (IGFBP-2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/
IGF-I excess on adrenocortical cells in vivo. FASEB J. 2002; 16: 1721–1731. PMID: 12409314
22. Nyengaard JR. Stereologic methods and their application in kidney research. J Am Soc Nephrol. 1999;
10: 1100–1123. PMID: 10232698
23. Kemter E, Prueckl P, Sklenak S, Rathkolb B, Habermann FA, HansW, et al. Type of uromodulin muta-
tion and allelic status influence onset and severity of uromodulin-associated kidney disease in mice.
HumMol Genet. 2013; 22: 4148–4163. doi: 10.1093/hmg/ddt263 PMID: 23748428
24. Howard V, Reed MG. Unbiased stereology. New York: Garland Science/BIOS Scientific Publishers;
2004.
25. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. J
Microsc. 1984: 127–136. PMID: 6737468
26. Blutke A, Schneider MR, Wolf E, Wanke R. Growth hormone (GH)-transgenic insulin-like growth factor
1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular
growth. Physiol Rep. 2016;4.
27. Blutke A, Schneider MR, Renner-Muller I, Herbach N, Wanke R, Wolf E. Genetic dissection of IGF1-
dependent and -independent effects of permanent GH excess on postnatal growth and organ pathology
of mice. Mol Cell Endocrinol. 2014; 394: 88–98. doi: 10.1016/j.mce.2014.07.002 PMID: 25017732
28. Kriz W, Bankir L. A standard nomenclature for structure of the kidney. The Renal Commission of the
International Union of Physiological Sciences(IUPS). Anat Embryol (Berl). 1988; 178: N1–8.
29. Kriz W, Koepsell H. The structural organization of the mouse kidney. Z Anat Entwicklungsgesch. 1974;
144: 137–163. PMID: 4472393
30. Weibel ER. Stereological methods I. Practical methods for biological morphometry. London: Academic
press; 1979.
31. Herbach N, Bergmayr M, Goke B, Wolf E, Wanke R. Postnatal development of numbers and mean
sizes of pancreatic islets and beta-cells in healthy mice and GIPR(dn) transgenic diabetic mice. PLoS
One. 2011; 6: e22814. doi: 10.1371/journal.pone.0022814 PMID: 21818396
Renal Alterations in Pou3f3L423P Mutant Mice
PLOS ONE | DOI:10.1371/journal.pone.0158977 July 15, 2016 29 / 31
63
32. El-Aouni C, Herbach N, Blattner SM, Henger A, Rastaldi MP, Jarad G, et al. Podocyte-specific deletion
of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive
glomerulosclerosis. J Am Soc Nephrol. 2006; 17: 1334–1344. PMID: 16611717
33. Ramage IJ, Howatson AG, McColl JH, Maxwell H, Murphy AV, Beattie TJ. Glomerular basement mem-
brane thickness in children: a stereologic assessment. Kidney Int. 2002; 62: 895–900. PMID:
12164871
34. Nyengaard JR, Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary
number and sizes. Diabetologia. 1993; 36: 189–194. PMID: 8462766
35. Massa F, Garbay S, Bouvier R, Sugitani Y, Noda T, Gubler MC, et al. Hepatocyte nuclear factor 1beta
controls nephron tubular development. Development. 2013; 140: 886–896. doi: 10.1242/dev.086546
PMID: 23362349
36. Graham LA, Padmanabhan S, Fraser NJ, Kumar S, Bates JM, Raffi HS, et al. Validation of uromodulin
as a candidate gene for human essential hypertension. Hypertension. 2014; 63: 551–558. doi: 10.
1161/HYPERTENSIONAHA.113.01423 PMID: 24324041
37. Siner JM, Jiang G, Cohen ZI, Shan P, Zhang X, Lee CG, et al.VEGF-induced heme oxygenase-1 con-
fers cytoprotection from lethal hyperoxia in vivo. FASEB J. 2007; 21: 1422–1432. PMID: 17264168
38. Cohen CD, Kretzler M (2003) Gene-Expression Analysis of Microdissected Renal Biopsies. In: Goli-
gorsky MS, editor. Renal disease: Techniques and Protokols. Totowa, New Jersey: Humana Press
Inc. pp. 285–293.
39. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of
protein using bicinchoninic acid. Anal Biochem. 1985; 150: 76–85. PMID: 3843705
40. Friedrich RP, Schlierf B, Tamm ER, Bosl MR, Wegner M. The class III POU domain protein Brn-1 can
fully replace the related Oct-6 during schwann cell development and myelination. Mol Cell Biol. 2005;
25: 1821–1829. PMID: 15713637
41. Song S, Meyer M, Turk TR, Wilde B, Feldkamp T, Assert R, et al. Serum cystatin C in mouse models: a
reliable and precise marker for renal function and superior to serum creatinine. Nephrol Dial Transplant.
2009; 24: 1157–1161. doi: 10.1093/ndt/gfn626 PMID: 19004848
42. Zhong J, Perrien DS, Yang HC, Kon V, Fogo AB, Ichikawa I, et al. Maturational regression of glomeruli
determines the nephron population in normal mice. Pediatr Res. 2012; 72: 241–248. doi: 10.1038/pr.
2012.81 PMID: 22717689
43. Benz K, Campean V, Cordasic N, Karpe B, Neuhuber W, Mall G, et al. Early glomerular alterations in
genetically determined low nephron number. Am J Physiol Renal Physiol. 2011; 300: F521–530. doi:
10.1152/ajprenal.00490.2009 PMID: 20943767
44. Wang Q, Lan Y, Cho ES, Maltby KM, Jiang R. Odd-skipped related 1 (Odd 1) is an essential regulator
of heart and urogenital development. Dev Biol. 2005; 288: 582–594. PMID: 16223478
45. Majumdar A, Vainio S, Kispert A, McMahon J, McMahon AP. Wnt11 and Ret/Gdnf pathways cooperate
in regulating ureteric branching during metanephric kidney development. Development. 2003; 130:
3175–3185. PMID: 12783789
46. Boyce RW, Dorph-Petersen KA, Lyck L, Gundersen HJ. Design-based stereology: introduction to basic
concepts and practical approaches for estimation of cell number. Toxicol Pathol. 2010; 38: 1011–1025.
doi: 10.1177/0192623310385140 PMID: 21030683
47. Dorph-Petersen KA, Nyengaard JR, Gundersen HJ. Tissue shrinkage and unbiased stereological esti-
mation of particle number and size. J Microsc. 2001; 204: 232–246. PMID: 11903800
48. Gundersen HJ. Stereology of arbitrary particles. A review of unbiased number and size estimators and
the presentation of some new ones, in memory of William R. Thompson. J Microsc. 1986; 143: 3–45.
PMID: 3761363
49. Weiner ID, MitchWE, Sands JM. Urea and Ammonia Metabolism and the Control of Renal Nitrogen
Excretion. Clin J Am Soc Nephrol. 2015; 10: 1444–1458. doi: 10.2215/CJN.10311013 PMID:
25078422
50. Murawski IJ, Maina RW, Gupta IR. The relationship between nephron number, kidney size and body
weight in two inbred mouse strains. Organogenesis. 2010; 6: 189–194. PMID: 21197222
51. Amann K, Benz K. [Clinical relevance of reduced nephron count]. Klin Padiatr. 2011; 223 Suppl 1: S18–
26. doi: 10.1055/s-0030-1255880 PMID: 21472673
52. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kid-
ney Int. 1996; 49: 1774–1777. PMID: 8743495
53. Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, HoyWE. Human nephron number: implica-
tions for health and disease. Pediatr Nephrol. 2011; 26: 1529–1533. doi: 10.1007/s00467-011-1843-8
PMID: 21604189
Renal Alterations in Pou3f3L423P Mutant Mice
PLOS ONE | DOI:10.1371/journal.pone.0158977 July 15, 2016 30 / 31
64
54. HoyWE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF. Reduced nephron number and glo-
merulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney
Int. 2006; 70: 104–110. PMID: 16723986
55. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N
Engl J Med. 2003; 348: 101–108. PMID: 12519920
56. Fogo A, Ichikawa I. Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis.
Am J Kidney Dis. 1991; 17: 666–669. PMID: 2042646
57. Fogo AB. Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases.
Kidney Int Suppl. 2000; 75: S15–21. PMID: 10828756
58. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J
Hypertens. 1988; 1: 335–347. PMID: 3063284
59. HoyWE, Hughson MD, Bertram JF, Douglas-Denton R, Amann K. Nephron number, hypertension,
renal disease, and renal failure. J Am Soc Nephrol. 2005; 16: 2557–2564. PMID: 16049069
60. Hughson MD, Douglas-Denton R, Bertram JF, HoyWE. Hypertension, glomerular number, and birth
weight in African Americans and white subjects in the southeastern United States. Kidney Int. 2006; 69:
671–678. PMID: 16395270
61. Douglas-Denton RN, McNamara BJ, HoyWE, Hughson MD, Bertram JF. Does nephron number matter
in the development of kidney disease? Ethn Dis. 2006; 16: S2–40-45.
62. HoyWE, Bertram JF, Denton RD, Zimanyi M, Samuel T, Hughson MD. Nephron number, glomerular
volume, renal disease and hypertension. Curr Opin Nephrol Hypertens. 2008; 17: 258–265. doi: 10.
1097/MNH.0b013e3282f9b1a5 PMID: 18408476
63. Luyckx VA, Brenner BM. The clinical importance of nephron mass. J Am Soc Nephrol. 2010; 21: 898–
910. doi: 10.1681/ASN.2009121248 PMID: 20150537
64. Fogo A, Ichikawa I. Evidence for the central role of glomerular growth promoters in the development of
sclerosis. Semin Nephrol. 1989; 9: 329–342. PMID: 2688009
65. Cullen-McEwen LA, Kett MM, Dowling J, AndersonWP, Bertram JF. Nephron number, renal function,
and arterial pressure in aged GDNF heterozygous mice. Hypertension. 2003; 41: 335–340. PMID:
12574104
Renal Alterations in Pou3f3L423P Mutant Mice
PLOS ONE | DOI:10.1371/journal.pone.0158977 July 15, 2016 31 / 31
65
 
 
 
Supporting Information 
S1 Table.  
Exact p values of statistically analyzed* parameters of homozygous (HOM) and het-
erozygous (HET) Pou3f3L423P mutant mice and control (CON) mice at 12 days of age. 
Parameter sex overall CON vs. 
HET 
CON vs. 
HOM 
HOM vs. 
HET 
male vs. female 
CON HET HOM 
Body weight  
m 0.025 0.999 0.074 0.028 
0.5458 0.3519 0.7445 
f 0.086 0.998 0.104 0.097 
Kidney weight  
m 0.001 0.924 0.003 0.001 
0.9625 0.7076 0.3208 
f 0.006 0.992 0.007 0.006 
Relative kidney weight  
m 0.003 0.623 0.040 0.019 
0.6509 0.4061 0.8708 
f 0.110 0.999 0.014 0.010 
Urine albumin con-
centration  
m 0.333 0.196 0.212 0.959 
0.2085 0.4325 0.4849 
f 0.212 0.431 0.309 0.085 
V (Kidney)  
m 0.001 0.993 0.004 0.009 
0.7104 0.6529 0.5682 
f 0.002 0.961 0.002 0.002 
VV (Cortex/Kid) 
m 0.277 0.942 0.340 0.464 
0.9057 0.6368 0.5407 
f 0.106 0.980 0.113 0.142 
V (Cortex, Kid)  
m 0.006 0.789 0.014 0.001 
0.7458 0.9556 0.4353 
f 0.028 0.426 0.021 0.154 
VV (Med/Kid) 
m 0.277 0.924 0.340 0.464 
0.9057 0.9861 0.5407 
f 0.131 0.901 0.124 0.232 
V (Med, Kid)  
m 0.000 0.260 0.001 0.005 
0.8016 0.9527 0.8763 
f 0.004 0.437 0.003 0.202 
VV (TAL/Kid)  
m 0.000 0.007 0.000004 0.000785 
0.0128 0.0551 0.9149 
f 0.000 0.503 0.00086 0.000023 
V (TAL, Kid)  
m 0.000 0.085 0.000005 0.000059 
0.3168 0.1097 0.6494 
f 0.000 0.949 0.000299 0.000041 
VV (Glom/Kid) 
m 0.558 0.615 0.808 0.997 
0.2478 0.9311 0.9329 
f 0.964 1.000 0.990 0.993 
V (Glom, Kid)  
m 0.018 1.000 0.700 0.018 
0.2938 0.8865 0.5625 
f 0.032 0.616 0.024 0.107 
V (Glom, Kid)/body weight    
m 0.403 1.000 0.629 0.470 
0.7057 0.0315 0.7707 
f 0.100 0.399 0.102 0.537 
NV (Glom/Kid)  
m 0.187 0.533 0.190 0.650 
0.8016 0.4646 0.4318 
f 0.036 0.464 0.027 0.174 
N (Glom, Kid)  
m 0.000 0.031 0.000009 0.000397 
0.5073 0.2454 0.7768 
f 0.000 0.012 0.000006 0.000139 
N (Glom, Kid)/body weight  
m 0.032 0.241 0.027 0.296 
0.5241 0.3856 0.8866 
f 0.000 0.028 0.000324 0.041 
v̅ (Glom)  
m 0.002 0.167 0.001486 0.023 
0.2478 0.6494 1.000 
f 0.028 1.000 0.044 0.054 
v̅ (Glom)/body weight  
m 0.565 0.632 0.786 1.000 
0.2134 0.6581 0.8185 
f 0.811 0.996 0.949 0.874 
 
*Statistically significant differences between genotypes were determined by using a 
1-way ANOVA with Gabriel’s post hoc test, differences between male and female 
mice of the identical genotype by Student’s t-test. 
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S2 Table.  
Exact p values of statistically analyzed* parameters of homozygous (HOM) and het-
erozygous (HET) Pou3f3L423P mutant mice and control (CON) mice at 60 weeks of 
age. 
Parameter sex overall CON vs. 
HET 
CON vs. 
HOM 
HOM vs. 
HET 
male vs. female 
CON HET HOM 
Body weight 
m 0.001 0.989 0.0040 0.0040 
0.6200 0.1079 0.0152 
f 0.002 0.269 0.01511 0.065 
Kidney weight  
m 0.000 0.484 0.000065 0.000004 
0.0006 0.0014 0.0022 
f 0.000 0.999 0.000039 0.000048 
Relative kidney weight  
m 0.005 0.054 0.109 0.013 
0.0006 0.0200 0.0022 
f 0.009 0.112 0.530 0.040 
Mean blood pressure  
m 0.775 0.923 0.999 0.882 
0.0369 0.7490 0.5264 
f 0.087 0.113 0.228 0.985 
Serum urea  
m 0.002 0.997 0.0081 0.00412 
0.9487 0.4757 0.4848 
f 0.014 0.241 0.0415 0.0295 
Serum cystatin c  
m 0.474 0.975 0.545 0.776 
0.4020 1.000 0.6905 
f 0.977 0.997 1.000 0.996 
Serum sodium 
m 0.822 0.998 0.905 0.948 
0.1098 0.0607 0.3358 
f 0.454 0.994 0.536 0.668 
Urine albumin con-
centration 
m 0.041 0.578 0.062 0.015 
0.1320 0.1709 0.1320 
f 0.006 0.116 0.005 0.246 
Urine creatinine con-
centration 
m 0.181 0.408 0.217 0.925 
0.7009 1.000 1.000 
f 0.012 0.676 0.013 0.132 
UACR  
m 0.067 0.378 0.575 0.066 
0.1905 0.3929 0.1143 
f 0.026 0.191 0.024 0.799 
Urine specific gravity 
m 0.002 0.999 0.00417 0.00817 
0.1373 0.5089 0.3341 
f 0.014 0.596 0.0141 0.0463 
V (Kidney)  
m 0.000 0.484 0.000065 0.000004 
0.0001 0.0001 0.0001 
f 0.000 0.999 0.000039 0.000048 
VV (Cortex/Kid) 
m 0.833 1.000 0.921 0.94 
0.0038 0.4484 0.3471 
f 0.013 0.170 0.009 0.419 
V (Cortex, Kid) 
m 0.003 0.813 0.004 0.016 
0.0006 0.0006 0.0043 
f 0.006 0.985 0.017 0.009 
VV (Med/Kid) 
m 0.833 1.000 0.921 0.940 
0.0279 0.5212 0.1474 
f 0.013 0.170 0.010 0.419 
V (Med, Kid)  
m 0.530 0.955 0.066 0.133 
0.0913 0.0040 0.0011 
f 0.000 0.183 0.014 0.041 
VV (TAL/Kid)  
m 0.009 0.494 0.00798 0.07602 
0.0006 0.0003 0.0087 
f 0.003 0.498 0.0040 0.0376 
V (TAL, Kid) 
m 0.006 0.981 0.0020 0.0247 
0.0379 0.0541 0.0303 
f 0.002 0.691 0.0030 0.0015 
VV (Glom/Kid) 
m 0.013 0.884 0.014 0.041 
0.0001 0.0001 0.0003 
f 0.020 0.177 0.019 0.551 
V (Glom, Kid)  
m 0.002 0.638 0.001576 0.009923 
0.2911 0.1993 0.9829 
f 0.001 0.549 0.000614 0.001013 
V (Glom, Kid)/body weight    
m 0.029 0.302 0.025 0.351 
0.7104 0.4908 0.6623 
f 0.343 0.677 0.387 0.934 
NV (Glom/Kid)  
m 0.295 0.351 0.126 0.471 
0.0070 0.0022 0.0022 
f 0.621 1.000 0.726 0.679 
N (Glom, Kid)  
m 0.000 0.0885 0.0001 0.0167 
0.0111 0.1893 0.1320 
f 0.000 0.620 0.027 0.0179 
N (Glom, Kid)/body weight  
m 0.036 0.320 0.033 0.453 
0.2086 0.4136 0.0411 
f 0.044 0.575 0.642 0.999 
v̅ (Glom)  
m 0.002 0.257 0.001771 0.0150 
0.0420 0.7789 0.1775 
f 0.002 0.215 0.000117 0.40877 
v̅ (Glom)/body weight  
m 0.023 0.657 0.020 0.116 
0.7104 0.4908 0.6623 
f 0.250 0.944 0.525 0.289 
VV (Mes/Glom) 
m 0.101 0.104 0.850 0.481 
0.1231 0.4107 0.7827 
f 0.908 0.961 0.999 0.992 
V(Mes, Glom)  
m 0.000 0.0033 0.000089 0.110 
0.0263 0.9426 0.2381 
f 0.001 0.140 0.0011 0.0478 
VV (Cap/Glom) 
m 0.003 0.0025 0.409 0.116 
0.0054 0.5478 0.5658 
f 0.470 0.915 0.519 0.825 
V (Cap, Glom)  
m 0.012 0.959 0.015 0.029 
0.9015 0.3969 0.1775 
f 0.005 0.122 0.0039 0.177 
VV (Pod/Glom) 
m 0.458 0.517 0.966 0.848 
0.1764 0.9069 0.5787 
f 0.205 0.988 0.249 0.346 
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v̅ (Pod, Glom)  
m 0.005 0.164 0.0037 0.129 
0.2136 0.4319 0.6534 
f 0.061 0.303 0.042 0.622 
LV (Cap/Glom)  
m 0.458 0.517 0.966 0.848 
0.1137 0.0552 0.4422 
f 0.205 0.988 0.249 0.346 
L (Cap, Glom)  
m 0.000 0.939 0.00096 0.000268 
0.4098 0.2021 0.5368 
f 0.010 0.980 0.0136 0.0213 
L (Glom-cap, Kid)  
m 0.000 0.486 0.0197 0.00121 
0.7308 0.8665 0.7922 
f 0.019 0.896 0.0206 0.0066 
NV (C/Glom)  
m 0.288 0.588 0.330 0.904 
0.2343 0.2180 0.0173 
f 0.206 0.742 0.212 0.664 
N (C, Glom) 
m 0.006 0.876 0.0082 0.0189 
1.000 0.7546 0.7922 
f 0.01 0.132 0.0088 0.363 
NV (M-E/Glom)  
m 0.777 0.950 0.994 0.867 
0.2824 0.1375 0.303 
f 0.518 1.000 0.689 0.632 
N (M-E, Glom) 
m 0.032 0.933 0.0403 0.075 
1.000 0.7546 0.7922 
f 0.057 0.244 0.00631 0.754 
NV (Pod/Glom)  
m 0.071 0.721 0.069 0.259 
0.5338 0.4908 0.4286 
f 0.249 0.428 0.349 0.991 
N (Pod, Glom) 
m 0.000 0.543 0.000016 0.0060 
0.6116 0.8972 0.2722 
f 0.000 0.130 0.000165 0.0095 
v̅ (Pod)  
m 0.091 0.376 0.092 0.647 
0.1320 0.4136 0.5368 
f 0.869 0.963 1.000 0.950 
Th (GBM)  m 0.022 0.821 0.109 0.024 0.4000 0.4000 0.6286 
f 0.007 0.079 0.129 0.030 
FSF  m 0.814 0.922 0.907 1.000 
1.000 1.000 0.8571 
f 0.648 0.734 0.571 0.376 
RT-qPCR: Pou3f3 
vs.Gapdh relative to 
CON 
m 0.589 0.684 0.995 0.865 
0.9930 0.3649 0.3853 
f 0.158 0.937 0.172 0.323 
RT-qPCR: Umod vs. 
Gapdh relative to 
CON 
m 0.009 1.000 0.018 0.014 
0.9894 0.1750 0.2204 
f 0.027 0.066 0.046 0.925 
RT-qPCR: Pou3f3 vs. 
Umod relative to CON 
m 0.000 0.673 0.00003 0.00014 
1.000 0.7244 0.0488 
f 0.002 0.095 0.00133 0.058 
 
UACR: Urine albumin-to-creatinine ratio. *Statistically significant differences between 
genotypes were determined by using a 1-way ANOVA with Gabriel’s post hoc test, 
differences between male and female mice of the identical genotype by Student’s t-
test. 
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4. Discussion 
4.1. Experimental design, general and methodological aspects of the study  
The aim of the present study was to analyze the renal phenotype of Pou3f3L423P 
mice, a mutant mouse line recently derived from the Munich ENU Mouse Mutagene-
sis project (Aigner et al., 2007, Kumar et al., 2016). Mutant Pou3f3L423P mice harbor a 
non-lethal point mutation in the Pou3f3 gene, and, in contrast to homozygous Pou3f3 
knock-out mice, homozygous Pou3f3L423P mutants are viable and fertile (Kumar et al., 
2016). Therefore they allow to investigate not only the impact of the POU3F3 muta-
tion on renal development in newborn animals but also to study the consequences of 
the mutation on morphology and function of the kidneys in the postnatal life. On initial 
establishment adult homozygous Pou3f3L423P mutant mice have been demonstrated 
to display elevated plasma urea levels, together with several other metabolic chang-
es that were pointing at an impaired renal function. These changes include increased 
creatinine, chloride, and potassium serum levels, as well as decreased bone mineral 
density and bone mineral content (Nakai et al., 2003, Kumar et al., 2016).  
For a comprehensive analysis, the present study examined homo- and heterozygous 
mutant mice together with wildtype controls of both sexes were at 12 days and 60 
weeks of age. The first age group thereby allowed to study immediate developmental 
effects of the Pou3f3L423P mutation, since 12 days marks the completion of neph-
ron(no)genesis in mice (Dressler, 2006), while the second age group made it possi-
ble to evaluate long-term ramifications on renal morphology and function. Analyses to 
assess renal function comprised blood pressure measurements, as well as determi-
nation of several relevant biochemical parameters in serum and urine. By applying 
qualitative histological and ultrastructural examinations, in combination with state-of-
the-art, unbiased, design-based quantitative stereological methods (Gundersen, 
1986, Dorph-Petersen et al., 2001, Weiner et al., 2015) a thorough morphological 
analysis of the development, growth and cellular structure of different nephron seg-
ments, such as the thick ascending limb of the loop of Henle (TAL) was facilitated. At 
last, renal Pou3f3 mRNA levels and protein abundances were determined in order to 
gain more insight into Pou3f3 gene expression in the mature kidney. 
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4.2. Renal morphology of Pou3f3L423P mutant mice 
In both 12-day-old and 60-week-old homozygous Pou3f3L423P mutant mice kidney 
weights and volumes were significantly smaller than in non-mutant controls. Absolute 
TAL volumes as well as volume densities of the TAL in the kidney were also signifi-
cantly lower. These findings are corresponding to those previously reported in Pou3f3 
knock-out mice by Nakai et al. (2003), and confirm the important role of POU3F3 in 
nephronogenesis, and in the development of the TAL in particular. Given the fact that 
the TAL occupies an important role for the renal nitrogen metabolism (Zhong et al., 
2012, Mount, 2014), its incomplete development in homozygous Pou3f3L423P mutants 
might provide a possible explanation for the raised serum urea levels detected in 
these animals (Nakai et al., 2003, Kumar et al., 2016). Equally in line with the findings 
by Nakai et al., immunohistochemical investigation showed the presence of POU3F3 
in the TAL and the MD of both 12-day-old and 60-week-old, mutant and non-mutant 
mice. This not only confirms the pivotal role of POU3F3 in the fetal development of 
the TAL, but also strengthens its presumed significance in maintaining TAL function 
in the mature kidney throughout adult life (Nakai et al., 2003). Moreover, the present 
study also found a positive signal for POU3F3 immunostaining within CD cell nuclei 
in the kidneys of 60-week-old animals, which has not been reported in the kidneys of 
neonates (Nakai et al., 2003). 
Fundamentally, since Nakai et al. (2003) used mice with a different age and another 
genetic background and only semiquantitatively evaluated the severity of the under-
development of the TAL, it is not feasible to compare the effects of a total POU3F3 
absence in Pou3f3 knock-out mice with the effects of the Pou3f3L423P mutation. Albeit, 
Pou3f3 knock-out mice also showed severe morphological alterations of the TAL 
cells on light and electron microscopical level (Nakai et al., 2003), which were not 
detectable in homozygous Pou3f3L423P mutants that were examined in the study at 
hand. Apart from the developmental deficits of the TAL, the kidneys of homozygous 
Pou3f3L423P mutants presented with several other altered parameters regarding quan-
titative stereological analyses, which were already observable in the 12-day-old ani-
mals. 
 
Probably the most striking feature of homozygously Pou3f3L423P mutant mice is the 
significant reduction of the total nephron numbers. Additionally, the relative numbers 
of nephrons per body weight and the mean glomerular volume were significantly de-
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creased in 12-day-old homozygous mutants, while the mean glomerular volume-to–
body weight ratio remained unchanged, as compared to control mice. The kidneys of 
the aged, 60-week-old homozygous Pou3f3L423P mutants basically presented with 
identical findings, whereas in these animals the relative nephron number just showed 
a significant reduction in male, but not in female homozygous mutant mice as com-
pared to wildtype controls. This difference, however, can be due to the reduced body 
weights of aged female homozygous Pou3f3L423P mutants as compared to the male 
homozygous Pou3f3L423P mutants. 
Absent POU3f3 function in Pou3f3 knock-out mice has not been reported to yield a 
similar effect on glomerular number or size. This is likely due to the fact that in mice 
the development of the nephron and differentiation of its segments is still in progress 
at the time of birth and continues until several days postnatally (Dressler, 2006). 
Likewise, not as accurate methods might have been applied for the determination of 
number and size of glomeruli in the study of Nakai et al. (2003). The results of the 
present study therefore, revealed novel functions of POU3F3: in addition to the al-
ready known importance in differentiation of distinct nephron segments like the TAL 
(nephron patterning), POU3F3 also seems to be one of the factors influencing the 
nephron endowment, i.e., the absolute nephron number present in the matured 
mouse kidney. Importantly, rather than changes of the nephron number in relation to 
the body weight, the decrease of the absolute number of nephrons in homozygous 
Pou3f3L423P mutants compared to wildtype littermates embodies the representative 
parameter since several studies carried out in various mouse strains show that kid-
ney and body weight are correlated at birth and at adult age, but so far no link be-
tween nephron number and body weight or size of the kidney has been revealed 
(Benz et al., 2011). For this reason, although 12-day-old male and female homozy-
gous Pou3f3L423P mutant mice showed a significantly reduced relative nephron num-
ber, which was also observed in male, yet not in female 60-week-old homozygous 
mutants, does not disagree with the presumed importance of POU3F3 in determina-
tion of the kidneys endowment with nephrons. Except for slightly altered serum and 
urine parameters regarding the function of the tubular system, the Pou3f3 mutation 
with the decrease of TAL did not yield any long-term implications in terms of patho-
morphologic changes of the tubular system that were detectable by light- or electron 
microscopy in the kidneys of 60-week-old Pou3f3L423P mutants. The functional ca-
pacity of the glomerular compartment was virtually unaltered in these animals either, 
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since neither glomerular filtration rate nor urine albumin excretion or blood pressure 
showed any differences between Pou3f3L423P mutants vs. non-mutant controls.  
Correspondingly, besides the reduced number of nephrons and a decrease in glo-
merular size, qualitative as well as quantitative morphological analyses did not reveal 
any pathomorphological glomerular alterations in kidneys of 60-week-old Pou3f3L423P 
mutants. Urine protein analyses furthermore did not display any evidence of albumi-
nuria in homo-, or heterozygous Pou3f3L423P mutants of both sexes. 
Even on ultrastructural level no glomerular lesions were observed in Pou3f3L423P mu-
tants. Hereby, quantitative morphological parameters, like the thickness of the GBM, 
or the mean podocyte volume, represent sensitive indicators able to detect even ear-
ly stages of glomerular damage (Herbach et al., 2009, Blutke et al., 2016, Herbach et 
al., 2011). As these parameters presented similar in mutants and non-mutant con-
trols, the reduction in nephron numbers in Pou3f3L423P mutant mice does not have 
any effect on the glomerular ultrastructure. 
 
4.3. Role of POU3F3 in kidney development  
Embryonic development of the mammalian kidney and, in this context, development 
of nephrons in sufficient numbers, is important to guarantee a fully operative func-
tional capacity of the kidneys. After the appropriate induction of the developing neph-
ron in the metanephric mesenchyme, it comprises the subsequent transformative 
processes that lead to formation of a renal vesicle and the following differentiation of 
the renal vesicle into the early nephron and its already distinct segments, a process 
also termed nephron patterning. At last, the final maturation of each segment con-
cludes the developmental processes. Each one of these steps requires the highly 
complex network interactions of a plethora of transcription factors as well as growth 
factors, receptors and several other signaling molecules that orchestrate the neph-
ron(no)genesis by activating or repressing specific genes in different cell types 
(Schedl, 2007, El-Dahr et al., 2008, O'Brien and McMahon, 2014). 
Early steps in the development of the ureteric bud involve coordinated signaling be-
tween the sprouting tip and the metanephric mesenchyme it is surrounded by. This 
leads to branching of the ureteric bud and subsequent formation of a renal vesicle 
that undergoes mesenchymal to epithelial transformation in the process and is con-
verted to a primitive nephron via the stages of comma- and S-shaped bodies. Here-
by, several transcriptional pathways play important roles in governing these accurate-
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ly timely and spatially coordinated processes, including the glial-derived neurotrophic 
factor (GDNF) and CRET (ret proto-oncogene) signaling pathway, the WNT-beta-
catenin cascade, and many other transcription- and transcription inducing factors 
such as EYA1 (eyes absent homolog 1 transcriptional coactivator and phosphatase 
1), LIF (leukemia inhibitory factor), FGF2 (fibroblast growth factor 2), and TGFB2 
(transforming growth factor beta 2) (Schedl, 2007, El-Dahr et al., 2008, O'Brien and 
McMahon, 2014). 
The following process, which is also termed nephron patterning and leads to the dif-
ferentiation of the distinct morphologically and functionally unique tubular segments 
that the nephron exhibits along its proximal to distal axis, and along with the for-
mation of a capillary cleft, its invasion by endothelial cell primordia and the further 
maturation of early glomerular structures is accomplished by transcription factors in-
cluding WT1 (Wilms’ tumor 1) , LHX1 (LIM homeobox 1), POU3F3, and DLL1 (delta-
like 1). In particular Notch–Delta pathway signaling plays an important role for deter-
mination of proximal tubular segments, while the distal tubular segments are speci-
fied by transcription factors POU3F3 and IRX (iroquois homeobox) (Schedl, 2007, El-
Dahr et al., 2008, O'Brien and McMahon, 2014). Although many pathways have been 
unraveled so far, there are still plenty of interactions and regulatory hierarchies of all 
in nephron(no)genesis involved factors, whose exact functions need to be elucidated.  
Many of those factors important for nephron(no)genesis and their presumed functions 
have been detected and studied in genetically modified animal models, preferably 
rodents. By altering gene expression and thereby generating total or partial loss of a 
single transcription or growth factor, the presumed function of the molecule in ques-
tion can be studied, as this results in a distinct phenotype that lacks the actions of the 
products of the modified genes, leading to e.g., typical malformations of either the 
entire kidney, or of a specific nephron segment (Cohen and Kretzler, 2003, Siner et 
al., 2007, Graham et al., 2014). Similarly, by using Pou3f3 knock-out mice Nakai et 
al. in 2003 discovered and described the vital function of POU3F3 in the develop-
ment of the nephron, more precisely in nephron patterning, especially the develop-
ment of the thick ascending limb (TAL) of the loop of Henle and the macula densa 
(MD) (Nakai et al., 2003). In the developing nephron, Nakai et al. detected POU3F3 
expression in distal renal vesicles, S-shaped bodies, and in distinct nephron regions 
that set out to differentiate into TAL and MD, as well as the distal convoluted tubule. 
Here, POU3F3 expression continues throughout adult life. Furthermore, the striking 
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absence of the TAL in kidneys of homozygous Pou3f3 knock-out mice at the time of 
birth was shown (Nakai et al., 2003). A circumstance that probably contributes largely 
to the fact that neonatal homozygous Pou3f3 knock-out mice display increased levels 
of plasma urea and potassium, and ultimately die due to renal failure within 24 hours 
after birth (Nakai et al., 2003). 
The underlying mechanism of POU3F3 deficiency triggering TAL underdevelopment 
potentially include a reduced proliferation of TAL cells or an early occurrence of 
apoptotic process in the primitive nephron stages of homozygous Pou3f3 knock-out 
embryos (Nakai et al., 2003). Since heterozygous Pou3f3 knock-out mice exhibit de-
creased expression levels of several genes that are typically expressed in the TAL, 
such as Umod, Nkcc2, and certain K+ and Cl- channels, a gene-dosage dependent 
function of POU3F3 in terms of gene expression in the TAL has been suggested 
(Nakai et al., 2003). Albeit, no evidence for pathologic alterations regarding cell mor-
phology or TAL function has been found in these mice, and neither histological 
and/or electron microscopical analyses nor determination of plasma levels of urea, 
creatinine, several electrolytes including Na+, K+, Cl-, and measurement of urine os-
molality and volume showed any abnormalities (Nakai et al., 2003). The observed 
differences between Pou3f3 knock-out and the Pou3f3L423P mutants, like the early 
postnatal death of homozygous Pou3f3 knock-out mice due to kidney failure, might 
originate from a remaining activity of the mutated POU3F3 transcription factor in con-
trast to a complete loss of function in Pou3f3 knock-out mice. In Pou3f3L423P mutant 
mice the locus of the mutation has been determined to be in the highly conserved 
homeodomain of the protein. It is possible that this alters the transcriptional regula-
tion of several, if not all POU3F3 target genes. In addition, a compensation of a lack 
of specific functions of POU3F3 in homozygous Pou3f3L423P mutants by other, yet 
unknown, but in synergy acting factors is indeed thinkable, since this has been 
shown to be true for POU3F3 actions in the brain (Sugitani et al., 2002). 
Eventually, the less pronounced phenotypes in heterozygous Pou3f3 knock-out mice 
and heterozygous Pou3f3L423P mutant mice can be construed as gene-dose depend-
ent effect (Nakai et al., 2003).  
In summary it can be stated that further studies are needed to clarify the molecular 
mechanisms and exact actions of POU3F3, in particular how it participates in 
nephro(no)genesis and how it helps to maintain TAL function once the kidney ma-
tured. This entails the transcriptional control of its target-genes, its interactions with 
74
 
 
 
other factors, and the involvement and influence on other important regulatory signal-
ing pathways. Hereby, Pou3f3L423P mutant mice might serve as a useful model sys-
tem. 
 
4.4. Pou3f3L423P mutant mice as an animal model for low nephron numbers 
The striking reduction of nephron numbers observed in homozygous Pou3f3L423P mu-
tant mice is particular interesting, as a low nephron endowment in humans is thought 
to be a crucial risk factor for development of different chronic kidney diseases 
(Amann and Benz, 2011, Brenner et al., 1996, Bertram et al., 2011). The low neph-
ron numbers are considered a “first hit” rendering the kidney of the affected individual 
susceptible to the emergence of glomerular hypertrophy, which is seen as a patho-
genic key lesion in the development of glomerulosclerotic lesions and therefore ulti-
mately to an accelerated decline in renal function in case a “second hit”, as e.g., a 
primary nephropathy, hypertension, obesity or diabetes mellitus challenges the renal 
reserve capacity (Douglas-Denton et al., 2006, Hoy et al., 2008, Luyckx et al., 2013, 
Bertram et al., 2011). How low nephron numbers exactly contribute to the develop-
ment of glomerular hypertrophy has not been fully elucidated yet. There is evidence 
that the glomerular growth serves as a compensatory mechanism that is mediated by 
different glomerular growth factors or hypertensive changes (Fogo and Ichikawa, 
1989, Fogo and Ichikawa, 1991, Benz et al., 2011). Hypertension in turn might de-
velop due to misguided renin angiotensin system activation, alterations in the struc-
ture of peritubular vessels, or an impaired salt excretion of the tubular system leading 
to salt and as a consequence thereof volume retention.  
Currently, there are only very few existing mouse models of a genetically determined 
low nephron endowment, inter alia heterozygous Gdnf knock-out mice (Cullen-
McEwen et al., 2001, Benz et al., 2011). These mice show an approximate reduction 
of 33% in nephron numbers as compared to wildtype controls, whereby displaying 
similar kidney and body weights (Cullen-McEwen et al., 2001, Benz et al., 2011). 
However, heterozygous Gdnf knock-out mice show a higher occurrence of unilateral 
renal agenesia and the reduction in nephron endowment is associated with a distinct 
set of glomerular alterations, including glomerular hypertrophy with accompanying 
endothelial and mesangial cell hyperplasia and thickening of the glomerular base-
ment membrane, changes that have been shown to predispose mice for the devel-
opment of glomerulosclerosis and hypertension (Fogo and Ichikawa, 1991, Fogo, 
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2000, Benz et al., 2011). Therefore it is difficult to evaluate the sole impact of the re-
duced nephron numbers in development of renal lesions. Contrary to that, homozy-
gous Pou3f3L423P mutant mice that show a comparable average reduction in nephron 
numbers of 37% and do not exhibit an “own” pattern of primary glomerular patholo-
gies. The lack thereof is particularly advantageous for the use of Pou3f3L423P mutant 
mice as a model system for low nephron numbers, because it allows for experiments 
that study the sole impact of a reduced nephron endowment and their role as predis-
posing factor in the development of renal lesions. 
Furthermore, using genetically modified animal models reduces the intra- and inter-
experimental variability related to technical differences in models with surgically re-
duced nephron numbers, such as unilateral nephrectomy (Woods, 1999, Moritz et al., 
2005). 
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4.5. Perspectives 
The present study confirmed not only the important role of POU3F3 in development 
of the distal nephron parts, in particular the thick ascending limb of the loop of Henle, 
but also showed the potential of Pou3f3L423P mutant mice as an experimental mouse 
model for low nephron numbers in nephrological research. These animal models are 
urgently required nowadays, since a priori low nephron numbers are seen as a trig-
ger for the facilitated development of chronic kidney diseases later in life in case a 
second hit such as diabetes follows. Therefore, to study possible implications of a 
reduced nephron endowment, challenging homo- as well as heterozygous 
Pou3f3L423P mutant mice with additional renal insults seems an appealing approach. 
This could entail evaluating cardiovascular and renal effects after exposure to a diet 
high in salt, or, crossing Pou3f3L423P mutant mice with another established genetically 
modified murine model of progressive renal disease, such as DN. We are currently 
considering such a study by crossing Pou3f3L423P mutant mice with GIPRdn trans-
genic mice.  GIPRdn transgenic mice express a dominant negative receptor for the 
glucose-dependent insulinotropic polypeptide and represent a well characterised 
mouse model of diabetic nephropathy  (Herbach et al., 2009, Herbach et al., 2011). 
Crossing these two lines creates an animal collective consisting of diabetic and non-
diabetic individuals with “normal” as well as reduced absolute nephron numbers re-
spectively. Therefore, the in depth characterization of the renal alterations in the dif-
ferent obtained genotypes will allow to study the impact of a priori low nephron num-
bers on onset, development and severity of diabetes associated kidney lesions. 
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5. Summary 
Mammalian nephrogenesis is a complex process that involves the precise timely and 
spatially coordinated interaction of a plethora of signaling molecules. During terminal 
nephron segmentation, POU3F3 (aka BRN1), a POU domain class 3 transcription 
factor, plays a critical role in the differentiation of the distal tubule, in particular the 
thick ascending limb of the loop of Henle (TAL). In knock-out mice, deficiency of 
POU3F3 leads to underdevelopment of the TAL, lack of differentiation of TAL and 
macula densa cells, and perinatal death due to renal failure.  
Pou3f3L423P mutant mice were established in the phenotype-driven Munich ENU 
Mouse Mutagenesis Project within a special screen for increased plasma urea levels 
to detect novel mouse models for kidney diseases. These mice carry a recessive 
point mutation in the highly conserved homeodomain of POU3F3. In contrast to 
Pou3f3 knock-out mice, homozygous Pou3f3L423P mutants are viable and fertile. 
The present study used functional, as well as qualitative and quantitative morpholog-
ical analyses to characterize the renal phenotype of juvenile (12 days) and aged (60 
weeks) homo- and heterozygous Pou3f3L423P mutant mice and age-matched wild-
type littermates of both sexes. In both age groups, homozygous mutants vs. control 
mice displayed significantly smaller kidney volumes, decreased nephron numbers 
and smaller mean glomerular volumes. Besides, the absolute TAL volumes and the 
volume densities of TAL in the kidney were significantly reduced in Pou3f3L423P mu-
tants. There were no histologically or ultrastructurally detectable lesions of TAL or 
glomerular cells. Aged homozygous mutants displayed increased serum urea con-
centrations and reduced specific urine gravity, but no evidence of glomerular dys-
function. These results confirm the important function of POU3F3 during nephron 
patterning, especially in development of the TAL. Furthermore they provide strong 
evidence that POU3F3 is also involved in the regulation of nephron induction, neph-
ron endowment, and nephron size in the murine kidney, while the mutation is not as-
sociated with a distinct pattern of morphological glomerular lesions.  
The detailed characterization of the renal morphology of Pou3f3L423P mutants provid-
ed the basis for further analyses of POU3F3 actions, and showed that Pou3f3L423P 
mutant mice represent a valuable research model for nephrological studies examin-
ing the role of congenital low nephron numbers in kidney disease development and 
progression. 
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6. Zusammenfassung 
Bei Säugetieren stellt die Nephrogenese einen hochkomplexen Prozess dar, der ein 
präzises, örtlich und zeitlich koordiniertes Zusammenspiel einer Vielzahl verschiede-
ner Signalmoleküle erfordert. Während der schlussendlichen Segmentierung des 
Nephrons spielt POU3F3 (aka BRN1), ein POU Domäne Klasse 3 Transkriptionsfak-
tor, eine kritische Rolle in der Ausdifferenzierung der distalen Tubulusabschnitte, ins-
besondere in der des dicken aufsteigenden Schenkels der Henle’schen Schleife 
(TAL). Homozygote Pou3f3 knock-out Mäuse versterben kurz nach der Geburt an 
Nierenversagen. Bei diesen Tieren bleibt die Entwicklung des TAL beinahe vollstän-
dig aus. Des Weiteren ist eine Abgrenzung der TAL- und der benachbarten Macula 
densa-Zellen aufgrund einer fehlenden Differenzierung nicht möglich. Die Mauslinie 
Pou3f3L423P stammt aus dem Phänotyp-basierten Münchner ENU-Mausmutagenese-
Projekt und wurde im Rahmen eines Screenings auf erhöhte Plasmaharnstoffwerte 
zur Identifikation neuer Mausmodelle für Nierenerkrankungen entdeckt. Pou3f3L423P 
mutante Mäuse besitzen eine rezessiv vererbte Punktmutation in der Homeodomäne, 
einer hochkonservierten DNA-Bindungsdomäne von POU3F3. Im Gegensatz zu 
Pou3f3 knock-out Mäusen sind homozygote Pou3f3L423P Mutanten lebensfähig und 
fruchtbar. In der hier vorliegenden Studie wurde anhand von funktionellen, sowie 
qualitativ und quantitativ morphologischen Untersuchungen der renale Phänotyp von 
juvenilen (12 Tage alten) sowie adulten (60 Wochen alten) homo- und heterozygoten 
Pou3f3L423P Mutanten beider Geschlechter im Vergleich zu nicht-mutanten Wurfge-
schwistern gleichen Alters und Geschlechts charakterisiert. In beiden Altersgruppen 
zeigten homozygote Pou3f3L423P mutante Mäuse gegenüber den Kontrolltieren ein 
signifikant geringeres Nierenvolumen, verminderte Nephronzahlen und kleinere mitt-
lere Glomerulusvolumina. Überdies waren das absolute TAL Volumen und die Volu-
menanteile von TAL in den Nieren von Pou3f3L423P Mutanten signifikant reduziert. Es 
konnten weder mittels Licht- noch Elektronenmikroskopie Veränderungen der TAL-
Zellen oder der Glomeruli festgestellt werden. Als Ausdruck einer eingeschränkten 
Nierenfunktion wiesen einzig adulte, homozygote Pou3f3L423P Mutanten erhöhte Ser-
umharnstoffwerte und eine reduziertes spezifisches Uringewicht auf. Anzeichen einer 
glomerulären Dysfunktion im Sinne einer Proteinurie fanden sich jedoch nicht. Die 
vorliegenden Ergebnisse belegen somit die zentrale Funktion von POU3F3 während 
der embryonalen Differenzierung des Nephrons, insbesondere im Rahmen der Ent-
wicklung des TAL. Überdies fanden sich überzeugende Indizien darauf, dass 
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POU3F3 auch an der Regulation von Induktion, Anzahl und Ausprägung der Ne-
phrone in der Mäuseniere beteiligt ist. 
Die detaillierte Charakterisierung der renalen Morphologie von Pou3f3L423P Mutanten 
schafft damit die Basis für weiterführende funktionelle Analysen von POU3F3 und 
zeigt, dass Pou3f3L423P mutante Mäuse ein vielversprechendes Modell für die ne-
phrologische Forschung darstellen, da sie es ermöglichen, die Auswirkungen einer a 
priori niedrigen Anzahl an Nephronen für die Entwicklung und den Verlauf von chro-
nischen Nierenerkrankungen zu untersuchen.  
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